Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.915564004352328,1.6523025048160789,0.0,0.1628830592696316,0.105,3/38,2.52%,Nfib;Nfia;Nfix
prerank,Transmission Across Chemical Synapses R-HSA-112315,0.6766283363652817,1.589391938908956,0.0,0.6338275567231316,0.49,50/236,2.61%,Grin2a;Ppfia2;Gria1;Cacna1e;Grin2b;Cacnb2;Gabrb3;Nbea;Lrrc7;Kcnj3;Gabra2;Kcnj6;Gabrb1;Gria2;Camk2a;Nsf;Camk2b;Rims1;Grik4;Adcy1;Cacna2d1;Gabrb2;Gabra4;Rasgrf1;Ppm1e;Gabrg2;Prkag2;Adcy2;Plcb1;Gria3;Rasgrf2;Gabbr2;Syn2;Gabra5;Arhgef9;Tspan7;Gng7;Epb41l1;Nrgn;Gnal;Ncald;Slc17a7;Nptn;Mapk1;Adcy9;Cacng8;Calm1;Camkk1;Gng2;Slc1a1
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,0.9560776793319244,1.5811080865068692,0.0,0.5358616587566141,0.566,3/21,2.52%,Nfib;Nfia;Nfix
prerank,Neuronal System R-HSA-112316,0.6397763758038517,1.5622228732015104,0.0,0.6636304353213794,0.727,87/373,3.33%,Grin2a;Lrrtm4;Ppfia2;Dlgap1;Gria1;Cacna1e;Kcnd2;Grm1;Grin2b;Cacnb2;Gabrb3;Dlgap2;Il1rap;Ntrk3;Nbea;Lrrc7;Kcnj3;Gabra2;Kcnj6;Gabrb1;Gria2;Camk2a;Nsf;Il1rapl1;Camk2b;Rims1;Grik4;Adcy1;Cacna2d1;Gabrb2;Kcnh1;Gabra4;Rasgrf1;Ppm1e;Kcnab1;Gabrg2;Grm5;Prkag2;Adcy2;Plcb1;Syt7;Gria3;Kcnd3;Rasgrf2;Kcnc3;Sipa1l1;Gabbr2;Syn2;Gabra5;Arhgef9;Tspan7;Kcng2;Gng7;Epb41l1;Kcnk10;Nrgn;Gnal;Ncald;Slc17a7;Lrfn2;Syt10;Nptn;Mapk1;Kcna4;Kcnc4;Adcy9;Cacng8;Nlgn1;Abcc8;Calm1;Kcnk1;Camkk1;Gng2;Slc1a1;Slitrk2;Kcna1;Rps6ka2;Grik5;Slitrk3;Kcnma1;Slitrk5;Kcng3;Syn3;Glra2;Kcng1;Kcnab2;Gabra1
prerank,EPH-Ephrin Signaling R-HSA-2682334,0.7448028332720027,1.516273731023192,0.01486988847583643,1.0,0.952,19/88,4.64%,Kalrn;Grin2b;Tiam1;Epha7;Epha4;Vav3;Epha6;Itsn1;Dnm1;Ptk2;Arpc2;Nck2;Actr3;Arhgef7;Fyn;Syngap1;Gprin1;Src;Efnb3
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,0.8661222654675476,1.5101209918957637,0.01056338028169014,1.0,0.96,11/32,4.63%,Kalrn;Grin2b;Tiam1;Itsn1;Ptk2;Arpc2;Actr3;Fyn;Syngap1;Gprin1;Src
prerank,ER To Golgi Anterograde Transport R-HSA-199977,0.7072739423449563,1.5032718175792332,0.007142857142857143,1.0,0.973,12/128,2.80%,Gria1;Ank3;Nsf;Cnih3;Sptb;Sptbn1;Sptbn4;Ank2;Dync1i2;Tgfa;Sptan1;Sec24d
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.6624200348395115,1.4967679931873568,0.003663003663003663,1.0,0.978,42/173,2.54%,Grin2a;Gria1;Grin2b;Gabrb3;Nbea;Lrrc7;Kcnj3;Gabra2;Kcnj6;Gabrb1;Gria2;Camk2a;Nsf;Camk2b;Grik4;Adcy1;Gabrb2;Gabra4;Rasgrf1;Ppm1e;Gabrg2;Prkag2;Adcy2;Plcb1;Gria3;Rasgrf2;Gabbr2;Gabra5;Arhgef9;Tspan7;Gng7;Epb41l1;Nrgn;Gnal;Ncald;Nptn;Mapk1;Adcy9;Cacng8;Calm1;Camkk1;Gng2
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,0.7280352344104314,1.487967457859383,0.0,1.0,0.984,18/86,1.78%,Grin2a;Lrrtm4;Ppfia2;Dlgap1;Gria1;Grm1;Grin2b;Dlgap2;Il1rap;Ntrk3;Il1rapl1;Grm5;Syt7;Gria3;Sipa1l1;Epb41l1;Lrfn2;Syt10
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,0.8729044004528848,1.4863686319690517,0.026936026936026935,1.0,0.985,2/27,0.63%,Sgip1;Nedd4l
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,0.6914178026672171,1.4813484452085586,0.0035587188612099642,1.0,0.992,19/125,8.41%,Sgip1;Nedd4l;Gtf2f2;Vps37b;Gtf2h2;Ccnh;Ssrp1;Nup93;Xpo1;Gtf2h5;Ndc1;Uba52;Nmt1;Ncbp1;Nup160;Ranbp2;Ranbp1;Vps4a;Polr2e
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.8133487206547646,1.4726506592172048,0.022222222222222223,1.0,0.996,8/37,6.86%,Nr3c2;Dync1i2;Fkbp5;Hspa2;Hsp90ab1;Dync1i1;Dynll1;Dnaja4
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.8538586326657276,1.4676891087059936,0.03383458646616541,1.0,0.997,1/27,0.31%,Ak5
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.8155044292064313,1.4607847484705265,0.07017543859649122,1.0,0.998,3/26,2.47%,Plxna4;Foxo1;Smad3
prerank,Initial Triggering Of Complement R-HSA-166663,-0.917153020566048,-1.4491896256119583,0.01971830985915493,1.0,0.966,4/15,3.56%,C1qa;C1qb;C1qc;Masp1
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,0.8178408736530989,1.4445908015557931,0.05860805860805861,1.0,1.0,12/29,2.46%,Ank3;Nrcam;Scn3a;Scn2a;Scn8a;Sptb;Scn3b;Sptbn1;Sptbn4;Ank2;Sptan1;Scn9a
prerank,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.8635129549213311,1.443885604114428,0.10902255639097744,1.0,1.0,7/20,3.15%,Ppfia2;Il1rap;Ntrk3;Il1rapl1;Slitrk2;Slitrk3;Slitrk5
prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.8187789282115335,-1.4437410691035937,0.008298755186721992,1.0,0.983,6/59,2.46%,Gab2;Pik3r1;Stat5b;Cux1;Fgf1;Fgfr3
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.8713459011759779,-1.4417829653972285,0.015781922525107604,1.0,0.984,4/25,3.35%,Elmo1;Dock2;Hck;Ap1m2
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.7878547551691294,-1.4417250860203668,0.004310344827586207,1.0,0.984,4/85,2.13%,Ldb2;Runx1;Tcf7l1;Spi1
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.8031988049336207,1.434718156317776,0.08934707903780069,1.0,1.0,1/31,0.58%,Sgip1
prerank,Signaling By NOTCH2 R-HSA-1980145,0.8158356979631436,1.4341888995727579,0.07526881720430108,1.0,1.0,4/28,2.01%,Maml2;Maml3;Cntn1;Notch2
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,-0.8572904619428602,-1.4333177785875684,0.012195121951219513,1.0,0.99,5/34,1.27%,Gab2;Pik3r1;Stat5b;Cux1;Fgf1
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.8017097398399098,1.4308043825628571,0.08191126279863481,1.0,1.0,1/33,0.58%,Sgip1
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,0.7247472049668506,1.4300008244026505,0.031746031746031744,1.0,1.0,8/76,2.34%,Ank3;Nsf;Sptb;Sptbn1;Sptbn4;Ank2;Dync1i2;Sptan1
prerank,Interleukin-7 Signaling R-HSA-1266695,-0.8770861090070878,-1.4289361150306343,0.01977401129943503,1.0,0.994,3/25,0.92%,Socs2;Pik3r1;Stat5b
prerank,Cardiac Conduction R-HSA-5576891,0.6841469353098285,1.4269937037572982,0.019455252918287938,1.0,1.0,25/120,2.46%,Cacna1c;Ryr2;Kcnip4;Kcnd2;Cacnb2;Fgf14;Camk2a;Camk2b;Scn3a;Kcnd3;Scn2a;Slc8a2;Atp2b1;Scn8a;Kcnk10;Orai2;Atp1b1;Scn3b;Kcnip2;Atp2b3;Ryr1;Cacng8;Calm1;Kcnk1;Scn9a
prerank,COPII-mediated Vesicle Transport R-HSA-204005,0.7433665334963355,1.424639626354747,0.041811846689895474,1.0,1.0,5/63,2.80%,Gria1;Nsf;Cnih3;Tgfa;Sec24d
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.8697664515871018,-1.423929907044096,0.01643835616438356,1.0,0.996,5/28,1.27%,Gab2;Pik3r1;Stat5b;Cux1;Fgf1
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.863212882745997,-1.4232918545634956,0.014084507042253521,1.0,0.997,7/28,5.84%,Gab2;Stat5b;Hck;Lyn;Csf3r;Jak2;Syk
prerank,GABA Receptor Activation R-HSA-977443,0.749447632260049,1.4231552050805323,0.030959752321981424,0.9966452092235398,1.0,18/57,2.54%,Gabrb3;Kcnj3;Gabra2;Kcnj6;Gabrb1;Adcy1;Gabrb2;Gabra4;Gabrg2;Adcy2;Gabbr2;Gabra5;Arhgef9;Gng7;Gnal;Nptn;Adcy9;Gng2
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.7167217357823331,1.4229124111226508,0.015015015015015015,0.9572330512150089,1.0,12/78,5.47%,Tnik;Map2k6;Tnrc6c;Mapk1;Mapk10;Jun;Ago1;Cbx6;Mapk3;Map2k4;Mink1;Tnrc6b
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.9010479577465167,-1.4227076584221028,0.01989389920424403,1.0,0.997,4/17,1.22%,Gab2;Pik3r1;Stat5b;Cux1
prerank,Signaling By SCF-KIT R-HSA-1433557,-0.8429976379289763,-1.4173810723124878,0.021216407355021217,1.0,0.997,11/40,5.81%,Kit;Gab2;Pik3r1;Ptpru;Stat5b;Tec;Vav1;Lyn;Fer;Jak2;Fes
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.8447954900303992,1.4139859799836914,0.08992805755395683,0.9983551221204725,1.0,5/21,1.67%,Grin2a;Gria1;Grin2b;Gria3;Lrfn2
prerank,PI-3K cascade:FGFR4 R-HSA-5654720,-0.874915771566266,-1.4103647253335367,0.034106412005457026,1.0,0.999,2/17,1.27%,Pik3r1;Fgf1
prerank,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.9056901798347518,-1.4091460685813804,0.029411764705882353,1.0,0.999,1/16,0.17%,Enpp2
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.8287674466051034,-1.408667644314513,0.015918958031837915,1.0,0.999,8/41,4.59%,Fa2h;Tbxas1;Pla2g4a;Ptgs1;Hpgd;Hpgds;Pon2;Ggt5
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.8193916111813588,-1.408056083019523,0.019858156028368795,1.0,0.999,11/45,10.00%,Runx1;Fli1;Csf3r;Spi1;Klf5;Rara;E2f1;Lef1;Tal1;Myc;Cdk2
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.8316064882804393,-1.4071996439864367,0.020028612303290415,0.993328386478819,0.999,13/42,7.72%,Gab2;Inpp5d;Pik3r1;Stat5b;Tec;Hck;Vav1;Lyn;Jak2;Syk;Blnk;Prkca;Inppl1
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.734071208076298,-1.4056613932971975,0.014245014245014245,0.9602308379938347,0.999,29/119,9.04%,Pcdh7;Prkcb;Phactr2;Fn1;Tgfb1;Sparc;Cyrib;Igf1;Selenop;Cd9;Sgpp2;Itih3;Prkcg;Sccpdh;Vcl;Pros1;Tmx3;Fermt3;Plek;Endod1;Cd109;Vegfa;Prkca;Calu;App;Clu;Vwf;Lamp2;Vegfd
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.8195821303552965,1.3990096592737338,0.1048951048951049,1.0,1.0,3/22,4.18%,Erc2;Jun;Cdk5r1
prerank,Complement Cascade R-HSA-166658,-0.8103339812684585,-1.3949376330649192,0.04341736694677871,1.0,1.0,13/40,13.26%,Cfh;C1qa;C1qb;C1qc;Cpne2;Masp1;Pros1;Cd81;Clu;Cr2;Cfi;Vtn;C3ar1
prerank,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.8808459986544276,-1.3889724115449524,0.031724137931034485,1.0,1.0,4/18,0.92%,Gab2;Pik3r1;Etv6;Stat5b
prerank,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.8833300777524256,-1.3879652939177543,0.0453920220082531,1.0,1.0,3/15,0.92%,Gab2;Pik3r1;Stat5b
prerank,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.8373477351429314,1.3868793907351045,0.16206896551724137,1.0,1.0,3/18,0.35%,Grin2a;Grin2b;Gria2
prerank,Signaling By KIT In Disease R-HSA-9669938,-0.8715674187082197,-1.386576939473883,0.038620689655172416,1.0,1.0,5/19,4.76%,Kit;Pik3r1;Stat5b;Lyn;Jak2
prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.8246346475113847,-1.3849893753812275,0.02564102564102564,1.0,1.0,7/33,7.40%,Dlc1;Sparc;Colec12;Masp1;Stab1;Apoe;Scarf1
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.8225909882888696,1.3843926944150693,0.12099644128113879,1.0,1.0,3/20,4.18%,Erc2;Jun;Cdk5r1
prerank,Other Interleukin Signaling R-HSA-449836,-0.8402572189704733,-1.3805211447614467,0.06367583212735166,1.0,1.0,4/20,2.47%,Csf1r;Il34;Csf3r;Stx1a
prerank,Muscle Contraction R-HSA-397014,0.6193690259377364,1.3793224941884634,0.021929824561403508,1.0,1.0,28/186,2.46%,Cacna1c;Ryr2;Kcnip4;Kcnd2;Cacnb2;Fgf14;Sorbs1;Camk2a;Camk2b;Scn3a;Kcnd3;Scn2a;Slc8a2;Atp2b1;Scn8a;Kcnk10;Orai2;Cald1;Atp1b1;Scn3b;Cacna1h;Kcnip2;Atp2b3;Ryr1;Cacng8;Calm1;Kcnk1;Scn9a
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.7371641501264768,-1.3769141144512371,0.02092050209205021,1.0,1.0,25/107,6.09%,Mertk;Mag;Inpp5d;Pik3r1;Selplg;Cd84;Itgam;Fn1;Tgfb1;Lyn;Jam3;Jam2;F11r;Angpt1;Selenop;Sirpa;Cd44;Itga6;Sdc4;Slc7a7;Pros1;Cxadr;Atp1b3;Fcer1g;L1cam
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.8100182299076841,-1.3759500869564738,0.038028169014084505,1.0,1.0,21/41,12.61%,Nrxn1;Itgb5;Lama4;Dmd;Tgfb1;Ntn4;Lama2;Lama1;Lamc2;Itga2;Itga6;Sdc4;Prkca;Itgb1;Ddr2;Ddr1;Cask;Pdgfb;Lamc3;Vtn;Itgb3
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.8712077687658071,-1.3758644899244015,0.04067321178120617,1.0,1.0,5/19,3.11%,Pik3r1;Etv6;Kank1;Pdgfra;Bin2
prerank,PKA Activation R-HSA-163615,0.8223846711023547,1.3747225178109888,0.1828358208955224,1.0,1.0,5/16,2.35%,Nbea;Adcy1;Adcy2;Adcy9;Calm1
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.8492369207610001,-1.3724841691504752,0.04551920341394026,1.0,1.0,6/23,5.84%,Stat5b;Hck;Lyn;Csf3r;Jak2;Syk
prerank,Regulation Of Complement Cascade R-HSA-977606,-0.8153683326559578,-1.3713631249951783,0.054929577464788736,1.0,1.0,12/33,13.26%,Cfh;C1qa;C1qb;C1qc;Cpne2;Pros1;Cd81;Clu;Cr2;Cfi;Vtn;C3ar1
prerank,Signaling By ALK R-HSA-201556,-0.8460183951999763,-1.3713325693280045,0.048678720445062586,1.0,1.0,3/26,0.83%,Alk;Ptn;Pik3r1
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.827501177675432,-1.3711211185328562,0.05329593267882188,1.0,1.0,4/28,3.34%,Pik3r1;Fgf1;Flrt2;Flrt1
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.7841674746579447,-1.3698490246825799,0.03314917127071823,0.9886597925309137,1.0,18/53,5.87%,Gpc6;Xylt1;Ext1;Hs6st2;Hs3st2;Gpc5;Hs3st5;Hs6st3;Bcan;Hs3st4;Ndst3;Cspg4;Vcan;Cspg5;Sdc4;Hpse;Hs3st1;Dcn
prerank,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.8331422374030292,-1.366737382571883,0.051175656984785614,1.0,1.0,2/23,1.27%,Pik3r1;Fgf1
prerank,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.861051902813765,-1.3644165011881357,0.08111888111888112,1.0,1.0,4/15,9.25%,Prkcb;Prkcg;Prkca;Ap2b1
prerank,PI-3K cascade:FGFR3 R-HSA-5654710,-0.8587476137283779,-1.3634587134180653,0.059722222222222225,0.9928561867297232,1.0,3/16,2.46%,Pik3r1;Fgf1;Fgfr3
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.8172348658624815,1.3611459306393057,0.18045112781954886,1.0,1.0,5/18,2.35%,Nbea;Adcy1;Adcy2;Adcy9;Calm1
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.793523662620513,1.3588010717291261,0.17293233082706766,1.0,1.0,8/21,0.79%,Grin2a;Gria1;Grin2b;Lrrc7;Gria2;Camk2a;Camk2b;Gria3
prerank,Platelet Degranulation R-HSA-114608,-0.7070934235227969,-1.353619075026378,0.04403409090909091,1.0,1.0,26/115,9.04%,Pcdh7;Phactr2;Fn1;Tgfb1;Sparc;Cyrib;Igf1;Selenop;Cd9;Sgpp2;Itih3;Sccpdh;Vcl;Pros1;Tmx3;Fermt3;Plek;Endod1;Cd109;Vegfa;Calu;App;Clu;Vwf;Lamp2;Vegfd
prerank,Zinc Transporters R-HSA-435354,0.8164237278555371,1.3524870838846508,0.15699658703071673,1.0,1.0,2/17,2.33%,Slc39a6;Slc30a3
prerank,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.8232834062400818,1.349463739571087,0.19636363636363635,1.0,1.0,2/15,1.98%,Foxo1;Bcl6
prerank,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.8249776799867544,-1.3483004214696412,0.06527777777777778,1.0,1.0,3/22,2.46%,Pik3r1;Fgf1;Fgfr3
prerank,Signaling By FGFR3 In Disease R-HSA-5655332,-0.8396928768503972,-1.3477587761722398,0.05655172413793103,1.0,1.0,3/19,2.46%,Pik3r1;Fgf1;Fgfr3
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7761364835523555,1.3464927066049928,0.1387900355871886,1.0,1.0,6/25,0.48%,Grin2a;Grin2b;Nbea;Lrrc7;Camk2a;Camk2b
prerank,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.8219794118711369,1.34647285627177,0.15862068965517243,1.0,1.0,1/18,0.58%,Cyp7b1
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.6834041940546088,1.3446290459204178,0.07801418439716312,1.0,1.0,18/72,2.40%,Grin2a;Gria1;Grin2b;Nbea;Lrrc7;Gria2;Camk2a;Camk2b;Adcy1;Rasgrf1;Ppm1e;Prkag2;Gria3;Rasgrf2;Nrgn;Mapk1;Calm1;Camkk1
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7402143402544997,1.3431508733705397,0.13688212927756654,1.0,1.0,12/32,2.46%,Cacna1c;Cacnb2;Fgf14;Camk2a;Camk2b;Scn3a;Scn2a;Scn8a;Scn3b;Cacng8;Calm1;Scn9a
prerank,FLT3 Signaling In Disease R-HSA-9682385,-0.8357379855587688,-1.342821747338151,0.047075606276747506,1.0,1.0,4/26,0.92%,Gab2;Pik3r1;Etv6;Stat5b
prerank,FGFR2 Alternative Splicing R-HSA-6803529,0.7682721555674955,1.339820129113502,0.1254355400696864,1.0,1.0,8/25,9.45%,Rbfox2;Gtf2f2;Hnrnpm;Tia1;Ncbp1;Polr2e;Polr2f;Hnrnph1
prerank,Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.8156915112918819,1.3392939778033561,0.1601423487544484,1.0,1.0,7/18,4.36%,Ppfia2;Rims1;Syn2;Syn3;Snap25;Syt1;Tspoap1
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.8292394935000812,-1.337516839985398,0.10190217391304347,1.0,1.0,1/21,0.18%,Asap1
prerank,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.8264547675689357,-1.3368393609931115,0.10743801652892562,1.0,1.0,5/20,11.12%,Tcf7l2;Pcsk1;Dpp4;Ucma;Ffar4
prerank,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.8247675330430102,-1.3366570130051094,0.07472826086956522,1.0,1.0,6/23,11.12%,Tcf7l2;Pcsk1;Dpp4;C1qtnf1;Ucma;Ffar4
prerank,Signaling By Erythropoietin R-HSA-9006335,-0.8268329717701197,-1.3348413875764624,0.07671232876712329,1.0,1.0,7/24,4.76%,Pik3r1;Stat5b;Vav1;Lyn;Pik3r5;Pik3cg;Jak2
prerank,PI-3K cascade:FGFR1 R-HSA-5654689,-0.8265164422343342,-1.3320300169362056,0.09712722298221614,1.0,1.0,2/19,1.27%,Pik3r1;Fgf1
prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.773026568322079,-1.3286620001186307,0.05923836389280677,1.0,1.0,21/54,12.21%,Lama4;Col27a1;Col6a2;Ctss;Col6a1;Lamc2;Itga6;Col6a5;Col11a2;Mmp28;Dst;Col11a1;Col6a3;Col9a1;Col8a1;Col9a3;Loxl2;Col24a1;Col8a2;Cd151;Col4a5
prerank,Cargo Concentration In ER R-HSA-5694530,0.7809099439584042,1.326807354832881,0.16967509025270758,1.0,1.0,4/29,2.80%,Gria1;Cnih3;Tgfa;Sec24d
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.7096207683953994,1.3262825535128895,0.08873720136518772,1.0,1.0,1/57,0.07%,Erc2
prerank,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.797533494271076,1.326239381179613,0.14925373134328357,1.0,1.0,4/21,2.46%,Grm1;Scn3a;Scn2a;Scn9a
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.7654158826869115,-1.3251030792382594,0.0691114245416079,1.0,1.0,5/47,2.83%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Post NMDA Receptor Activation Events R-HSA-438064,0.6839711467020313,1.3240166867467085,0.11228070175438597,1.0,1.0,15/59,2.40%,Grin2a;Gria1;Grin2b;Lrrc7;Gria2;Camk2a;Camk2b;Adcy1;Rasgrf1;Prkag2;Rasgrf2;Nrgn;Mapk1;Calm1;Camkk1
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.8107531352636429,-1.3234382647075287,0.11267605633802817,1.0,1.0,7/24,6.53%,St6gal1;Mgat4c;Chst8;Mgat5;Man2a1;St8sia6;Mgat4a
prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.8062267137264381,1.3214155830101475,0.14963503649635038,1.0,1.0,3/20,1.84%,Mmp16;Spock3;Mmp17
prerank,PI3K Cascade R-HSA-109704,-0.772266915799085,-1.321258394073974,0.08111888111888112,1.0,1.0,4/40,2.46%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,IGF1R Signaling Cascade R-HSA-2428924,-0.7592665784221702,-1.3159913329849549,0.08392603129445235,1.0,1.0,5/48,2.83%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.7582821704990251,-1.315702930082964,0.07637906647807638,1.0,1.0,5/49,2.83%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,IRS-mediated Signaling R-HSA-112399,-0.762685749155027,-1.3147035957830304,0.08567415730337079,1.0,1.0,4/43,2.46%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.8041629916343831,1.3143162926997685,0.20075757575757575,1.0,1.0,2/16,0.98%,Plxna4;Nrp1
prerank,Activation Of GABAB Receptors R-HSA-991365,0.722468175560444,1.312267030328183,0.11949685534591195,1.0,1.0,9/40,2.54%,Kcnj3;Kcnj6;Adcy1;Adcy2;Gabbr2;Gng7;Gnal;Adcy9;Gng2
prerank,PI-3K cascade:FGFR2 R-HSA-5654695,-0.809931973755504,-1.3122648941146915,0.1043360433604336,1.0,1.0,2/21,1.27%,Pik3r1;Fgf1
prerank,Regulation Of Signaling By CBL R-HSA-912631,-0.8256815539605905,-1.312024728323231,0.10818307905686546,1.0,1.0,6/18,6.61%,Pik3r1;Hck;Vav1;Lyn;Syk;Blnk
prerank,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.8071839432230598,-1.310842384414897,0.12022630834512023,1.0,1.0,10/23,13.26%,Entpd1;P2rx7;P2rx4;Casp1;Txnip;Il1a;Nlrp3;Entpd5;Il18;C3ar1
prerank,Signaling By Nuclear Receptors R-HSA-9006931,-0.6357971892155977,-1.3085335689182134,0.046052631578947366,1.0,1.0,38/229,8.59%,Erbb4;Runx1;Pik3r1;Tbl1x;Kcnh8;Rxrg;Abca1;Tle3;Bcl2;Gng4;Kat2b;Kank1;Arl4c;Ctsd;Aldh1a1;Rara;Apod;Gng12;Nrip1;Cyp26b1;Fosb;Gnb4;Gnai1;Esr1;Cav2;Apoe;Dhrs3;Kdm3a;Ccnd1;Gngt2;Egfr;Pmepa1;Gnai2;Ncoa3;Myc;Greb1;Foxo3;Mylip
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.8086717765252764,1.3085269781954314,0.2158273381294964,1.0,1.0,7/16,7.64%,Map2k1;Tnip2;Btrc;Fbxw11;Map2k4;Uba52;Cul1
prerank,Interleukin Receptor SHC Signaling R-HSA-912526,-0.8056068400927099,-1.3076284860877752,0.0970873786407767,1.0,1.0,4/25,4.76%,Gab2;Inpp5d;Pik3r1;Jak2
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.7710028452826968,1.307329330682238,0.20134228187919462,1.0,1.0,7/23,4.36%,Ppfia2;Rims1;Syn2;Syn3;Snap25;Syt1;Tspoap1
prerank,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.800661271591506,1.3039747555820198,0.20136518771331058,1.0,1.0,2/18,0.51%,Ppfia2;Rims1
prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.7434640315846336,-1.3012833646709558,0.08157524613220815,1.0,1.0,17/53,8.88%,Fnbp1l;Cpne8;Pik3r1;Dock8;Fmnl3;Arhgap26;Fnbp1;Prex1;Cdc42ep1;Wwp2;Ophn1;Syde1;Depdc1b;Rhoj;Slc1a5;Arhgap5;Gja1
prerank,Neurexins And Neuroligins R-HSA-6794361,0.6781121549035924,1.3011405765162039,0.09900990099009901,1.0,1.0,12/55,2.30%,Grin2a;Lrrtm4;Dlgap1;Grm1;Grin2b;Dlgap2;Grm5;Syt7;Sipa1l1;Epb41l1;Syt10;Nlgn1
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.695610659087161,1.298023732601332,0.10559006211180125,1.0,1.0,15/57,3.04%,Cacna1c;Cacnb2;Cacna1d;Gfra1;Ncam1;Sptb;Sptbn1;Cacna1h;Mapk1;Sptbn4;Gfra2;Ptk2;Sptan1;St8sia4;Ptpra
prerank,FOXO-mediated Transcription R-HSA-9614085,0.6810436656454523,1.2977894848144962,0.10580204778156997,1.0,1.0,7/61,4.17%,Plxna4;Foxo1;Akt3;Bcl6;Smad3;Btg1;Ywhaz
prerank,Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.791721473652034,-1.2966568129060585,0.1031636863823934,1.0,1.0,8/27,11.68%,Sall1;Sox2;Smad2;Epas1;Nr6a1;Hhex;Pbx1;Stat3
prerank,Regulation Of KIT Signaling R-HSA-1433559,-0.8206990975341854,-1.2932285498850484,0.14789687924016282,1.0,1.0,2/15,1.95%,Kit;Lyn
prerank,Assembly Of HIV Virion R-HSA-175474,0.7940134723700214,1.292714503495125,0.23272727272727273,1.0,1.0,2/17,4.32%,Sgip1;Vps37b
prerank,Sensory Perception Of Taste R-HSA-9717189,0.7704476346476165,1.2916396577431182,0.15636363636363637,1.0,1.0,6/26,4.22%,Grm1;Scn3a;Scn2a;Scn9a;Scnn1a;Kcnj2
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,-0.6760252428946285,-1.291304871200903,0.09140518417462483,1.0,1.0,15/103,8.50%,Erbb4;Runx1;Tle3;Bcl2;Kat2b;Kank1;Ctsd;Nrip1;Fosb;Esr1;Ccnd1;Pmepa1;Ncoa3;Myc;Greb1
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.7607638680763119,1.2910471633123697,0.2206896551724138,1.0,1.0,7/23,4.36%,Ppfia2;Rims1;Slc17a7;Slc1a1;Snap25;Syt1;Tspoap1
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.6435197134818116,-1.2908822757268685,0.07029177718832891,1.0,1.0,17/184,8.11%,Ldb2;Prkcq;Prkcb;Runx1;Tcf7l1;Kat2b;Spi1;Nfatc2;Nr4a3;Hipk2;Zfpm1;Ccnd3;Smarcd3;Esr1;Ccnd1;Tal1;Pcgf5
prerank,N-Glycan Antennae Elongation R-HSA-975577,-0.8077839780478085,-1.288746208043605,0.16496350364963502,1.0,1.0,5/15,6.53%,St6gal1;Mgat4c;Mgat5;St8sia6;Mgat4a
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.7390805433352782,-1.2885812509189336,0.10603829160530191,1.0,1.0,9/53,5.52%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Gsn;Clic5;Msn;Myo3a
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.8035472539944164,1.2868506190013005,0.23985239852398524,1.0,1.0,2/15,4.32%,Sgip1;Vps37b
prerank,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.8086929074161862,-1.2859057281301292,0.15918367346938775,1.0,1.0,6/18,7.60%,Itpr2;Prkcb;Prkcd;Vegfa;Prkca;Itpr3
prerank,Signaling By NOTCH4 R-HSA-9013694,0.6382583257450388,1.2854156559304641,0.12413793103448276,1.0,1.0,6/80,4.40%,Maml2;Maml3;Notch2;Smad3;Ywhaz;Jag1
prerank,Syndecan Interactions R-HSA-3000170,-0.7911017323830511,-1.2838239607345816,0.1596045197740113,1.0,1.0,10/20,12.61%,Itgb5;Tgfb1;Itga2;Itga6;Sdc4;Prkca;Itgb1;Cask;Vtn;Itgb3
prerank,Regulation Of Beta-Cell Development R-HSA-186712,0.7241537940480003,1.2835862931942372,0.17096774193548386,1.0,1.0,6/36,3.29%,Maml2;Maml3;Foxo1;Akt3;Onecut1;Neurod1
prerank,Metabolism Of Porphyrins R-HSA-189445,-0.7991828617379457,-1.2835574374973038,0.14246947082767977,1.0,1.0,1/22,0.71%,Slco2b1
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.7557856830836123,1.2829359815859047,0.2363013698630137,1.0,1.0,5/16,7.88%,Mapk1;Src;Mapk3;Uba52;Cbl
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.5982401988483326,-1.2828382431439624,0.0422360248447205,1.0,1.0,53/340,17.83%,Gatm;Folh1;Aspa;Slc6a7;Carns1;Slc25a13;Glul;Smox;Gadl1;Sqor;Nnmt;Qdpr;Bcat1;Bbox1;Asrgl1;Aass;Cdo1;Atat1;Soat1;Ass1;Dio2;Dhtkd1;Chdh;Heca;Ckb;Gpt2;Rpl3l;Serinc5;Bckdhb;Psmb8;Psmb11;Gls2;Serinc3;Haao;Tshb;Psme2;Hibadh;Psme4;Chga;Amdhd1;Psma8;Hnmt;Enoph1;Psmb9;Acadsb;Papss2;Pcbd1;Agxt2;Glud1;Tph1;Asl;Slc25a21;Aldh18a1
prerank,Interleukin-20 Family Signaling R-HSA-8854691,-0.798239056100969,-1.281507349104099,0.17207334273624825,1.0,1.0,4/18,11.68%,Stat5b;Jak2;Stat5a;Stat3
prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.7730670250032737,-1.2798367567224755,0.13172804532577903,1.0,1.0,6/32,7.93%,Tcf7l2;Ppp2r5a;Lrp5;Rnf43;Ppp2r5c;Dkk2
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.7739272477070566,-1.2783760090779206,0.13480055020632736,1.0,1.0,2/27,1.27%,Pik3r1;Fgf1
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.7424569627370228,-1.2782573735856355,0.11559888579387187,1.0,1.0,3/50,5.37%,Satb2;Satb1;Hdac4
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7324293820330227,1.2779480137815138,0.17472118959107807,1.0,1.0,14/26,4.95%,Grin2b;Lrrc7;Camk2a;Camk2b;Rasgrf1;Rasgrf2;Mapk1;Calm1;Rps6ka2;Camk2g;Actn2;Gprin1;Mapk3;Nefl
prerank,mRNA Capping R-HSA-72086,0.720846106893123,1.276985640934265,0.1951219512195122,1.0,1.0,9/28,10.80%,Gtf2f2;Gtf2h2;Ccnh;Gtf2h5;Ncbp1;Polr2e;Polr2f;Mnat1;Rngtt
prerank,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.7729122133186707,1.2752423975973275,0.24642857142857144,0.9968765471219032,1.0,2/17,0.51%,Ppfia2;Rims1
prerank,Stimuli-sensing Channels R-HSA-2672351,0.6347319867126296,1.2744710378085427,0.11071428571428571,0.9852470194023469,1.0,13/91,2.99%,Ryr2;Trpm3;Ano3;Trpc6;Nedd4l;Unc79;Unc80;Ryr1;Ano2;Best3;Calm1;Nalcn;Ano6
prerank,FLT3 Signaling R-HSA-9607240,-0.7475874265366722,-1.2742648773625882,0.1402002861230329,1.0,1.0,5/36,1.70%,Socs2;Gab2;Pik3r1;Stat5b;Hck
prerank,CRMPs In Sema3A Signaling R-HSA-399956,0.7758016377112493,1.2741141332277033,0.23863636363636365,0.9716691751970998,1.0,2/16,0.98%,Plxna4;Nrp1
prerank,FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.7914308175721577,-1.2729018903475502,0.15620641562064155,1.0,1.0,2/17,2.46%,Fgf1;Fgfr3
prerank,Formation Of Early Elongation Complex R-HSA-113418,0.6977962223585853,1.272787796900474,0.17832167832167833,0.9635459321902152,1.0,8/31,9.51%,Gtf2f2;Gtf2h2;Ccnh;Gtf2h5;Ncbp1;Polr2e;Polr2f;Mnat1
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.7623998839678873,-1.2718178320545543,0.13706293706293707,1.0,1.0,12/40,14.09%,Tbl1x;Hmgcs1;Srebf2;Elovl6;Hmgcr;Smarcd3;Fdft1;Sqle;Acaca;Dhcr7;Idi1;Tm7sf2
prerank,Laminin Interactions R-HSA-3000157,-0.7883339943866241,-1.271238835160741,0.1510204081632653,1.0,1.0,11/22,11.85%,Lama4;Lama2;Lama1;Lamc2;Itga2;Itga6;Itgb1;Nid2;Itga3;Lamc3;Itga1
prerank,Nicotinamide Salvaging R-HSA-197264,-0.8095466404771839,-1.270623380515694,0.13900709219858157,1.0,1.0,3/18,4.69%,Parp8;Parp4;Nnmt
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.7627794694988221,-1.2698280417858936,0.1565934065934066,1.0,1.0,10/30,7.60%,Itpr2;Pik3r1;Pik3ap1;Vav1;Dapp1;Lyn;Syk;Btk;Blnk;Itpr3
prerank,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.7576578901244395,1.2692129217894144,0.22181818181818183,0.9673978278966634,1.0,4/19,2.47%,Maml2;Maml3;Notch2;Smad3
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.7237288091299654,-1.268071655004302,0.1174785100286533,1.0,1.0,5/54,3.09%,Prkcq;Runx1;Kat2b;Nr4a3;Zfpm1
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.7384497803100936,1.2671543851264808,0.2564102564102564,0.963256114041795,1.0,6/19,0.90%,Grin2b;Lrrc7;Camk2a;Camk2b;Rasgrf1;Rasgrf2
prerank,Growth Hormone Receptor Signaling R-HSA-982772,-0.7854982172874112,-1.266989830116179,0.1916083916083916,1.0,1.0,5/21,5.03%,Socs2;Stat5b;Lyn;Jak2;Adam17
prerank,Downstream TCR Signaling R-HSA-202424,-0.6897880743450256,-1.2663999944090865,0.11318051575931232,1.0,1.0,3/83,0.83%,Prkcq;Inpp5d;Pik3r1
prerank,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.7757224652260538,1.2659363325188677,0.25555555555555554,0.954581625654539,1.0,3/15,2.67%,Maml2;Maml3;Onecut1
prerank,Acyl Chain Remodelling Of PG R-HSA-1482925,-0.7802339207938089,-1.2654806460564185,0.19688385269121814,1.0,1.0,2/17,6.22%,Pla2g4a;Lpgat1
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.7884072013079154,-1.2653356678344527,0.12670299727520437,1.0,1.0,3/23,2.94%,Pde5a;Rhobtb1;Myo6
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.7396604101106878,-1.2646503924357195,0.1434659090909091,1.0,1.0,11/41,8.12%,Tcf7l2;Sox6;Sox2;Tle3;Tcf7l1;Sox4;Lef1;Tle2;Ctnnbip1;Bcl9;Sox13
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.7407690123087112,-1.2641596607240544,0.128099173553719,1.0,1.0,2/40,1.27%,Pik3r1;Fgf1
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.7672461361404261,1.2641438841923094,0.1976284584980237,0.9493924070576197,1.0,7/22,4.63%,Grin2b;Tiam1;Ntf3;Dock3;Cdk5r1;Fyn;Src
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.6042401547033774,-1.2630372696667116,0.0754226267880364,1.0,1.0,60/263,13.53%,Rxfp1;Chrm3;Htr2c;Htr1f;Adra1a;Lpar1;Cx3cr1;Chrm2;Ccr5;Htr7;P2ry6;Tacr3;Ntsr1;Qrfpr;Drd2;P2ry13;P2ry12;Cckbr;S1pr1;Htr2a;Ednrb;Npsr1;Ptger3;Oprk1;Insl5;Lpar6;Npffr1;Adra1b;Hrh2;App;P2ry1;Chrm5;Adrb3;Ucma;Adrb2;Adora2b;Nlrp3;Gpr55;Pnoc;Chrm4;Hrh3;Gpr17;Lhcgr;Opn3;Hcrt;Ece1;Tac1;Ffar4;Gpr37l1;Adrb1;Tshb;Prok2;Cysltr1;Edn1;Htr5a;Adora2a;Cmklr1;C3ar1;Chga;Bdkrb2
prerank,Platelet Sensitization By LDL R-HSA-432142,-0.7951570753707098,-1.2630027330046205,0.1589041095890411,1.0,1.0,5/17,14.10%,Pla2g4a;Ppp2r5a;Ppp2r5c;Ptpn6;Ppp2r5e
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.6679439053036099,-1.2625288911783294,0.10330578512396695,1.0,1.0,23/114,14.08%,Satb2;Maf;Runx1;Itgbl1;Smurf1;Wwtr1;Smad1;Gli3;Hdac4;Esr1;Dlx5;Ccnd1;Ucma;Smad6;Ccnb1;Psmb8;Psmb11;Gli2;Psme2;Psme4;Sox9;Psma8;Abl1
prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.6916716341336053,-1.2618784561800296,0.13865546218487396,1.0,1.0,19/79,14.53%,Tcf7l2;Cpe;Stx1a;Ctsd;Pcsk1;Igf1;Ctsz;Kif5a;Dpp4;C1qtnf1;Ucma;Inhbb;Ffar4;Tshb;Chga;Ache;Gnb1;Aopep;Cpb1
prerank,FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.7780179130734863,-1.2616610630406349,0.17103448275862068,1.0,1.0,1/18,1.27%,Fgf1
prerank,RHOC GTPase Cycle R-HSA-9013106,-0.6925003107295126,-1.2612167552586704,0.12947658402203857,1.0,1.0,18/72,5.73%,Dlc1;Vav2;Pik3r1;Fmnl3;Arhgap26;Prex1;Mcf2;Anln;Arhgap18;Arhgef40;Tjp2;Akap13;Arhgef11;Ophn1;Iqgap1;Arhgef10;Mcam;Depdc1b
prerank,RHOB GTPase Cycle R-HSA-9013026,-0.6989977015102911,-1.2607540207202657,0.1369472182596291,1.0,1.0,18/68,8.41%,Pcdh7;Dlc1;Vav2;Pik3r1;Arhgap26;Prex1;Mcf2;Anln;Tjp2;Akap13;Arhgef11;Ophn1;Arhgef10;Mcam;Depdc1b;Rhpn2;Erbin;Arhgap5
prerank,Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.8069355481616116,-1.2601266507024254,0.17774762550881953,1.0,1.0,3/15,9.08%,Prkcb;Prkca;Ccnb1
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.6652585970687854,1.2584183275467515,0.1597222222222222,0.9620706681008491,1.0,6/48,1.97%,Tiam1;Epha7;Epha4;Vav3;Epha6;Dnm1
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.7665835195474281,-1.2578243771851723,0.14835948644793154,1.0,1.0,9/30,1.72%,Gpc6;Ext1;Hs6st2;Hs3st2;Gpc5;Hs3st5;Hs6st3;Hs3st4;Ndst3
prerank,TCR Signaling R-HSA-202403,-0.6657071194009592,-1.2572803547761537,0.12181303116147309,1.0,1.0,5/104,1.07%,Prkcq;Inpp5d;Lcp2;Pik3r1;Ptprc
prerank,Signaling By PDGF R-HSA-186797,-0.722748396952395,-1.256859028237043,0.1276595744680851,1.0,1.0,18/52,13.03%,Pik3r1;Stat5b;Col6a2;Pdgfra;Stat6;Col6a1;Col6a5;Col6a3;Col9a1;Col9a3;Stat5a;Pik3ca;Thbs4;Pdgfb;Stat3;Thbs2;Col4a5;Grb7
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.6438266850852259,-1.2567041625709519,0.1020979020979021,1.0,1.0,21/147,9.34%,Fa2h;Elovl7;Tbxas1;Pla2g4a;Ptgs1;Hpgd;Hpgds;Acadl;Pon2;Phyh;Ggt5;Elovl6;Prkab2;Hsd17b12;Prkaa2;Acsl3;Ltc4s;Crot;Ptgds;Acaca;Acot9
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.720282832561134,1.2566506616767235,0.21455938697318008,0.9565117494227521,1.0,6/21,0.69%,Grin2a;Grin2b;Lrrc7;Camk2a;Camk2b;Ppm1e
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.7221014840384293,1.2532062501871124,0.22336769759450173,0.9589469289480425,1.0,8/26,10.80%,Gtf2f2;Gtf2h2;Ccnh;Gtf2h5;Polr2e;Polr2f;Mnat1;Rngtt
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.7704000693639285,-1.2531962686702958,0.16044260027662519,1.0,1.0,10/27,8.27%,Sox10;Mag;Utrn;Lama2;Wwtr1;Srebf2;Hmgcr;Pou3f2;Adgrg6;Egr2
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.6353931791871446,1.2483469242684018,0.12871287128712872,0.9685895669024331,1.0,10/73,1.57%,Kalrn;Tiam1;Vav3;Plekhg5;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,Neutrophil Degranulation R-HSA-6798695,-0.5737095627718334,-1.2474004445525175,0.056555269922879174,1.0,1.0,96/395,14.40%,Dock2;Dlc1;Rab31;Lair1;Arhgap45;Ptprc;Nckap1l;Itgam;Ostf1;Gsn;Padi2;Tmem63a;Cd33;Ctss;Cst3;Ctsd;Tspan14;Bin2;Prkcd;Ctsz;Nfam1;Sirpa;Aifm2;Frmpd3;Tnfrsf1b;Cd53;Cd44;Sting1;Ctsc;Ctsh;Irag2;Tom1;Ampd3;Vcl;Tarm1;Rhog;Tyrobp;Hpse;Ptprn2;Iqgap1;Slc2a5;Adam10;Abca13;Timp2;Fcer1g;Manba;Rap1b;Tmbim1;Mmp28;Tnfaip6;Pgm2;Cda;Cd93;Cyba;Ceacam1;Lamp2;Gca;Tbc1d10c;Adgrg3;Asah1;Npc2;Itgb2;Lamp1;Cd68;Plau;Crispld2;Rcan1;Nfasc;Dync1h1;Syngr1;Stk11ip;Ptprb;Qpct;Trpm2;Gmfg;Plekho2;Cd300a;Dnajc13;Arhgap9;Jup;Hook3;Gusb;Krt1;Svip;C3ar1;Golga7;Stom;Idh1;Fuca1;Ptpn6;Tlr2;B2m;Slc15a4;Magt1;Rab37;Glyat
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.7682396514073334,-1.2464793051927299,0.19742489270386265,1.0,1.0,10/25,14.09%,Hmgcs1;Srebf2;Hmgcr;Msmo1;Fdft1;Sqle;Dhcr7;Idi1;Dhcr24;Tm7sf2
prerank,TRP Channels R-HSA-3295583,0.72673202808449,1.2435439928421541,0.23208191126279865,0.9783370301986393,1.0,2/24,0.24%,Trpm3;Trpc6
prerank,Purine Catabolism R-HSA-74259,0.7567625712377157,1.24351078184316,0.28214285714285714,0.9656350091731392,1.0,2/15,2.39%,Gda;Nt5c2
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.7467803713658774,-1.2414110417950797,0.15151515151515152,1.0,1.0,8/34,8.47%,Kit;Esr1;Apoe;Egfr;Wwox;Vegfa;Kctd1;Myc
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.7434770868962776,1.2408975553242985,0.2517985611510791,0.9649127437328034,1.0,5/27,2.54%,Cacna1c;Cacnb2;Cacna1d;Gng7;Gng2
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.6651511260053432,1.2388334235300744,0.16906474820143885,0.9610614991892951,1.0,11/41,10.60%,Gtf2f2;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Ncbp1;Polr2e;Polr2f;Mnat1;Ccnk;Ccnt2
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.6844713612029745,-1.2377462581134713,0.1354309165526676,1.0,1.0,12/72,2.58%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Vav1;Cd86;Pdgfra;Fgfr3;Erbb3
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.7123925344595536,-1.2374057287842912,0.16766467065868262,1.0,1.0,2/46,2.01%,Myo1e;Kat2b
prerank,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.7820294829799614,-1.2357974798644205,0.22344827586206897,1.0,1.0,4/16,6.75%,Tnfrsf11a;Birc3;Traf3;Ltbr
prerank,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.7809791625362629,-1.2350012818004836,0.17397260273972603,1.0,1.0,7/22,7.99%,Trim25;S100b;Map3k1;Ifih1;Rigi;Rnf135;App
prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.7641234948489324,-1.2349979135488856,0.19525801952580196,1.0,1.0,9/26,5.87%,Gpc6;Xylt1;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Sdc4;Dcn
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.7688185302998017,-1.23489260397949,0.18873239436619718,1.0,1.0,2/22,4.31%,Tubb4a;Tubb3
prerank,SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.7780145475818627,-1.2330595443778014,0.20055710306406685,1.0,1.0,2/15,2.46%,Fgf1;Fgfr3
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.7637651313342466,-1.2323644712689656,0.18972895863052783,1.0,1.0,4/24,6.84%,Elovl7;Elovl6;Hsd17b12;Acsl3
prerank,Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.7803322315967564,-1.2295013191910824,0.21379310344827587,1.0,1.0,4/15,11.06%,Pik3r1;Egfr;Erbin;Pik3ca
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.7149420506293824,1.2283145606582286,0.2568493150684932,0.9962281699724606,1.0,6/27,3.73%,Map2k6;Pdzd2;Akt3;Chd4;Chd3;Gatad2b
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.6609377300290772,1.2281943682395529,0.18248175182481752,0.9842326887569859,1.0,9/39,9.51%,Gtf2f2;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Ncbp1;Polr2e;Polr2f;Mnat1
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.6441911900587064,1.2273594936514685,0.19292604501607716,0.9757246062528656,1.0,10/56,1.57%,Kalrn;Tiam1;Vav3;Plekhg5;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,Collagen Formation R-HSA-1474290,-0.6705366480975421,-1.2263869773004545,0.17367706919945725,1.0,1.0,23/86,7.97%,Col26a1;Adamts2;Lama4;Col27a1;Col16a1;Col6a2;Ctss;P4ha3;P3h2;Col6a1;Lamc2;Itga6;Col6a5;Plod1;Col11a2;Mmp28;Dst;Col11a1;Col6a3;Col9a1;Col8a1;Col12a1;Col9a3
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.6598043776821249,-1.2261038997409568,0.11814345991561181,1.0,1.0,15/113,12.40%,Enpp2;Parp8;Parp4;Tcn2;Nnmt;Aldh1l1;Cyb5a;Acaca;Aox1;Parp14;Mthfd1l;Tpk1;Enpp1;Ldlrap1;Sp8
prerank,Chemokine Receptors Bind Chemokines R-HSA-380108,-0.7293006739943021,-1.2255460538138676,0.2019099590723056,1.0,1.0,2/35,1.41%,Cx3cr1;Ccr5
prerank,Long-term Potentiation R-HSA-9620244,0.7176368313378927,1.2253481318939112,0.26811594202898553,0.972922564700684,1.0,8/23,1.49%,Grin2a;Gria1;Grin2b;Lrrc7;Gria2;Camk2a;Camk2b;Nrgn
prerank,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.7770674858855423,-1.2253390111038054,0.22052704576976423,1.0,1.0,4/22,4.81%,Satb2;Maf;Wwtr1;Gli3
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,0.704561937250484,1.2230933559977766,0.22661870503597123,0.9718945174370265,1.0,9/33,4.53%,Kcnj3;Kcnj6;Gabbr2;Gng7;Abcc8;Gng2;Kcnj2;Kcnj4;Kcnj9
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.7542070777693558,-1.2228948208931099,0.21798365122615804,1.0,1.0,1/19,1.27%,Fgf1
prerank,Meiotic Synapsis R-HSA-1221632,0.6795855509486525,1.2228023024634103,0.20284697508896798,0.9616170673030113,1.0,1/46,0.45%,Syne1
prerank,Ion Channel Transport R-HSA-983712,0.5524937623066883,1.2210371366298032,0.1297709923664122,0.9579690104768409,1.0,18/162,2.52%,Ryr2;Trpm3;Ano3;Trpc6;Camk2a;Camk2b;Nedd4l;Unc79;Unc80;Atp2b1;Atp1b1;Atp2b3;Ryr1;Atp6v1a;Ano2;Best3;Calm1;Nalcn
prerank,NCAM1 Interactions R-HSA-419037,0.6987786604567123,1.2190082240919737,0.24915824915824916,0.9556684515556949,1.0,8/37,2.36%,Cacna1c;Cacnb2;Cacna1d;Gfra1;Ncam1;Cacna1h;Gfra2;St8sia4
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6844869002170052,-1.2171171868091342,0.19796215429403202,1.0,1.0,9/64,14.69%,Gpc5;Adam17;Psmb8;Shh;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,-0.7589986640374055,-1.2165632580630543,0.19630156472261737,1.0,1.0,6/28,5.37%,Satb2;Maf;Wwtr1;Smad1;Gli3;Hdac4
prerank,ESR-mediated Signaling R-HSA-8939211,-0.6071997934919772,-1.215919306930033,0.13557046979865772,1.0,1.0,26/168,8.50%,Erbb4;Runx1;Pik3r1;Kcnh8;Tle3;Bcl2;Gng4;Kat2b;Kank1;Ctsd;Gng12;Nrip1;Fosb;Gnb4;Gnai1;Esr1;Cav2;Ccnd1;Gngt2;Egfr;Pmepa1;Gnai2;Ncoa3;Myc;Greb1;Foxo3
prerank,Inflammasomes R-HSA-622312,-0.7737756490786282,-1.2154949147574756,0.2247191011235955,1.0,1.0,6/19,8.97%,Bcl2;P2rx7;Casp1;Txnip;App;Nlrp3
prerank,Interleukin-1 Signaling R-HSA-9020702,0.5853925573510187,1.2150188626102947,0.17391304347826086,0.9606790196519975,1.0,9/109,3.30%,Il1rap;Map2k6;Il1r1;Map2k1;Tnip2;Btrc;Peli1;Fbxw11;Ripk2
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.7222317360586429,-1.214572373997627,0.2057142857142857,1.0,1.0,10/39,5.87%,Gpc6;Ext1;Gpc5;Bcan;Cspg4;Vcan;Chst3;Cspg5;Sdc4;Dcn
prerank,LDL Clearance R-HSA-8964038,-0.763744049380678,-1.2142477594298262,0.24355300859598855,1.0,1.0,7/16,17.82%,Soat1;Ap2b1;Npc2;Ldlrap1;Pcsk9;Cltc;Ldlr
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.6595447224338581,1.214226545553291,0.19798657718120805,0.9529410074924889,1.0,7/47,2.36%,Maml2;Nbea;Maml3;Tle1;Hdac7;Ncor1;Tle4
prerank,Biological Oxidations R-HSA-211859,-0.6225406123031111,-1.2135888481571426,0.14985994397759103,1.0,1.0,17/141,7.56%,Acss1;Ugp2;Tbxas1;Ptgs1;Arnt2;Aldh1a1;Hpgds;Smox;Ggt5;Cyp26b1;Nnmt;Slc38a3;Fmo1;Cyp27a1;Gsta3;Maob;As3mt
prerank,SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.7585491129948709,-1.2125046182621984,0.23763736263736263,1.0,1.0,1/16,1.27%,Fgf1
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,-0.6225001507510337,-1.2110693249339182,0.1592442645074224,1.0,1.0,34/153,17.30%,Rxfp1;Cx3cr1;Ccr5;Tacr3;Ntsr1;Qrfpr;Cckbr;Ednrb;Npsr1;Oprk1;Insl5;Npffr1;App;Ucma;Nlrp3;Pnoc;Hcrt;Ece1;Tac1;Gpr37l1;Prok2;Edn1;C3ar1;Bdkrb2;Tacr2;Ntsr2;Npy;Cxcr4;Ccl17;Cxcl16;Npffr2;Cxcr2;Ccr2;Cd200r1
prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.7232808505227903,1.2108466944417966,0.27702702702702703,0.9563710255797274,1.0,5/17,1.26%,Gria1;Gria2;Nsf;Gria3;Tspan7
prerank,Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.6465962336844217,-1.2100330581015597,0.1949509116409537,1.0,1.0,14/95,14.88%,Ldb2;Or51e1;Or51d1;Or52i2;Or2t6;Or52k2;Or1n2;Or4k15;Reep1;Ebf1;Or51e2;Or52m1;Or2t1;Or52e5
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,-0.6962827855154035,-1.2096880199860243,0.19322990126939352,1.0,1.0,4/48,2.46%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.6431000295184599,-1.2089761294988415,0.1908713692946058,1.0,1.0,12/108,8.26%,Tbl1x;Hmgcs1;Abca1;Cdk19;Arnt2;Npas2;Srebf2;Fhl2;Hmgcr;Smarcd3;Fdft1;Ncoa3
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,0.6109439811238523,1.2076301607935487,0.17627118644067796,0.9586756547995225,1.0,10/79,5.47%,Prkag2;Tnrc6c;Akt3;Rragd;Ago2;Ago1;Ywhaz;Txnrd1;Ywhab;Tnrc6b
prerank,MET Promotes Cell Motility R-HSA-8875878,-0.7349651224707046,-1.2058666667004159,0.21016483516483517,1.0,1.0,9/28,9.07%,Lama4;Lama2;Tns3;Lama1;Lamc2;Itga2;Rap1b;Itgb1;Itga3
prerank,Basigin Interactions R-HSA-210991,-0.7392265232928006,-1.2048222478477761,0.21389645776566757,1.0,1.0,10/24,11.27%,Mag;Itga6;Slc7a7;Atp1b3;L1cam;Itgb1;Itga3;Slc16a1;Slc7a10;Cav1
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.7444850507436259,-1.2046612601707969,0.25655172413793104,1.0,1.0,3/20,8.90%,Stx1a;App;Cyb5a
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.6396024197468757,-1.2040131187515746,0.2,1.0,1.0,12/110,8.26%,Tbl1x;Hmgcs1;Abca1;Cdk19;Arnt2;Npas2;Srebf2;Fhl2;Hmgcr;Smarcd3;Fdft1;Ncoa3
prerank,Surfactant Metabolism R-HSA-5683826,-0.7516717701440027,-1.2036519148823828,0.24466571834992887,1.0,1.0,11/22,18.31%,Zdhhc2;Ctsh;Lmcd1;Adgrf5;Adora2b;Csf2rb;Abca3;Adora2a;Slc34a1;Adra2a;Gata6
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.6963868612206731,-1.2031579570786939,0.19482288828337874,1.0,1.0,3/50,6.00%,Asap1;Smox;Bbs9
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.6539022243175046,-1.2029040336549766,0.16666666666666666,1.0,1.0,21/93,14.69%,Itgb5;Ctss;Ncf2;Mrc1;Btk;Cyba;Ncf1;Tapbp;Ncf4;Tlr1;Psmb8;Psmb11;Tirap;Psme2;Psme4;Psma8;Tlr2;B2m;S100a1;Ctsl;Psmb9
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.7031662855482067,1.2027043409992657,0.25517241379310346,0.968634087136175,1.0,8/27,4.53%,Kcnj3;Kcnj6;Gabbr2;Gng7;Gng2;Kcnj2;Kcnj4;Kcnj9
prerank,NLRP3 Inflammasome R-HSA-844456,-0.774813296765413,-1.2019701641082023,0.24862637362637363,1.0,1.0,5/15,8.97%,P2rx7;Casp1;Txnip;App;Nlrp3
prerank,RND2 GTPase Cycle R-HSA-9696270,-0.7084548060039007,-1.201474760519813,0.21237693389592124,1.0,1.0,8/41,9.24%,Pik3r1;Prag1;Fnbp1;Depdc1b;Dst;Plxnd1;Arhgap5;Ptpn13
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.7069956925125711,-1.2012046997758807,0.22816901408450704,1.0,1.0,13/40,7.60%,Kcnc2;Itpr2;Kcns3;Gng4;Rapgef3;Gng12;Prkar1b;Gnb4;Iqgap1;Gngt2;Gnas;Prkca;Itpr3
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.6786369467649707,-1.1988991095881016,0.22931785195936139,1.0,1.0,12/51,8.45%,Khdrbs3;Dock1;Erbb4;Elmo1;Nrg1;Erbb3;Arap1;Epas1;Ccnd1;Egfr;Lrrk2;Khdrbs2
prerank,Neurotransmitter Release Cycle R-HSA-112310,0.6355557529555148,1.1988465970334243,0.21779141104294478,0.9737574195467107,1.0,8/50,3.64%,Ppfia2;Rims1;Syn2;Slc17a7;Slc1a1;Syn3;Snap25;Syt1
prerank,Amine Ligand-Binding Receptors R-HSA-375280,-0.7044394562468346,-1.1982300087667106,0.2376237623762376,1.0,1.0,15/34,10.19%,Chrm3;Htr2c;Htr1f;Adra1a;Chrm2;Htr7;Drd2;Htr2a;Adra1b;Hrh2;Chrm5;Adrb3;Adrb2;Chrm4;Hrh3
prerank,Cellular Senescence R-HSA-2559583,0.5533025698898437,1.1963431093103862,0.12582781456953643,0.9734020567868891,1.0,16/138,5.55%,Tnik;Map2k6;Tnrc6c;Mapk1;Mapk10;Jun;Rps6ka2;Rad50;Ago1;Cbx6;Mapk3;Map2k4;Mink1;Hira;Tnrc6b;Ehmt1
prerank,Downstream Signal Transduction R-HSA-186763,-0.7290702002949341,-1.1934986410649755,0.2375533428165007,1.0,1.0,4/28,3.00%,Pik3r1;Stat5b;Pdgfra;Stat6
prerank,Signaling By FGFR1 R-HSA-5654736,-0.6837987227938291,-1.1925499959522712,0.22002820874471085,1.0,1.0,4/46,3.34%,Pik3r1;Fgf1;Flrt2;Flrt1
prerank,MET Activates PTK2 Signaling R-HSA-8874081,-0.7462331814367129,-1.1920117631478344,0.28435374149659864,1.0,1.0,7/17,9.07%,Lama4;Lama2;Lama1;Lamc2;Itga2;Itgb1;Itga3
prerank,Signaling By FGFR3 R-HSA-5654741,-0.6970334646559346,-1.1914435256765066,0.2496551724137931,1.0,1.0,3/37,2.46%,Pik3r1;Fgf1;Fgfr3
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.7011815051648888,-1.1895917536478913,0.23741007194244604,1.0,1.0,11/35,12.61%,Apbb1ip;Fn1;Rasgrp1;Rapgef3;Syk;Rap1b;Vwf;Ptpn1;Rasgrp2;Gp5;Itgb3
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.6253394494822303,1.1894727280397723,0.2229965156794425,0.9914118738585439,1.0,19/59,15.20%,Utp4;Rcl1;Wdr75;Dkc1;Sppl2a;Nop58;Heatr1;Rps7;Nop56;Rps14;Rps9;Mphosph10;Wdr36;Utp15;Emg1;Wdr43;Nat10;Utp20;Gar1
prerank,Signaling By Hippo R-HSA-2028269,-0.7371839916486508,-1.1887271752393456,0.252112676056338,1.0,1.0,6/20,10.87%,Lats2;Wwtr1;Tjp2;Amotl2;Sav1;Amot
prerank,Interleukin-2 Family Signaling R-HSA-451927,-0.6970885526760726,-1.1871373269260135,0.24089635854341737,1.0,1.0,10/40,5.84%,Gab2;Inpp5d;Pik3r1;Stat5b;Havcr2;Il21r;Il15;Lgals9;Jak2;Syk
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7414298103738892,-1.1871149995707493,0.2673130193905817,1.0,1.0,2/20,4.31%,Tubb4a;Tubb3
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.716601773115392,-1.1868690193077542,0.2565217391304348,1.0,1.0,5/33,9.14%,Elovl7;Elovl6;Hsd17b12;Acsl3;Acaca
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.6869131905467155,-1.1866794731572854,0.23066298342541436,1.0,1.0,5/49,9.08%,Prkcb;Vrk2;Prkca;Nek7;Ccnb1
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.6429944909357688,-1.1850244279967228,0.21540656205420827,1.0,1.0,11/87,14.69%,Enpp2;Prkcd;Mapk11;Zfp36l1;Prkca;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.7441046604026191,-1.1849520508401774,0.2755244755244755,1.0,1.0,3/19,9.08%,Vrk2;Sirt2;Ccnb1
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.6021112329980312,-1.1849364121185257,0.16643356643356644,1.0,1.0,12/171,5.98%,Enpp2;Gpc6;Gpc5;Akr1b10;Parp8;Parp4;Tcn2;Bco2;Prkg2;Nnmt;Sdc4;Apoe
prerank,"Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.7431521996519128,-1.1806311524063506,0.29036827195467424,1.0,1.0,2/17,2.83%,Pcsk1;Igf1
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.5425008875842373,-1.1802014579753333,0.12254901960784313,1.0,1.0,62/409,8.50%,Camk2d;Kit;Tcf7l2;Erbb4;Apbb1ip;Alk;Gab2;Rrbp1;Dusp10;Qki;Pik3r1;Etv6;Stat5b;Nrg1;Cux1;Fgf1;Tbl1x;Pik3ap1;Hip1;Nr4a1;Vav1;Fn1;Tgfb1;Lyn;Kat2b;Cd86;Kank1;Pdgfra;Fgfr3;Tgfbr2;Erbb3;Nf1;Smad2;Bin2;Dusp16;Ppp2r5a;Dusp6;Jak2;Vcl;Msn;Notch1;Rhog;Adam17;Iqgap1;Adam10;Hdac4;Esr1;Lrp5;Rap1b;Rnf43;Prr5;Hes5;Egfr;Spred3;Cd80;Zc3hav1;Ppp2r5c;Dkk2;Jag2;Erbin;Myc;Foxo3
prerank,Signaling By Interleukins R-HSA-449147,-0.5418729220193217,-1.1801412810517633,0.14698492462311558,1.0,1.0,61/407,8.50%,Socs2;Gab2;Inpp5d;Csf1r;Pik3r1;Stat5b;Tec;Il34;Il10ra;Kcnh8;Ccr5;Hck;Itgam;Sox2;Vav1;Fn1;Bcl2;Tgfb1;Lyn;Cd86;Csf3r;Ptpn14;Stx1a;Havcr2;Stat6;Il21r;Il15;Irak2;Casp8;Tnfrsf1b;Il1rl2;S1pr1;Il17ra;Dusp6;Lgals9;Rps6ka5;Alpk1;Jak2;Msn;Casp1;Mapk11;Il17re;Irak3;Ptpn9;Syk;Rap1b;Ccnd1;Blnk;S100b;Mef2a;Vegfa;Prkca;Cd80;Inppl1;Rps6ka1;Itgb1;App;Cish;Il6st;Myc;Foxo3
prerank,Integrin Signaling R-HSA-354192,-0.7120661806132075,-1.1785132412464336,0.2794326241134752,1.0,1.0,10/26,12.61%,Apbb1ip;Fn1;Rasgrp1;Rapgef3;Syk;Rap1b;Vwf;Ptpn1;Rasgrp2;Itgb3
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,-0.6963173750238759,-1.1765869109987963,0.2514367816091954,1.0,1.0,4/37,6.59%,Tcf7l2;Csf1r;Lef1;Ccnd1
prerank,Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.7417161043739363,-1.1764909151004919,0.2979310344827586,1.0,1.0,3/16,11.47%,Fgf1;Fgfr2;Fgf23
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.5704920579317755,-1.1757326309536846,0.16339869281045752,1.0,1.0,33/263,7.21%,Gpc6;Xylt1;Ext1;Hs6st2;Hs3st2;Gpc5;Hs3st5;Hs6st3;Ugp2;Pfkp;St3gal6;Bcan;Hs3st4;Ndst3;Cspg4;Aldh1a1;Vcan;Slc25a13;Chst3;Phkb;Cd44;Gbe1;Cspg5;Sdc4;Hpse;Pfkfb4;Hs3st1;Has2;Dcn;Manba;Pck2;Pfkfb3;Prkca
prerank,Interleukin-10 Signaling R-HSA-6783783,-0.7028974880302669,-1.175642243214881,0.26666666666666666,1.0,1.0,9/35,13.22%,Il10ra;Ccr5;Cd86;Tnfrsf1b;Cd80;Il1a;Stat3;Il18;Il12a
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.6512841224283543,-1.1754718373057538,0.22913719943422914,1.0,1.0,11/76,14.69%,Prkcq;Lyn;Rasgrp1;Bcl10;Psmb8;Psmb11;Rasgrp2;Psme2;Psme4;Psma8;Psmb9
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,0.573915661374321,1.1707674855428192,0.21359223300970873,1.0,1.0,7/87,3.96%,Kalrn;Foxo1;Tnrc6c;Jun;Ago2;Arhgef7;Ago1
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.574727612298278,1.1707542039807486,0.21035598705501618,1.0,1.0,11/76,1.57%,Kalrn;Tiam1;Vav3;Plekhg5;Rasgrf2;Abr;Itsn1;Arhgef9;Gng7;Fgd4;Arhgef4
prerank,Striated Muscle Contraction R-HSA-390522,-0.7161168031390853,-1.1702819962473503,0.2934472934472934,1.0,1.0,8/32,11.21%,Dmd;Tnni1;Myh6;Tnnt2;Tcap;Tmod3;Actn3;Neb
prerank,Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.7455585467233584,-1.169878296909642,0.2857142857142857,1.0,1.0,3/15,11.47%,Fgf1;Fgfr2;Fgf23
prerank,Signaling By FGFR R-HSA-190236,-0.636942253157155,-1.1688964122270673,0.2387005649717514,1.0,1.0,5/80,3.34%,Pik3r1;Fgf1;Flrt2;Fgfr3;Flrt1
prerank,RA Biosynthesis Pathway R-HSA-5365859,-0.7344708984691339,-1.1686241839850653,0.29680998613037446,1.0,1.0,4/17,9.61%,Aldh1a1;Cyp26b1;Dhrs3;Rdh16
prerank,Synthesis Of PC R-HSA-1483191,0.6886642236297078,1.1684680665057925,0.27906976744186046,1.0,1.0,1/27,0.47%,Slc44a5
prerank,Signaling By FGFR4 R-HSA-5654743,-0.6822910461695118,-1.167651749058561,0.2802197802197802,1.0,1.0,2/37,1.27%,Pik3r1;Fgf1
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.6263310578863334,-1.1672720218624655,0.22109826589595374,1.0,1.0,13/99,2.58%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Nr4a1;Vav1;Cd86;Pdgfra;Fgfr3;Erbb3
prerank,Insulin Processing R-HSA-264876,-0.7217949056394273,-1.1656536788855472,0.2642857142857143,1.0,1.0,4/26,4.37%,Cpe;Stx1a;Pcsk1;Kif5a
prerank,Phototransduction Cascade R-HSA-2514856,-0.7108865242128092,-1.1652895634628617,0.28451882845188287,1.0,1.0,5/28,8.09%,Prkcq;Camkmt;Prkca;Gucy2f;Slc24a1
prerank,FGFR2 Ligand Binding And Activation R-HSA-190241,-0.7395480498678819,-1.164238881912143,0.3106796116504854,1.0,1.0,3/17,11.47%,Fgf1;Fgfr2;Fgf23
prerank,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.7320955038482218,-1.162944731719217,0.2937062937062937,1.0,1.0,8/20,5.87%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Sdc4;Dcn
prerank,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.7314738632024824,-1.1624785543135705,0.2928870292887029,1.0,1.0,8/20,5.87%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Sdc4;Dcn
prerank,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.7310123964944877,-1.1615220980889567,0.30374479889042993,1.0,1.0,8/20,5.87%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Sdc4;Dcn
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.7367506709143145,-1.1609410228134314,0.3054393305439331,1.0,1.0,3/18,11.06%,Pik3r1;Egfr;Pik3ca
prerank,Signaling By NTRKs R-HSA-166520,0.545708181556946,1.1597300017676224,0.17894736842105263,1.0,1.0,16/129,2.99%,Grin2b;Ntrk3;Tiam1;Bcl11b;Pcsk5;Ntf3;Rit2;Mapk1;Dnm1;Map2k1;Adcyap1r1;Chd4;Dock3;Rps6ka2;Pik3cb;Mef2c
prerank,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.7072172237791109,-1.1583170448284679,0.2893258426966292,1.0,1.0,4/27,7.53%,Prkcq;Camkmt;Prkca;Gucy2f
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.6159975720311486,-1.1575129440186804,0.2689075630252101,1.0,1.0,22/97,20.00%,Abca9;Abca12;Cftr;Abca7;Abcb9;Abcc3;Abca6;Psmb8;Psmb11;Abcc10;Abcd1;Psme2;Abca3;Psme4;Psma8;Psmb9;Abca2;Abcc5;Abcc1;Abcb5;Apoa1;Ubc
prerank,Collagen Chain Trimerization R-HSA-8948216,-0.6757926585534152,-1.1574168738423298,0.27369826435246997,1.0,1.0,13/43,7.97%,Col26a1;Col27a1;Col16a1;Col6a2;Col6a1;Col6a5;Col11a2;Col11a1;Col6a3;Col9a1;Col8a1;Col12a1;Col9a3
prerank,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.7383958390997766,-1.1570460649409517,0.31345353675450766,1.0,1.0,6/17,12.58%,Abca9;Abca12;Abca7;Abca6;Abcd1;Abca3
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.621464851329022,-1.156308540015047,0.2219020172910663,1.0,1.0,22/95,13.22%,Pik3r1;Itgam;Sox2;Fn1;Bcl2;Tgfb1;Stat6;Tnfrsf1b;S1pr1;Jak2;Ccnd1;Vegfa;Itgb1;Myc;Foxo3;Il1a;Itgb2;Il13ra1;Stat3;Il18;Vcam1;Il12a
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.6427570062633021,-1.1550127710302536,0.2691751085383502,1.0,1.0,10/63,7.50%,Acss1;Tbxas1;Ptgs1;Arnt2;Aldh1a1;Smox;Cyp26b1;Fmo1;Cyp27a1;Maob
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.69748117036129,-1.154502916776059,0.3011527377521614,1.0,1.0,6/35,8.81%,Agbl4;Ttll7;Tubb4a;Tubb3;Ttl;Vash2
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.6282000887118554,-1.1534100614683533,0.2661971830985915,1.0,1.0,13/80,13.66%,Tbl1x;Tgfb1;Cdk19;Klf5;Ccnd3;Srebf2;Smarcd3;Ncoa3;Egr2;Pparg;Ebf1;Nr2f2;Lpl
prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.6336266958501358,-1.152739540200952,0.2688953488372093,1.0,1.0,16/73,14.12%,Lair1;Cd33;Colec12;Tyrobp;Cd81;Trem2;Cxadr;Nectin2;Itgb1;Slamf6;Itgb2;Cd300a;Vcam1;Slamf7;Pilra;B2m
prerank,Signaling By MET R-HSA-6806834,-0.6497692487549986,-1.1515362655728314,0.2668621700879765,1.0,1.0,18/63,11.78%,Pik3r1;Lama4;Lama2;Tns3;Eps15;Lama1;Lamc2;Itga2;Rap1b;Stam2;Itgb1;Itga3;Sh3gl2;Lrig1;Pik3ca;Ptpn1;Stat3;Lamc3
prerank,CD28 Co-Stimulation R-HSA-389356,-0.6870549744406952,-1.15094647027609,0.2880886426592798,1.0,1.0,8/33,11.06%,Pik3r1;Vav1;Lyn;Cd86;Prr5;Cd80;Grap2;Pik3ca
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.6038566048219263,-1.150629889804667,0.23109243697478993,1.0,1.0,22/117,5.87%,Gpc6;Xylt1;Ext1;Hs6st2;Hs3st2;Gpc5;Hs3st5;Hs6st3;St3gal6;Bcan;Hs3st4;Ndst3;Cspg4;Vcan;Chst3;Cd44;Cspg5;Sdc4;Hpse;Hs3st1;Has2;Dcn
prerank,PKA Activation In Glucagon Signaling R-HSA-164378,0.6821979379160963,1.1502857591061562,0.32234432234432236,1.0,1.0,3/15,2.17%,Adcy1;Adcy2;Adcy9
prerank,Interleukin-1 Family Signaling R-HSA-446652,0.537776468870173,1.1494763166844344,0.20833333333333334,1.0,1.0,11/140,3.30%,Il1rap;Il1rapl1;Map2k6;Il1r1;Map2k1;Tnip2;Smad3;Btrc;Peli1;Fbxw11;Ripk2
prerank,Nephrin Family Interactions R-HSA-373753,0.6904781655540514,1.1491979938822148,0.32116788321167883,1.0,1.0,8/21,4.29%,Kirrel3;Sptbn1;Sptan1;Pik3cb;Nck2;Actn1;Actn2;Fyn
prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.7062827526093738,-1.1483790956615743,0.3025210084033613,1.0,1.0,14/29,22.42%,Unc93b1;Traf3;Btk;Tlr5;Tlr3;Tlr1;Tirap;Ticam1;Tlr2;S100a1;Tlr6;Chuk;Nfkbia;Tlr4
prerank,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.7065770363978799,1.1473307169480647,0.34024896265560167,1.0,1.0,7/15,12.75%,Dcp1b;Lsm7;Dcp1a;Edc3;Edc4;Lsm4;Lsm1
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.6430458077233078,-1.1465761467035491,0.28378378378378377,1.0,1.0,17/66,7.97%,Col26a1;Adamts2;Col27a1;Col16a1;Col6a2;P4ha3;P3h2;Col6a1;Col6a5;Plod1;Col11a2;Col11a1;Col6a3;Col9a1;Col8a1;Col12a1;Col9a3
prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.7082051282048099,-1.145910360255196,0.29859154929577464,1.0,1.0,3/25,7.14%,Gadl1;Sqor;Cdo1
prerank,Costimulation By CD28 Family R-HSA-388841,-0.6526361115134526,-1.1458409035797414,0.2807262569832402,1.0,1.0,14/56,14.67%,Pik3r1;Vav1;Lyn;Cd86;Ppp2r5a;Prr5;Cd80;Ppp2r5c;Grap2;Pik3ca;Icos;Ptpn6;Ppp2r5e;Cdc42
prerank,PTEN Regulation R-HSA-6807070,0.5276006896143263,1.1437412407261176,0.1993006993006993,1.0,1.0,23/136,7.66%,Tnrc6c;Akt3;Prex2;Hdac7;Mapk1;Chd4;Chd3;Rragd;Jun;Cnot6l;Ago2;Gatad2b;Ago1;Cbx6;Nedd4;Tnks;Mapk3;Tnrc6b;Rbbp7;Hdac1;Suz12;Uba52;Cbx4
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.6471566779269249,1.1390721443923504,0.31636363636363635,1.0,1.0,13/29,12.92%,Ube2w;Ube2e3;Ube2q2;Ube2g2;Uba52;Ube2r2;Ube2k;Uchl3;Ube2b;Ubb;Ube2d1;Ube2h;Ube2t
prerank,RORA Activates Gene Expression R-HSA-1368082,-0.7242448722427604,-1.1354326024328771,0.3202170963364993,1.0,1.0,2/18,5.28%,Tbl1x;Smarcd3
prerank,Acyl Chain Remodelling Of PS R-HSA-1482801,-0.6963846059268222,-1.1353368242324156,0.318941504178273,1.0,1.0,4/21,4.20%,Mboat1;Pla2g4a;Plaat3;Osbpl10
prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.6995830443743952,-1.1352018983433234,0.34074074074074073,1.0,1.0,5/21,4.76%,Dusp10;Dusp5;Dusp16;Dusp6;Jak2
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.6447226312992674,-1.1343898657460982,0.28730822873082285,1.0,1.0,3/57,2.95%,Rab31;Rab3c;Rab3b
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.5863183016982205,-1.1335474006292792,0.27450980392156865,1.0,1.0,24/131,11.67%,Fnbp1l;Synj2;Chrm2;Hip1;Syt9;Fnbp1;Grk3;Dab2;Eps15;Cftr;Dnm3;Hip1r;Pacsin3;Egfr;Stam2;Trip10;Adrb2;Nlrp3;Ap2b1;Sh3gl2;Picalm;Pik3c2a;Fcho2;Ldlrap1
prerank,Scavenging By Class A Receptors R-HSA-3000480,-0.7145878326302197,-1.1334398241344168,0.33706293706293705,1.0,1.0,8/17,21.69%,Colec12;Masp1;Apoe;Msr1;Col4a1;Col3a1;Apoa1;Col4a2
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.6632378108755744,-1.1334327732233025,0.3237822349570201,1.0,1.0,14/53,14.75%,Tbl1x;Hmgcs1;Srebf2;Elovl6;Hmgcr;Smarcd3;Fdft1;Sqle;Acaca;Insig1;Dhcr7;Idi1;Tm7sf2;Sec24a
prerank,SARS-CoV Infections R-HSA-9679506,-0.5319572963326376,-1.1331587709850324,0.21882951653944022,1.0,1.0,43/332,9.57%,St6gal1;Gpc6;Mgat4c;Gpc5;Parp8;Vav1;Parp4;Zdhhc2;Mgat5;Man2a1;Tlr7;Irak2;Fxyd7;Atp1a2;Masp1;S1pr1;Ywhaq;Il17ra;Sting1;Trim25;Nfe2l2;Jak2;Sdc4;Atp1b3;Syk;Traf3;Btk;Mgat4a;Blnk;Vegfa;Ifih1;Zdhhc9;Rigi;Ifngr1;Itgb1;Rnf135;St6galnac2;Irf3;Nlrp12;Gja1;Nlrp3;Ap2b1;Gatad2a
prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.7284885876900011,-1.133023743791515,0.34349030470914127,1.0,1.0,2/17,4.31%,Tubb4a;Tubb3
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.6854105327766615,-1.1317815415979247,0.30945558739255014,1.0,1.0,8/36,7.41%,Prkcq;Gsn;Prkcd;Casp8;Tjp2;Satb1;Mapt;Gas2
prerank,RHOV GTPase Cycle R-HSA-9013424,-0.678154047128935,-1.1316403677205829,0.3287101248266297,1.0,1.0,7/35,6.37%,Pik3r1;Sh3rf1;Peak1;Ccp110;Iqgap1;Depdc1b;Dst
prerank,Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.7085879280123407,-1.1299528322763714,0.3338048090523338,1.0,1.0,4/19,12.12%,Serpine2;Pros1;Vwf;Gp5
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.6388900284237193,-1.1297973542918687,0.307909604519774,1.0,1.0,5/65,9.08%,Vrk2;Tubb4a;Tubb3;Sirt2;Ccnb1
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6695550168158895,-1.1292153586699292,0.33238231098430815,1.0,1.0,11/33,20.00%,Apoe;Mylip;Soat1;Ap2b1;Npc2;Ldlrap1;Pcsk9;Cltc;Ldlr;Apoa1;Ubc
prerank,Apoptotic Execution Phase R-HSA-75153,-0.670772380171938,-1.1288362119340645,0.3120567375886525,1.0,1.0,8/44,7.41%,Prkcq;Gsn;Prkcd;Casp8;Tjp2;Satb1;Mapt;Gas2
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,0.6345330577022252,1.1269692493918098,0.32081911262798635,1.0,1.0,10/29,16.30%,Gtf2f2;Ssrp1;Polr2e;Polr2f;Ccnk;Ccnt2;Elob;Polr2k;Cdk9;Polr2g
prerank,Pyroptosis R-HSA-5620971,-0.6976583169039218,-1.1259972344097056,0.3536931818181818,1.0,1.0,6/20,16.45%,Casp1;Casp4;Il1a;Irf2;Il18;Casp3
prerank,Signaling To RAS R-HSA-167044,-0.7058212762000233,-1.1258238692442875,0.359612724757953,1.0,1.0,4/19,6.19%,Ngf;Shc3;Mapk11;Ralb
prerank,Notch-HLH Transcription Pathway R-HSA-350054,0.6659646226543192,1.1256811290365387,0.336734693877551,1.0,1.0,5/28,2.01%,Maml2;Maml3;Hdac7;Ncor1;Notch2
prerank,Nicotinate Metabolism R-HSA-196807,-0.6869184511063968,-1.1254537260526374,0.33237410071942447,1.0,1.0,3/30,4.69%,Parp8;Parp4;Nnmt
prerank,Generation Of Second Messenger Molecules R-HSA-202433,-0.684007738790737,-1.125352731676308,0.3508771929824561,1.0,1.0,1/21,0.78%,Lcp2
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.5433623846614222,1.125244595809891,0.24050632911392406,1.0,1.0,10/94,1.57%,Kalrn;Tiam1;Vav3;Plekhg5;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,SLC Transporter Disorders R-HSA-5619102,0.5540601365742834,1.125215936502199,0.2655172413793103,1.0,1.0,3/91,2.61%,Slc4a4;Slc24a4;Slc1a1
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.5404645939584367,-1.12486690745929,0.23087071240105542,1.0,1.0,28/252,8.97%,St6gal1;Gpc6;Mgat4c;Gpc5;Parp8;Parp4;Zdhhc2;Mgat5;Man2a1;Tlr7;Irak2;Masp1;Ywhaq;Il17ra;Sting1;Trim25;Sdc4;Traf3;Mgat4a;Ifih1;Zdhhc9;Rigi;Rnf135;St6galnac2;Irf3;Nlrp12;Gja1;Nlrp3
prerank,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.6925055111851297,-1.1222310320093893,0.3398328690807799,1.0,1.0,1/20,1.27%,Fgf1
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.6098927276629666,-1.122162489674826,0.29985855728429983,1.0,1.0,20/94,14.75%,Tlr7;Irak2;Masp1;Il17ra;Sting1;Trim25;Traf3;Ifih1;Rigi;Rnf135;Irf3;Nlrp12;Nlrp3;Il17rc;Tlr1;Nod1;Ptpn6;Tlr2;B2m;Sec24a
prerank,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.6872839042030919,-1.121456569996794,0.3774104683195592,1.0,1.0,3/22,11.47%,Fgf1;Fgfr2;Fgf23
prerank,Signaling By Retinoic Acid R-HSA-5362517,-0.6729474514200893,-1.1213747944808217,0.3443072702331962,1.0,1.0,11/35,18.29%,Rxrg;Aldh1a1;Rara;Cyp26b1;Dhrs3;Rdh16;Aldh1a2;Cpt1a;Pdk4;Ppard;Crabp2
prerank,Visual Phototransduction R-HSA-2187338,-0.6211165974160292,-1.12061807995314,0.2972181551976574,1.0,1.0,13/83,8.09%,Gpc6;Prkcq;Gpc5;Akr1b10;Rlbp1;Bco2;Sdc4;Camkmt;Apoe;Dhrs3;Prkca;Gucy2f;Slc24a1
prerank,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.7111295143565363,-1.1198761406961744,0.3726541554959786,1.0,1.0,4/16,7.21%,Lyn;Relb;Rps6ka5;Prkca
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.6564566087980959,-1.1198749922040905,0.3342981186685962,1.0,1.0,7/47,8.47%,Tcf7l2;Tle3;Tcf7l1;Lef1;Tle2;Bcl9;Myc
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.6938872900446469,-1.1187113307427143,0.363013698630137,1.0,1.0,4/25,8.97%,Tbl1x;Npas2;Smarcd3;Nlrp3
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.630824531786593,-1.1180228267892773,0.3201754385964912,1.0,1.0,7/57,2.56%,St6gal1;Mgat4c;Parp8;Parp4;Zdhhc2;Mgat5;Man2a1
prerank,Signaling By NOTCH1 R-HSA-1980143,0.5652564442351953,1.1179051470762493,0.27491408934707906,1.0,1.0,8/72,2.36%,Maml2;Nbea;Maml3;Cntn1;Tle1;Hdac7;Ncor1;Tle4
prerank,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.6918094413259832,-1.1177538015137145,0.3687150837988827,1.0,1.0,3/16,9.53%,Pold4;Fen1;Wrn
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.49989678582840036,1.116747620575132,0.22916666666666666,1.0,1.0,3/161,2.01%,Slit3;Robo2;Lhx9
prerank,Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.6984344966014456,-1.1159377442799558,0.38028169014084506,1.0,1.0,3/19,11.80%,Serpine2;Pros1;Thbd
prerank,Glycogen Metabolism R-HSA-8982491,-0.6876022180879491,-1.1156893709058575,0.36633663366336633,1.0,1.0,3/22,4.24%,Ugp2;Phkb;Gbe1
prerank,Processive Synthesis On Lagging Strand R-HSA-69183,-0.7060261347758481,-1.115402260336661,0.3649425287356322,1.0,1.0,5/15,21.15%,Pold4;Fen1;Lrig1;Prim2;Dna2
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.6103695072179468,-1.1151232596090708,0.2959326788218794,1.0,1.0,15/84,14.69%,Tcf7l2;Tle3;Tcf7l1;Ppp2r5a;Lef1;Tle2;Ppp2r5c;Myc;Psmb8;Psmb11;Psme2;Psme4;Psma8;Ppp2r5e;Psmb9
prerank,Cell-extracellular Matrix Interactions R-HSA-446353,-0.6963023721374573,-1.1135384322128334,0.3669985775248933,1.0,1.0,4/16,7.92%,Lims1;Arhgef6;Lims2;Itgb1
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.6395586167129772,-1.113407312344,0.32814710042432815,1.0,1.0,7/53,4.82%,Alk;Rrbp1;Pik3r1;Hip1;Fn1;Vcl;Msn
prerank,Integration Of Energy Metabolism R-HSA-163685,0.5344246366919104,1.1126810404220346,0.27419354838709675,1.0,1.0,15/102,2.54%,Cacna1c;Cacna1e;Cacnb2;Adcy1;Prkag2;Adcy2;Plcb1;Cacna1d;Kcng2;Gng7;Gnaq;Rapgef4;Adcy9;Abcc8;Gng2
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.6821977518290385,-1.11162231313079,0.38472622478386165,1.0,1.0,3/22,14.60%,Ankrd28;Cdk2;Pif1
prerank,HIV Life Cycle R-HSA-162587,0.515398867215291,1.1095887368418373,0.25,1.0,1.0,19/138,8.41%,Sgip1;Nedd4l;Gtf2f2;Vps37b;Gtf2h2;Ccnh;Ssrp1;Nup93;Xpo1;Gtf2h5;Ndc1;Uba52;Nmt1;Ncbp1;Nup160;Ranbp2;Ranbp1;Vps4a;Polr2e
prerank,GPVI-mediated Activation Cascade R-HSA-114604,-0.6550317521453197,-1.1086940443837614,0.34339080459770116,1.0,1.0,10/32,5.84%,Vav2;Lcp2;Pik3r1;Vav1;Lyn;Pik3r5;Pik3cg;Rhog;Fcer1g;Syk
prerank,Degradation Of DVL R-HSA-4641258,0.5878588380829587,1.1086172103704566,0.3275862068965517,1.0,1.0,1/55,0.64%,Hecw1
prerank,RAS Processing R-HSA-9648002,-0.700948845984756,-1.1071146356359358,0.3945086705202312,1.0,1.0,3/17,7.32%,Prkcq;Prkg2;Zdhhc9
prerank,Death Receptor Signaling R-HSA-73887,0.5100046018387974,1.1064189333331524,0.2655172413793103,1.0,1.0,11/134,2.17%,Kalrn;Tiam1;Vav3;Plekhg5;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4;Usp2
prerank,Processing Of SMDT1 R-HSA-8949664,0.6796853311297634,1.106167432307201,0.4015151515151515,1.0,1.0,4/15,5.63%,Mcu;Micu1;Yme1l1;Micu3
prerank,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.6719930509191745,-1.1060444912231195,0.3864265927977839,1.0,1.0,4/18,10.80%,Pold4;Fen1;Wrn;Lrig1
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.6854215366212912,-1.105510346801835,0.3668061366806137,1.0,1.0,2/24,4.31%,Tubb4a;Tubb3
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,0.5704624121725825,1.105334039890799,0.30944625407166126,1.0,1.0,13/60,3.52%,Grin2a;Grin2b;Gria2;Camk2a;Camk2b;Rbfox1;Tnrc6c;Ncor1;Calm1;Fkbp5;Mef2c;Camk2g;Ago2
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.6788669554229744,-1.1045685007237263,0.3724137931034483,1.0,1.0,4/22,7.37%,Pik3r1;Cd86;Prr5;Cd80
prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6596904450705378,-1.1044514253594584,0.386685552407932,1.0,1.0,13/33,25.14%,Serpine2;Pros1;Vwf;F3;Thbd;Gp5;Tfpi;Procr;F7;Fam110a;Prcp;F9;F13b
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.6141229711918579,-1.1041531446080335,0.3510028653295129,1.0,1.0,4/70,2.46%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.649828961706477,1.1035112235475846,0.3879003558718861,1.0,1.0,3/18,4.19%,Dtd1;Fars2;Rars2
prerank,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.6802783438365367,-1.1002941932028347,0.38705035971223023,1.0,1.0,4/25,10.56%,Wls;Wnt2;Wnt5b;Wnt10a
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.6668399606869178,-1.0997270947298827,0.3677685950413223,1.0,1.0,7/30,14.40%,Ncf2;Atp7a;Cyba;Ncf1;Ncf4;Gpx8;Glyat
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.6838101448219108,-1.0983258670566312,0.3646723646723647,1.0,1.0,2/26,4.31%,Tubb4a;Tubb3
prerank,Host Interactions Of HIV Factors R-HSA-162909,-0.575518220262485,-1.0980096582957126,0.32867132867132864,1.0,1.0,4/122,3.35%,Elmo1;Dock2;Hck;Ap1m2
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.5975890975431598,1.0979121537301402,0.34294871794871795,1.0,1.0,7/49,3.96%,Maml2;Maml3;Tnrc6c;Notch2;Jun;Ago2;Ago1
prerank,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.6860281115269646,-1.0961491050996157,0.40827586206896554,1.0,1.0,4/17,10.00%,Ccnd3;E2f1;Ccnd1;Cdk2
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,0.6435590681176518,1.0949980640314736,0.3795379537953795,1.0,1.0,5/27,0.71%,Prkce;Dgkh;Trpc6;Dgki;Dgkg
prerank,ABC Transporter Disorders R-HSA-5619084,-0.6000368123546403,-1.0948640372490146,0.3695345557122708,1.0,1.0,11/77,14.69%,Abca1;Abca12;Cftr;Psmb8;Psmb11;Abcd1;Psme2;Abca3;Psme4;Psma8;Psmb9
prerank,Toll-like Receptor Cascades R-HSA-168898,-0.5596517865644985,-1.0947462196448654,0.30185979971387694,1.0,1.0,30/152,10.52%,Ly86;Kcnh8;Itgam;Ctss;Lgmn;Unc93b1;Cd180;Tlr7;Irak2;Casp8;Dnm3;Dusp6;Rps6ka5;Alpk1;Mapk11;Irak3;Birc3;Traf3;Btk;S100b;Tlr5;Map3k1;Mef2a;Rps6ka1;App;Irf3;Tlr3;Mapk8;Itgb2;Tlr1
prerank,Metabolism Of Nucleotides R-HSA-15869,0.5349555496959364,1.0935689220564802,0.28865979381443296,1.0,1.0,6/86,2.83%,Ak5;Dpyd;Gda;Nt5c2;Adk;Upp2
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.5314755233219592,1.092951247112862,0.27181208053691275,1.0,1.0,48/102,18.30%,Rplp1;Eif3a;Rpl15;Rpl6;Eif4a1;Uba52;Eif3h;Rps21;Eif5b;Rpl18;Eif4b;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Eif4e;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Eif4a2;Rpsa;Rpl41;Rps13;Rpl21;Eif5
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.6590013391139751,-1.0929159531249582,0.40463215258855584,1.0,1.0,9/28,20.17%,Ppp2r5a;Lrp5;Ppp2r5c;Fzd2;Cav1;Ppp2r5e;Amer1;Wnt1;Wnt3a
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.4893993573834224,1.0910539146066476,0.25793650793650796,1.0,1.0,71/182,15.84%,Utp4;Rcl1;Rplp1;Wdr75;Bop1;Dkc1;Mtrex;Sppl2a;Rpl15;Pelp1;Rpl6;Nob1;Uba52;Rps21;Nol12;Nop58;Rpl18;Heatr1;Rps7;Gnl3;Nop56;Exosc8;Rbm28;Tsr1;Rpl31;Rrp1b;Rps15a;Rpl9;Rpl35a;Ebna1bp2;Rpl7;Rps14;Rps17;Dnajc5;Rps9;Mphosph10;Rpl4;Wdr36;Wdr12;Rps28;Rplp2;Rpl3;Utp15;Emg1;Rpl13a;Rps20;Exosc2;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Eri1;Rpl23;Rpl8;Wdr43;Rplp0;Nat10;Rps8;Utp20;Rps29;Rpl12;Riok2;Rsl24d1;Rps12;Gar1;Bysl;Rps25;Exosc1;Nip7
prerank,Paracetamol ADME R-HSA-9753281,-0.6818017409176164,-1.0897787163822366,0.4070422535211268,1.0,1.0,8/21,20.74%,Ggt5;Slc38a3;Abcc3;Abcc5;Gstt1;Abcc1;Slc38a1;Ggt1
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.5393558397085594,1.0895892601654842,0.33221476510067116,1.0,1.0,38/87,15.52%,Rplp1;Upf1;Rpl15;Rpl6;Uba52;Ncbp1;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,Collagen Degradation R-HSA-1442490,-0.6580233236377607,-1.0888817189302633,0.4056603773584906,1.0,1.0,10/34,7.97%,Col26a1;Col16a1;Ctsd;Mmp14;Adam17;Adam10;Mmp28;Col9a1;Col12a1;Col9a3
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.639515619180776,-1.0884182745460487,0.38596491228070173,1.0,1.0,6/41,5.98%,Gpc6;Gpc5;Akr1b10;Bco2;Sdc4;Apoe
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.6070223657701289,-1.0879344021969337,0.38825214899713467,1.0,1.0,14/74,18.22%,Ugp2;Hpgds;Ggt5;Nnmt;Slc38a3;Gsta3;As3mt;Podxl2;Ugdh;Glyat;Papss2;Gstt1;Tpst2;Sult6b1
prerank,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.6920568928240319,-1.087916648958189,0.3954154727793696,1.0,1.0,3/17,16.85%,Tcn2;Ldlrap1;Abcc1
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.6131420218590282,1.0875630862900005,0.3538961038961039,1.0,1.0,9/31,2.23%,Gria1;Gria2;Camk2a;Nsf;Camk2b;Gria3;Tspan7;Epb41l1;Cacng8
prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.6135273732244332,-1.0871065486795597,0.3695652173913043,1.0,1.0,22/58,9.91%,Cpne8;Dlc1;Srgap2;Arhgap26;Cdc42ep3;Fnbp1;Prex1;Rhoq;Cftr;Cdc42ep1;Wwp2;Ophn1;Iqgap1;Syde1;Depdc1b;Slc1a5;Trip10;Cdc42ep2;Arhgap5;Gja1;Arhgap33;Plekhg3
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.6485824236505137,-1.086688851861233,0.38552437223042835,1.0,1.0,6/37,5.98%,Gpc6;Gpc5;Akr1b10;Bco2;Sdc4;Apoe
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.6496392868515148,-1.0864365600246126,0.3870014771048744,1.0,1.0,7/37,18.91%,Kif13a;Fkbp9;Kifc3;Stat3;Arfgef2;Fbxl3;Fbxl5
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.6108997462550345,-1.086007288089181,0.38619676945668135,1.0,1.0,15/59,21.29%,Stat6;Sting1;Irf3;Tlr3;Dtx4;Trim21;Trim56;Aim2;Ticam1;Ep300;Prkdc;Chuk;Ubc;Ripk1;Nfkbia
prerank,rRNA Processing R-HSA-72312,0.48136664659429407,1.0854209690694117,0.2823529411764706,1.0,1.0,72/192,15.84%,Utp4;Rcl1;Rplp1;Wdr75;Bop1;Dkc1;Mtrex;Sppl2a;Rpl15;Pelp1;Rpl6;Nob1;Uba52;Rps21;Nol12;Nop58;Rpl18;Heatr1;Rps7;Gnl3;Nop56;Exosc8;Rbm28;Tsr1;Rpl31;Rrp1b;Rps15a;Rpl9;Rpl35a;Ebna1bp2;Rpl7;Rps14;Rps17;Dnajc5;Rps9;Mphosph10;Rpl4;Wdr36;Wdr12;Rps28;Rplp2;Rpl3;Utp15;Emg1;Rpl13a;Rps20;Exosc2;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Eri1;Rpl23;Rpl8;Wdr43;Rplp0;Nat10;Rps8;Utp20;Mterf4;Rps29;Rpl12;Riok2;Rsl24d1;Rps12;Gar1;Bysl;Rps25;Exosc1;Nip7
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,0.5039728516448035,1.0849072510082853,0.2972027972027972,1.0,1.0,59/128,19.00%,Gtf2f2;Parp1;Rplp1;Nup93;Rpl15;Ndc1;Rpl6;Uba52;Rps21;Rpl18;Nup160;Ranbp2;Rps7;Polr2e;Gnl3;Rpl31;Rps15a;Rpl9;Polr2f;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Nup155;Rps15;Rpl23;Nup153;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Polr2k;Nup210;Polr2g;Rpsa;Rpl41;Tpr;Rps13;Rpl21;Nup62;Grsf1;Rps23;Ipo5
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.6184545666943606,1.0844697395858833,0.3732394366197183,1.0,1.0,3/29,4.07%,Prkag2;Rragd;Strada
prerank,Peptide Chain Elongation R-HSA-156902,0.5461332000248208,1.0841653579602908,0.34563758389261745,1.0,1.0,38/81,15.52%,Rplp1;Rpl15;Eef1a1;Rpl6;Uba52;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Eef2;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.6384707143176802,1.0840603121563879,0.4007352941176471,1.0,1.0,6/25,12.31%,Atf6;Exosc8;Asns;Khsrp;Exosc2;Atf3
prerank,GPCR Ligand Binding R-HSA-500792,-0.505164601667017,-1.0838336620658093,0.2812105926860025,1.0,1.0,86/358,14.07%,Rxfp1;Chrm3;Grm8;Grm3;Htr2c;Htr1f;Adra1a;Lpar1;Cx3cr1;Chrm2;Ccr5;Htr7;P2ry6;Tacr3;Gng4;Ntsr1;Qrfpr;Drd2;P2ry13;P2ry12;Cckbr;Gng12;Smox;S1pr1;Htr2a;Ednrb;Npsr1;Ptger3;Oprk1;Adgre1;Insl5;Gnb4;Grm4;Lpar6;Npffr1;Adra1b;Gngt2;Gnas;Wnt2;Hrh2;App;Pth2r;P2ry1;Chrm5;Adrb3;C1qtnf1;Ucma;Adrb2;Adora2b;Crhr1;Nlrp3;Gpr55;Pthlh;Pnoc;Fzd2;Sctr;Chrm4;Hrh3;Gpr17;Lhcgr;Wnt10a;Opn3;Hcrt;Shh;Ece1;Tac1;Ffar4;Gpr37l1;Adrb1;Tshb;Prok2;Cysltr1;Calcr;Edn1;Adm;Htr5a;Adora2a;Cmklr1;C3ar1;Chga;Bdkrb2;Glp1r;Gnb1;Adcyap1;Calcb;Gng11
prerank,MTOR Signaling R-HSA-165159,0.5810923819066635,1.0834328735245875,0.3355048859934853,1.0,1.0,4/41,5.34%,Prkag2;Rragd;Strada;Ywhab
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.5673707225300737,1.0823068494240697,0.3313253012048193,1.0,1.0,6/63,2.01%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3;Notch2
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.6092992965398113,1.0821861448184509,0.3543859649122807,1.0,1.0,8/27,16.30%,Gtf2f2;Ssrp1;Polr2e;Polr2f;Elob;Polr2k;Cdk9;Polr2g
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.6868443378321769,-1.0821463263852826,0.42112482853223593,1.0,1.0,2/18,1.78%,Alk;Fn1
prerank,GAB1 Signalosome R-HSA-180292,-0.691256311502491,-1.08189393380758,0.41120218579234974,1.0,1.0,3/16,6.80%,Pik3r1;Pag1;Egfr
prerank,Gap Junction Trafficking R-HSA-190828,-0.6756630301786863,-1.080072952661338,0.420391061452514,1.0,1.0,6/20,9.10%,Dab2;Myo6;Gja3;Gjd2;Gja1;Gjc2
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.5246444294617999,1.0799925813006104,0.2976588628762542,1.0,1.0,42/101,15.92%,Rplp1;Eif3a;Rpl15;Rpl6;Eif4a1;Uba52;Eif3h;Rps21;Rpl18;Eif4b;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Eif4e;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Eif4a2
prerank,RHO GTPase Cycle R-HSA-9012999,-0.4962185668412447,-1.079101343842751,0.2876543209876543,1.0,1.0,97/426,8.41%,Fnbp1l;Dock1;Srgap1;Dock2;Cpne8;Wipf1;Pcdh7;Plekhg1;Dlc1;Vav2;Arap2;Arhgap22;Pik3r1;Sh3rf1;Arhgap23;Vrk2;Arhgap31;Srgap2;Arhgap45;Dock8;Prag1;Nckap1l;Farp1;Dock5;Arhgef26;Stmn2;Fmnl3;Vav1;Homer2;Arhgap25;Arhgap26;Pde5a;Peak1;Cdc42ep3;Fnbp1;Prex1;Mcf2;Rhobtb1;Garre1;Anln;Arhgap18;Rhoh;Ncf2;Myo6;Rhoq;Cftr;Dock6;Arhgef40;Arhgap42;Rnd3;Akap12;Arhgap24;Ccp110;Tjp2;Cdc42ep1;Akap13;Swap70;Arhgef11;Arap1;Plxnb1;Plxna1;Wwp2;Ophn1;Arhgef6;Rhog;Iqgap1;Syde1;Arhgef10;Mcam;Depdc1b;Arhgap28;Baiap2l2;Dst;Arhgap11a;Rhoj;Arhgef19;Epsti1;Plxnd1;Rhpn2;Pld2;Arhgap6;Plekhg2;Stam2;Gmip;Itgb1;Cyba;Slc1a5;Trip10;Arhgap30;Ncoa3;Egr2;Fgd5;Tmod3;Ncf1;Erbin;Cdc42ep2;Arhgap5
prerank,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.6532410214451257,-1.0788329756044497,0.40555555555555556,1.0,1.0,9/26,15.88%,Mboat1;Pla2g4a;Plaat3;Pla2g4c;Pla2g6;Plaat1;Lpcat3;Pnpla8;Pla2r1
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.5197871854225745,-1.0786750523348994,0.33031088082901555,1.0,1.0,67/269,8.16%,Adamts16;Col26a1;Nrxn1;Adamts2;Scube1;Itga9;Itgb5;Lama4;Dmd;Col27a1;Col16a1;Bcan;Lrp4;Itgam;Fn1;Tgfb1;Sparc;Col6a2;Jam3;Ntn4;Lama2;Jam2;Ctss;Adamts4;Ltbp1;Ctsd;P4ha3;F11r;Adam19;P3h2;Vcan;Col6a1;Lama1;Mmp14;Bmp7;Bmp4;Lamc2;Cd44;Itga2;Itga6;Col6a5;Sdc4;Plod1;Adam17;Htra1;Adam10;Timp2;Col11a2;Dcn;Tnn;Ltbp3;Mmp28;Dst;Hapln1;Col11a1;Fbln2;Col6a3;Col9a1;Col8a1;Fbln5;Prkca;Capn2;Col12a1;Itgb1;Nid2;Col9a3;Ceacam1
prerank,Eukaryotic Translation Elongation R-HSA-156842,0.542877752228987,1.0785023182056648,0.3448275862068966,1.0,1.0,44/85,18.11%,Rplp1;Rpl15;Eef1a1;Rpl6;Uba52;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Eef2;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Eef1g;Rps25;Rpsa;Rpl41;Eef1d;Rps13;Rpl21
prerank,SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.6769790871986734,-1.077709602093119,0.39745403111739747,1.0,1.0,1/18,1.27%,Fgf1
prerank,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.670297326402267,-1.0757641359052623,0.4192200557103064,1.0,1.0,3/20,11.47%,Fgf1;Fgfr2;Fgf23
prerank,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.6616852011654302,-1.0756428289813642,0.4053295932678822,1.0,1.0,10/23,11.75%,Prkcb;Ncf2;Prkcd;Mapk11;Prkca;Cyba;Ncf1;Nox3;Ncf4;Rac2
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,0.5452624282526217,1.0754793309841468,0.3424657534246575,1.0,1.0,14/69,8.69%,Sgip1;Pdzd2;Eif4e3;Nedd4;Mapk3;Nup93;Ndc1;Eif4g2;Eif4a1;Uba52;Nup160;Ranbp2;Gnl3;Eif4g3
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.484852294855815,1.074252592574095,0.29133858267716534,1.0,1.0,68/172,15.84%,Utp4;Rcl1;Rplp1;Wdr75;Bop1;Mtrex;Sppl2a;Rpl15;Pelp1;Rpl6;Nob1;Uba52;Rps21;Nol12;Nop58;Rpl18;Heatr1;Rps7;Gnl3;Nop56;Exosc8;Rbm28;Tsr1;Rpl31;Rrp1b;Rps15a;Rpl9;Rpl35a;Ebna1bp2;Rpl7;Rps14;Rps17;Dnajc5;Rps9;Mphosph10;Rpl4;Wdr36;Wdr12;Rps28;Rplp2;Rpl3;Utp15;Emg1;Rpl13a;Rps20;Exosc2;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Eri1;Rpl23;Rpl8;Wdr43;Rplp0;Rps8;Utp20;Rps29;Rpl12;Riok2;Rsl24d1;Rps12;Bysl;Rps25;Exosc1;Nip7
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.6613806167860812,-1.0723277782768716,0.4229137199434229,1.0,1.0,1/20,3.06%,Cdc14a
prerank,NGF-stimulated Transcription R-HSA-9031628,-0.6403780518840798,-1.0720341639573476,0.41304347826086957,1.0,1.0,9/38,10.48%,Kcnh8;Trib1;Fosb;Sgk1;Egr1;Vgf;Arc;Egr2;F3
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.6247959022429517,1.0707703967115278,0.40569395017793597,1.0,1.0,4/21,9.37%,Gtf2f2;Ncbp1;Polr2e;Polr2f
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.6171246592309589,1.0707161437325565,0.41496598639455784,1.0,1.0,4/20,5.16%,Cntn1;Notch2;Jag1;Psen1
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.4452076238292047,1.0696873848714148,0.24186046511627907,1.0,1.0,33/294,3.52%,Prkce;Il1rap;Pip5k1b;Nbea;Camk2a;Camk2b;Nrg2;Adcy1;Foxo1;Nrg3;Adcy2;Tnrc6c;Akt3;Prex2;Hdac7;Mapk1;Pde1b;Adcy9;Chd4;Tgfa;Calm1;Pip5k1a;Camkk1;Flt3;Chd3;Rragd;Jun;Pik3cb;Itpr1;Cnot6l;Fgf5;Camk2g;Ago2
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,-0.6587411240819626,-1.069669336001347,0.4379263301500682,1.0,1.0,5/21,7.76%,Lyn;Cd86;Ppp2r5a;Cd80;Ppp2r5c
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.6407973691853355,-1.0694603205860056,0.42083333333333334,1.0,1.0,3/31,11.47%,Fgf1;Fgfr2;Fgf23
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.6372682383213037,-1.0690144158938772,0.422283356258597,1.0,1.0,5/35,9.93%,Pde5a;Rhobtb1;Myo6;Tmod3;Msi2
prerank,Olfactory Signaling Pathway R-HSA-381753,-0.5672935233560775,-1.0689665199750282,0.3713490959666203,1.0,1.0,15/103,14.88%,Ldb2;Or51e1;Or51d1;Or52i2;Or2t6;Or52k2;Or1n2;Or4k15;Reep1;Ebf1;Or51e2;Or52m1;Gnb1;Or2t1;Or52e5
prerank,Metabolism Of Steroids R-HSA-8957322,-0.5543421751245048,-1.0680636693865002,0.3607681755829904,1.0,1.0,28/136,14.75%,Osbpl1a;Tbl1x;Hmgcs1;Stard4;Lgmn;Srebf2;Elovl6;Hmgcr;Msmo1;Smarcd3;Hsd17b12;Cyp27a1;Fdft1;Sqle;Acaca;Abcc3;Insig1;Hsd17b11;Dhcr7;Ldlrap1;Idi1;Chga;Osbpl3;Dhcr24;Tm7sf2;Stard3;Osbpl9;Sec24a
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.6368224763376877,-1.0677162095958521,0.4129834254143646,1.0,1.0,12/34,22.61%,Acadl;Acot9;Acsf2;Dbi;Pctp;Decr1;Acot7;Eci1;Acsm3;Acot1;Acads;Acot11
prerank,G Alpha (Q) Signaling Events R-HSA-416476,0.4671988865550142,1.0671500347112288,0.3215686274509804,1.0,1.0,19/193,3.30%,Kalrn;Prkce;Dgkh;Grm1;Trpc6;Dgki;Grm5;Dgkg;Plcb1;Gng7;Gnaq;Mapk1;Dagla;Arhgef25;Gng2;Chrm1;Rps6ka2;Itpr1;Ripk2
prerank,Triglyceride Metabolism R-HSA-8979227,-0.648491957409171,-1.0660825469751134,0.41244573082489144,1.0,1.0,7/30,13.98%,Agmo;Prkca;Fabp7;Cav1;Abhd5;Lpin3;Plin3
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.5100971338853821,1.0651849743124557,0.3367003367003367,1.0,1.0,50/107,18.11%,Rplp1;Smg7;Upf1;Rpl15;Rpl6;Dcp1a;Uba52;Ncbp1;Rps21;Rpl18;Rps7;Smg1;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Upf2;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Upf3a;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Ppp2r1a;Rps25;Magoh;Rnps1;Rpsa;Rpl41;Rps13;Rpl21
prerank,tRNA Aminoacylation R-HSA-379724,0.6124415235009898,1.0648399079818238,0.40728476821192056,1.0,1.0,4/26,5.39%,Dtd1;Fars2;Rars2;Farsa
prerank,Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.6386258989986875,1.0646153911322076,0.4420289855072464,1.0,1.0,3/17,3.29%,Foxo1;Akt3;Neurod1
prerank,Semaphorin Interactions R-HSA-373755,0.5490737763684168,1.0642574043437243,0.37681159420289856,1.0,1.0,4/64,1.34%,Plxna4;Sema5a;Nrp1;Sema6d
prerank,Extension Of Telomeres R-HSA-180786,-0.6057778574505523,-1.0639026822235615,0.4144542772861357,1.0,1.0,10/49,18.17%,Ankrd28;Pold4;Fen1;Wrn;Cdk2;Lrig1;Pif1;Dscc1;Prim2;Chtf8
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.5135756340674625,1.061625520429012,0.3504823151125402,1.0,1.0,11/102,2.61%,Ahcyl2;Slc4a4;Slc8a2;Slc16a10;Slc17a7;Slc4a10;Slc24a4;Slc6a15;Slc4a7;Calm1;Slc1a1
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.5208175483142803,1.061254083354788,0.35906040268456374,1.0,1.0,38/92,15.52%,Rplp1;Eif3a;Rpl15;Rpl6;Uba52;Eif3h;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.5549258451255363,1.061003250538107,0.3651877133105802,1.0,1.0,24/52,18.85%,Eif3a;Eif4a1;Eif3h;Rps21;Eif4b;Rps7;Rps15a;Rps14;Rps17;Rps9;Eif4e;Rps28;Rps20;Rps3;Rps15;Rps8;Rps29;Rps12;Rps25;Eif4a2;Rpsa;Rps13;Eif5;Rps23
prerank,Formation Of Cornified Envelope R-HSA-6809371,-0.6273716684702386,-1.0584667454887657,0.42934051144010765,1.0,1.0,7/33,12.37%,Pcsk6;Kazn;Klk8;Evpl;Dsc3;Rcan1;Jup
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6306498258260714,-1.0561157765992477,0.41737891737891736,1.0,1.0,13/41,22.05%,Irak2;Casp8;Alpk1;S100b;App;Nod1;Nod2;Tifa;Chuk;Ube2v1;Ubc;Nfkbia;Usp14
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5970515239890841,-1.0555524425281302,0.4281609195402299,1.0,1.0,10/66,14.69%,Prkcb;Rel;Bcl10;Nfkbie;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Leishmania Infection R-HSA-9658195,-0.5176373936928337,-1.0549676078274213,0.37889039242219213,1.0,1.0,49/216,9.93%,Dock1;Elmo1;Itpr2;Rxfp1;Wipf1;Vav2;Entpd1;Myo1e;Nckap1l;Htr7;Hck;Vav1;Lyn;Gng4;P2rx7;Gng12;Prkar1b;Npsr1;P2rx4;Ggt5;Adcy7;Adam17;Casp1;Gnb4;Gnai1;Syk;Btk;Gngt2;Gnas;Prkca;Itpr3;Hrh2;Gnai2;Txnip;Cyba;Pth2r;Adrb3;C1qtnf1;Adrb2;Adora2b;Il1a;Crhr1;Nlrp3;Arpc1b;Wasf2;Pthlh;Plk2;Mapk8;Sctr
prerank,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.6728801284181593,-1.0548263262199753,0.4340136054421769,1.0,1.0,4/15,15.82%,Ppp2r5a;Ppp2r5c;Ppp2r5e;Amer1
prerank,Cap-dependent Translation Initiation R-HSA-72737,0.5037224475463411,1.0547156555400696,0.33666666666666667,1.0,1.0,44/109,15.92%,Rplp1;Eif3a;Rpl15;Rpl6;Eif4a1;Uba52;Eif3h;Rps21;Eif5b;Rpl18;Eif4b;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Eif4e;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Eif2b5;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Eif4a2
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.5313025448880834,-1.053649285949317,0.38857938718662954,1.0,1.0,2/180,3.23%,Elavl2;Colec12
prerank,Eukaryotic Translation Termination R-HSA-72764,0.5245660474982237,1.0524662234991435,0.3711340206185567,1.0,1.0,37/85,15.52%,Rplp1;Rpl15;Rpl6;Uba52;Rps21;Rpl18;N6amt1;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.6620659973256389,-1.0515805221224632,0.45725915875169604,1.0,1.0,4/17,15.82%,Ppp2r5a;Ppp2r5c;Ppp2r5e;Amer1
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.611495537442827,-1.049244217600399,0.4289897510980966,1.0,1.0,6/46,10.00%,Lyn;Ccnd3;E2f1;Jak2;Ccnd1;Cdk2
prerank,Dectin-2 Family R-HSA-5621480,-0.6481889900449755,-1.0486929692069007,0.44579945799457993,1.0,1.0,3/17,5.84%,Lyn;Fcer1g;Syk
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.5556617960500666,1.0468002278979756,0.4006849315068493,1.0,1.0,4/56,1.78%,Maml2;Maml3;Hdac7;Ncor1
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,0.6302829819602455,1.0464731173776642,0.46402877697841727,1.0,1.0,4/21,5.63%,Mcu;Micu1;Yme1l1;Micu3
prerank,Translation Initiation Complex Formation R-HSA-72649,0.5476866177115957,1.0458720183433867,0.3741496598639456,1.0,1.0,22/52,17.84%,Eif3a;Eif4a1;Eif3h;Rps21;Eif4b;Rps7;Rps15a;Rps14;Rps17;Rps9;Eif4e;Rps28;Rps20;Rps3;Rps15;Rps8;Rps29;Rps12;Rps25;Eif4a2;Rpsa;Rps13
prerank,Gap Junction Trafficking And Regulation R-HSA-157858,-0.6432133701821414,-1.0446088097243036,0.4589041095890411,1.0,1.0,6/22,9.10%,Dab2;Myo6;Gja3;Gjd2;Gja1;Gjc2
prerank,Gluconeogenesis R-HSA-70263,-0.6437392508516122,-1.0446020902766677,0.463519313304721,1.0,1.0,2/27,6.35%,Slc25a13;Pck2
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.6366299022180872,-1.044244211244902,0.4508670520231214,1.0,1.0,8/26,9.13%,Plcb4;Inpp5d;Plch2;Pld4;Plcb2;Inppl1;Plch1;Plcd3
prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.6491138539938622,-1.044168326124132,0.4707482993197279,1.0,1.0,4/20,13.61%,Arhgef11;Plxnb1;Limk1;Myh14
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,0.45449257233567175,1.0437553446471248,0.3076923076923077,1.0,1.0,18/227,2.61%,Ahcyl2;Slc4a4;Slc2a13;Slc44a5;Slc16a2;Slc8a2;Slc29a4;Slc16a10;Slc16a7;Slc17a7;Slc39a6;Slc4a10;Slc24a4;Slc6a15;Slc4a7;Slc30a3;Calm1;Slc1a1
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.5701085156077552,-1.0437085514480422,0.41630901287553645,1.0,1.0,5/69,8.27%,Meis1;Mafb;Rara;Ncoa3;Egr2
prerank,DAG And IP3 Signaling R-HSA-1489509,0.5848991794422358,1.0432718636142104,0.4107142857142857,1.0,1.0,10/38,2.40%,Prkce;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Calm1;Camkk1
prerank,Sema4D In Semaphorin Signaling R-HSA-400685,-0.6489188922161471,-1.0414080018357177,0.48005502063273725,1.0,1.0,5/24,13.61%,Arhgef11;Plxnb1;Rras;Limk1;Myh14
prerank,Acyl Chain Remodelling Of PC R-HSA-1482788,-0.6287059229613394,-1.040269769088692,0.4643356643356643,1.0,1.0,8/26,15.88%,Pla2g4a;Lpcat2;Plaat3;Pla2g4c;Pla2g6;Lpcat3;Pnpla8;Pla2r1
prerank,Viral mRNA Translation R-HSA-192823,0.5150749935250275,1.0391724065866066,0.39603960396039606,1.0,1.0,43/85,18.85%,Rplp1;Rpl15;Rpl6;Uba52;Rps21;Rpl18;Rps7;Gnl3;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Rpsa;Rpl41;Rps13;Rpl21;Grsf1;Rps23
prerank,HS-GAG Degradation R-HSA-2024096,-0.647404209227842,-1.0386618245137342,0.4649859943977591,1.0,1.0,4/21,5.11%,Gpc6;Gpc5;Sdc4;Hpse
prerank,Aquaporin-mediated Transport R-HSA-445717,0.5651550688971486,1.0385846145854214,0.39464882943143814,1.0,1.0,8/42,4.30%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2;Rab11fip2;Aqp11
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.5216323917490132,1.03815382213002,0.3904109589041096,1.0,1.0,15/75,8.69%,Sgip1;Pdzd2;Eif4e3;Nedd4;Mapk3;Nup93;Abce1;Ndc1;Eif4g2;Eif4a1;Uba52;Nup160;Ranbp2;Gnl3;Eif4g3
prerank,RHO GTPases Activate CIT R-HSA-5625900,0.6146857588796822,1.0380932748464302,0.44534412955465585,1.0,1.0,2/19,2.42%,Ppp1r12b;Ppp1cb
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.5918722426858418,-1.0380167880415048,0.4507845934379458,1.0,1.0,6/54,16.01%,Tgfb1;Smurf1;Psmb8;Psme2;Psmb9;Ep300
prerank,Hedgehog On State R-HSA-5632684,-0.5619838432237311,-1.0362413302521056,0.43557422969187676,1.0,1.0,17/85,14.69%,Gpr161;Hhip;Smurf1;Numb;Smox;Gli3;Dzip1;Psmb8;Shh;Psmb11;Gli2;Kif7;Psme2;Gas1;Psme4;Psma8;Psmb9
prerank,Interleukin-37 Signaling R-HSA-9008059,-0.6439078292308137,-1.036231335349552,0.47083926031294454,1.0,1.0,10/20,18.61%,Ptpn14;Casp1;Ptpn9;Ptpn13;Ptpn5;Stat3;Ptpn6;Ptpn4;Ptpn18;Ptpn7
prerank,mRNA Splicing R-HSA-72172,-0.5213600555009774,-1.0356642913003629,0.4086471408647141,1.0,1.0,2/188,3.23%,Elavl2;Colec12
prerank,Translation R-HSA-72766,0.43701209137534847,1.0351899849902106,0.31451612903225806,1.0,1.0,88/256,18.30%,Dtd1;Fars2;Rars2;Rplp1;Ssr1;Farsa;Eif3a;Mrps26;Rpl15;Spcs2;Eef1a1;Rpl6;Eif4a1;Uba52;Eif3h;Rps21;Eif5b;Rpl18;N6amt1;Mrps22;Eif4b;Rps7;Rpl31;Rps15a;Rpl9;Sec61a2;Rpl35a;Eef2;Rpl7;Rps14;Rps17;Rps9;Mrpl58;Rpl4;Eif4e;Lars2;Rps28;Rplp2;Rpl3;Mrpl33;Rpl13a;Rps20;Eif2b5;Mtif2;Rpl27;Mrpl21;Spcs1;Mrpl23;Rpl36a;Iars2;Rps3;Rpl34;Rpl5;Rps15;Ptcd3;Rpl23;Mrps15;Rpl8;Rplp0;Mrpl16;Mrpl45;Mrpl18;Rps8;Rps29;Rpl12;Mrpl41;Rsl24d1;Rps12;Mrpl9;Eef1g;Rps25;Eif4a2;Farsb;Mrpl50;Mrpl30;Mrpl1;Mrpl34;Rpsa;Rpl41;Eef1d;Gadd45gip1;Pars2;Mrpl3;Rps13;Mrpl39;Rpl21;Mrps17;Eif5
prerank,Potassium Channels R-HSA-1296071,0.4977821467409073,1.0350938693325238,0.38127090301003347,1.0,1.0,27/99,4.63%,Kcnd2;Kcnj3;Kcnj6;Kcnh1;Kcnab1;Kcnd3;Kcnc3;Gabbr2;Kcng2;Gng7;Kcnk10;Kcna4;Kcnc4;Abcc8;Kcnk1;Gng2;Kcna1;Kcnma1;Kcng3;Kcng1;Kcnab2;Kcnq3;Kcnmb4;Kcnj2;Kcnj4;Kcnj9;Kcnk9
prerank,Other Semaphorin Interactions R-HSA-416700,0.6194993674296461,1.0350006374966214,0.4773662551440329,0.999621648239809,1.0,3/19,1.34%,Plxna4;Sema5a;Sema6d
prerank,Synthesis Of PA R-HSA-1483166,-0.6145401807386597,-1.0344827694606984,0.46088193456614507,1.0,1.0,6/37,17.40%,Pla2g4a;Gpat3;Pld2;Agpat2;Pla2r1;Lipi
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.5688586680935275,1.0343066195985255,0.42955326460481097,0.9956879083819938,1.0,6/38,2.54%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2
prerank,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.6374777195849555,1.0338194655557695,0.4854014598540146,0.9912014174919646,1.0,3/17,3.66%,Foxo1;Smad3;Btg1
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.4949303094588258,-1.0321196384254343,0.4008152173913043,1.0,1.0,63/241,9.04%,Itpr2;Apbb1ip;Prkcq;Pcdh7;Vav2;Prkcb;Lcp2;Pik3r1;Trpc3;Phactr2;Vav1;Fn1;Pla2g4a;Tgfb1;Sparc;Lyn;Gng4;Rasgrp1;Rapgef3;Cyrib;Pik3r5;Igf1;P2ry12;Selenop;Prkcd;Gna15;Trpc7;Prkch;Gng12;Cd9;Pik3cg;Sgpp2;Itih3;Prkcg;Sccpdh;Gna12;Vcl;Rhog;Gnb4;Pros1;Tmx3;Gnai1;Fermt3;Plek;Fcer1g;Syk;Rap1b;Endod1;Gngt2;Cd109;Vegfa;Prkca;Itpr3;Gnai2;Calu;App;Gna14;P2ry1;Clu;Vwf;Pik3r6;Lamp2;Vegfd
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.5530012309487722,-1.0313755690097788,0.44733044733044736,1.0,1.0,17/96,15.27%,Tnfrsf11a;Relb;Tnfrsf1b;Tnfrsf13b;Birc3;Traf3;Ltbr;Tnfrsf11b;Psmb8;Psmb11;Edaradd;Tnfrsf17;Psme2;Psme4;Psma8;Psmb9;Ltb
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.5316238561709071,1.031168998685525,0.4227129337539432,0.993052642324277,1.0,8/65,3.96%,Maml2;Maml3;Tnrc6c;Notch2;B4galt1;Jun;Ago2;Ago1
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.5859063517094354,-1.0308769906895177,0.46120689655172414,1.0,1.0,13/59,8.27%,Kcnh8;Trib1;Dusp6;Rps6ka5;Fosb;Sgk1;Mapk11;Egr1;Vgf;Mef2a;Arc;Rps6ka1;Egr2
prerank,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.6649633457783379,-1.0294170836942917,0.4806924101198402,1.0,1.0,1/15,1.95%,Lyn
prerank,MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.6615936216115272,-1.0291780217479627,0.5130674002751031,1.0,1.0,6/16,16.61%,Btk;Tlr1;Tirap;Tlr2;S100a1;Tlr6
prerank,Glutathione Conjugation R-HSA-156590,-0.6191030960165252,-1.0289288578139058,0.4652173913043478,1.0,1.0,3/32,7.45%,Hpgds;Ggt5;Gsta3
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.5173348766157513,-1.0287377708238574,0.41621621621621624,1.0,1.0,32/174,16.85%,Tbl1x;Ncf2;Prkcd;Nfe2l2;Notch1;Smarcd3;Atp7a;Gsta3;Txnip;Cyba;Ncf1;Myc;Nlrp3;Ncf4;Psmb8;Psmb11;Mafg;Gpx8;Stat3;Psme2;Trim21;Cox16;Psme4;Idh1;Slc7a11;Psma8;Glyat;Psmb9;Ep300;Mafk;Tkt;Abcc1
prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.5973909769387761,1.0284996940946947,0.48026315789473684,0.9950745700352263,1.0,5/38,0.89%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3
prerank,Selenocysteine Synthesis R-HSA-2408557,0.5096069310394259,1.0273615257735658,0.4067796610169492,0.9927775078803174,1.0,43/84,18.11%,Rplp1;Rpl15;Rpl6;Uba52;Rps21;Rpl18;Secisbp2;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Sephs2;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25;Rpsa;Rpl41;Eefsec;Rps13;Rpl21
prerank,Defective B3GALTL Causes PpS R-HSA-5083635,0.5975035693273623,1.0272534866474015,0.4723127035830619,0.9872214579008132,1.0,5/37,0.89%,Sema5a;Thsd7a;Adamts17;Spon1;Adamts3
prerank,Metabolism Of Steroid Hormones R-HSA-196071,-0.623004928511658,-1.0271335861373603,0.48413793103448277,1.0,1.0,5/29,14.36%,Stard4;Hsd17b12;Hsd17b11;Chga;Stard3
prerank,CDC42 GTPase Cycle R-HSA-9013148,-0.5214803820691359,-1.0267144257738487,0.42993197278911566,1.0,1.0,33/144,5.28%,Fnbp1l;Srgap1;Cpne8;Wipf1;Plekhg1;Dlc1;Vav2;Arap2;Arhgap22;Pik3r1;Arhgap31;Srgap2;Arhgap45;Dock8;Farp1;Arhgef26;Fmnl3;Arhgap26;Cdc42ep3;Fnbp1;Prex1;Mcf2;Dock6;Arhgap42;Arhgap24;Cdc42ep1;Arhgef11;Arap1;Ophn1;Arhgef6;Iqgap1;Syde1;Arhgef10
prerank,Signal Amplification R-HSA-392518,-0.6228755015866994,-1.0265177415440399,0.49140401146131807,1.0,1.0,11/32,8.36%,Pla2g4a;Gng4;P2ry12;Gna15;Gng12;Gnb4;Gnai1;Gngt2;Gnai2;Gna14;P2ry1
prerank,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6362678493519972,-1.0252057746069645,0.4722617354196302,1.0,1.0,7/18,20.21%,Birc3;Tlr3;Ticam1;Chuk;Ube2v1;Ubc;Ripk1
prerank,Metalloprotease DUBs R-HSA-5689901,-0.6268699712084693,-1.025019851174066,0.48424068767908307,1.0,1.0,3/27,8.97%,Kat2b;Stambpl1;Nlrp3
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.5847335819237954,-1.0248686311038009,0.4782608695652174,1.0,1.0,9/55,1.95%,Dock1;Elmo1;Wipf1;Vav2;Myo1e;Nckap1l;Hck;Vav1;Lyn
prerank,MHC Class II Antigen Presentation R-HSA-2132295,-0.5656854083406333,-1.024855862536572,0.4660056657223796,1.0,1.0,15/85,10.76%,Osbpl1a;Kif26a;Ctss;Lgmn;Ctsd;Dnm3;Ap1m2;Ctsc;Ctsh;Kif5a;Lag3;Ap2b1;Dync1li2;Sh3gl2;Dync1h1
prerank,Inositol Phosphate Metabolism R-HSA-1483249,-0.5881756414180151,-1.0237960478774688,0.47564469914040114,1.0,1.0,10/47,9.13%,Plcb4;Inpp5d;Plch2;Pld4;Plcb2;Nudt4;Inppl1;Plch1;Inpp5a;Plcd3
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.5353900078506411,-1.023260062594306,0.43162393162393164,1.0,1.0,12/127,2.31%,Itpr2;Prkcq;Gab2;Vav2;Lcp2;Pik3r1;Tec;Nfatc1;Vav1;Lyn;Rasgrp1;Nfatc2
prerank,ERK/MAPK Targets R-HSA-198753,-0.6369879730838756,-1.0222023524594541,0.49789621318373073,1.0,1.0,6/21,7.90%,Kcnh8;Dusp6;Rps6ka5;Mapk11;Mef2a;Rps6ka1
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,0.5434393943022311,1.022110504895787,0.43884892086330934,0.9971809926835701,1.0,18/49,16.30%,Gtf2f2;Eftud2;Ncbp1;Srsf1;Snrnp40;Polr2e;Sf3b3;Snrnp48;Polr2f;Zcrb1;Snrpd3;Ybx1;Snrnp25;Ddx42;Snrpb;Srsf7;Polr2k;Polr2g
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.5903188375876705,-1.0201024017187938,0.48801128349788436,1.0,1.0,7/46,14.69%,Mrc1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6135746118911481,-1.0177139645839173,0.5111111111111111,1.0,1.0,2/27,2.46%,Fgf1;Fgfr3
prerank,RHOA GTPase Cycle R-HSA-8980692,-0.5220496768920962,-1.0176999259668267,0.43306010928961747,1.0,1.0,40/144,8.41%,Srgap1;Dock2;Pcdh7;Dlc1;Vav2;Arap2;Arhgap22;Pik3r1;Arhgap23;Arhgap31;Arhgap45;Farp1;Fmnl3;Vav1;Arhgap26;Prex1;Mcf2;Anln;Arhgap18;Arhgef40;Arhgap42;Arhgap24;Tjp2;Akap13;Arhgef11;Arap1;Ophn1;Iqgap1;Arhgef10;Mcam;Depdc1b;Arhgap28;Arhgap11a;Arhgef19;Rhpn2;Arhgap6;Gmip;Arhgap30;Erbin;Arhgap5
prerank,Signaling By ERBB4 R-HSA-1236394,0.5327033459442351,1.0169839237104783,0.43686006825938567,1.0,1.0,7/56,1.78%,Gabrb3;Gabrb1;Nrg2;Gabrb2;Nrg3;Gabrg2;Ncor1
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.5901871117903408,-1.016766148622019,0.48787446504992865,1.0,1.0,9/49,5.73%,Cpne8;Pik3r1;Vrk2;Arhgap26;Akap12;Plxnb1;Plxna1;Mcam;Depdc1b
prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.5351677031671623,-1.0167003628632783,0.4479768786127168,1.0,1.0,17/115,13.86%,Rab31;Optn;Dennd1c;Rin3;Rin2;Rab3il1;Dennd4a;Dennd2c;Dennd3;Dennd5a;Tbc1d10c;Rab7b;Rinl;Chml;Dennd5b;Dennd2d;Rab1a
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.5878258179722314,-1.016403086914471,0.48911465892597966,1.0,1.0,13/50,9.42%,Bcl2;P2rx7;Irak2;Casp8;Casp1;Mapk11;Casp4;Cyld;Birc3;Txnip;App;Nlrp3;Tnfaip3
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5439860444712336,-1.0162471677999785,0.4406294706723891,1.0,1.0,12/108,3.05%,Itpr2;Prkcb;Rasgrp3;Pik3r1;Nfatc1;Pik3ap1;Vav1;Dapp1;Lyn;Rasgrp1;Nfatc2;Rel
prerank,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.6260467198507287,-1.016214532272709,0.49931224209078406,1.0,1.0,10/23,24.82%,Rbbp8;Rad51b;Wrn;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.5279983302481649,1.0161115572824844,0.4471830985915493,1.0,1.0,19/53,16.30%,Gtf2f2;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Ncbp1;Polr2e;Skic8;Polr2f;Mnat1;Ccnk;Ccnt2;Rtf1;Dmap1;Elob;Cdc73;Polr2k;Cdk9;Polr2g
prerank,Glucose Metabolism R-HSA-70326,-0.5645727252522665,-1.014685935471137,0.48295454545454547,1.0,1.0,7/79,8.06%,Pfkp;Slc25a13;Pfkfb4;Pck2;Pfkfb3;Prkca;Map4k2
prerank,G Alpha (I) Signaling Events R-HSA-418594,-0.49382581090134314,-1.0144965074840533,0.4348404255319149,1.0,1.0,37/246,5.38%,Pde4b;Camk2d;Itpr2;Rgs20;Pde4d;Plcb4;Grm8;Grm3;Htr1f;Lpar1;Cx3cr1;Chrm2;Rgs12;Ccr5;Pde1a;Camk4;Pla2g4a;Gng4;Rgs10;Pde1c;Rgs3;P2ry13;P2ry12;Prkcd;Gna15;Gng12;Prkar1b;Rgs6;Ptger3;Oprk1;Plcb2;Prkcg;Insl5;Adcy7;Gnb4;Gnai1;Grm4
prerank,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.620148377896216,-1.0133742529887149,0.5048143053645117,1.0,1.0,11/26,24.82%,Rbbp8;Rad51b;Wrn;Xrcc3;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Acyl Chain Remodelling Of PI R-HSA-1482922,-0.6390989213912731,-1.0132903504873345,0.5207756232686981,1.0,1.0,3/16,6.04%,Pla2g4a;Plaat3;Pla2g4c
prerank,Antimicrobial Peptides R-HSA-6803157,-0.6008007523518512,-1.011449083687124,0.5081521739130435,1.0,1.0,10/33,18.59%,Atp7a;Clu;Tlr1;Trim21;Chga;Tlr2;Tspan32;Ltf;Ccr2;Ro60
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.5840654503156548,-1.0112284600989978,0.49199417758369723,1.0,1.0,18/48,23.66%,Egr1;Irf8;Irf3;Irf2;Psmb8;Ifi27;Ptpn1;Mx2;Ptpn6;Rnasel;Xaf1;Irf5;Ifitm1;Isg20;Oas2;Ifit1;Irf6;Rsad2
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.5042026580986717,-1.010327661990437,0.45566166439290584,1.0,1.0,13/164,5.98%,Kif21b;Akr1b10;Cux1;Pla2g4a;Kif26a;Usp6nl;Kif6;Man2a1;Golim4;Kif13b;Kif5a;Cyth4;Kif16b
prerank,Endogenous Sterols R-HSA-211976,0.587725823159474,1.0090321049032922,0.4785714285714286,1.0,1.0,3/21,5.21%,Cyp7b1;Cyp11a1;Ncoa1
prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.42593008689554956,1.0078689130215737,0.39565217391304347,1.0,1.0,48/300,4.63%,Kalrn;Grin2b;Lrrc7;Camk2a;Camk2b;Nrg2;Rasal2;Rasgrf1;Foxo1;Nrg3;Rasgrf2;Tnrc6c;Rapgef2;Gfra1;Cnksr2;Ncam1;Ksr2;Sptb;Sptbn1;Mapk1;Ptpn3;Map2k1;Rasgef1a;Sptbn4;Gfra2;Tgfa;Ptk2;Sptan1;Calm1;Flt3;Ppp1cb;Jun;Pik3cb;Ptpra;Fgf5;Abhd17c;Camk2g;Ago2;Spred2;Arhgef7;Actn2;Ago1;Fyn;Mras;Syngap1;Ksr1;Gprin1;Src
prerank,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.6158731180924908,-1.0064030668143757,0.5225718194254446,1.0,1.0,10/24,24.82%,Rbbp8;Rad51b;Wrn;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,RHOU GTPase Cycle R-HSA-9013420,-0.6039694908194008,-1.0063884881024705,0.504225352112676,1.0,1.0,12/39,8.19%,Pik3r1;Arhgap31;Srgap2;Peak1;Myo6;Wwp2;Arhgef6;Iqgap1;Depdc1b;Dst;Stam2;Arhgap30
prerank,IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.6418528445046789,-1.0059517748616598,0.5321477428180574,1.0,1.0,6/17,16.61%,Btk;Tlr1;Tirap;Tlr2;S100a1;Tlr6
prerank,Ca2+ Pathway R-HSA-4086398,0.5196159381998366,1.0054058239485777,0.43042071197411,1.0,1.0,11/60,3.52%,Ppp3ca;Prkg1;Camk2a;Plcb1;Tnrc6c;Gng7;Calm1;Gng2;Ppp3r1;Itpr1;Ago2
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.6208308999635483,-1.005393466570584,0.5145228215767634,1.0,1.0,8/27,22.16%,Phyh;Crot;Abcd1;Ehhadh;Hao2;Acox3;Acox1;Nudt7
prerank,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.6297538528978357,-1.0049473933341928,0.496551724137931,1.0,1.0,4/16,20.00%,Ngf;Mapk8;Ngfr;Ubc
prerank,HCMV Early Events R-HSA-9609690,-0.5547474295245199,-1.004173181448358,0.49344978165938863,1.0,1.0,7/80,10.76%,Tbl1x;Kcnh8;Pcsk1;Egfr;Itgb1;Dync1li2;Dync1h1
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.6047685614051331,1.0035452857302118,0.47601476014760147,1.0,1.0,2/20,7.71%,B4galt1;Alg2
prerank,Regulation Of Insulin Secretion R-HSA-422356,0.5104018467529156,1.0031750603424587,0.4309210526315789,1.0,1.0,11/74,2.54%,Cacna1c;Cacna1e;Cacnb2;Plcb1;Cacna1d;Kcng2;Gng7;Gnaq;Rapgef4;Abcc8;Gng2
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.6047029252271444,1.0031373996161594,0.4568345323741007,1.0,1.0,2/16,3.28%,Mtmr12;Inpp4a
prerank,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.5996087698293252,-1.0026097726882695,0.5139664804469274,1.0,1.0,12/31,24.82%,Rbbp8;Rad51b;Wrn;Eme1;Xrcc3;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Resolution Of D-Loop Structures R-HSA-5693537,-0.5991098759797856,-1.0023162566204933,0.511921458625526,1.0,1.0,12/32,24.82%,Rbbp8;Rad51b;Wrn;Eme1;Xrcc3;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Signaling By FGFR2 R-HSA-5654738,-0.5611801294918587,-1.0015268686031775,0.48732394366197185,1.0,1.0,2/68,1.27%,Pik3r1;Fgf1
prerank,VLDLR Internalisation And Degradation R-HSA-8866427,-0.639149206249444,-1.0013297490209843,0.5306406685236769,1.0,1.0,5/16,20.00%,Mylip;Ap2b1;Pcsk9;Cltc;Ubc
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.5301580379709335,1.0008941488789356,0.4863013698630137,1.0,1.0,19/45,18.85%,Eif3a;Eif3h;Rps21;Rps7;Rps15a;Rps14;Rps17;Rps9;Rps28;Rps20;Rps3;Rps15;Rps8;Rps29;Rps12;Rps25;Rpsa;Rps13;Rps23
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,0.5188220662944746,1.0008580132196099,0.4847457627118644,1.0,1.0,20/54,11.63%,Cnot2;Cnot6l;Dcp1b;Lsm7;Nt5c3b;Dcp1a;Eif4a1;Edc3;Edc4;Cnot4;Eif4b;Exosc8;Skic3;Skic8;Pan3;Cnot3;Cnot1;Eif4e;Lsm4;Exosc2
prerank,CaM Pathway R-HSA-111997,0.568566429172908,1.0004557471951407,0.48120300751879697,0.9975944472877729,1.0,9/32,2.40%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Calm1;Camkk1
prerank,Apoptotic Factor-Mediated Response R-HSA-111471,-0.618340258462065,-0.9998462358202993,0.5289855072463768,1.0,1.0,1/19,0.92%,Septin4
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.6216901194033587,-0.9996169646938494,0.5368852459016393,1.0,1.0,2/23,6.80%,Pik3r1;Egfr
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.5806451253062297,0.9991970401656156,0.5105633802816901,0.995684994031318,1.0,10/32,11.34%,Chd4;Chd3;Gatad2b;Rbbp7;H2bc4;Hdac1;Mta3;H2az1;Cbx3;H2ac6
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.5052011988546455,0.996143494926699,0.47101449275362317,0.9987265617495859,1.0,6/72,2.94%,Negr1;Lsamp;Cntn5;Ntng2;Nrn1;Rtn4rl1
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,0.46103932571565165,0.9960515641649541,0.4397163120567376,0.993550344251716,1.0,13/141,3.52%,Ppp3ca;Prkg1;Camk2a;Plcb1;Tnrc6c;Prickle1;Gng7;Calm1;Gng2;Ppp3r1;Vangl2;Itpr1;Ago2
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.57134712380951,-0.9944769077123087,0.5091164095371669,1.0,1.0,9/47,12.55%,Plagl1;E2f1;Plk3;Rgcc;E2f7;Ccnb1;Plk2;Cdk2;E2f8
prerank,Deubiquitination R-HSA-5688426,-0.48229634922808196,-0.9935419807158528,0.48456375838926175,1.0,1.0,38/246,16.52%,Tgfb1;Kat2b;Tgfbr2;Smad7;Cnksr3;Smad2;Cftr;Ccp110;Josd2;Smad1;Trim25;Stambpl1;Esr1;Cyld;Birc3;Traf3;Ifih1;Rigi;Stam2;Rnf135;Myc;Adrb2;Nlrp3;Tnfaip3;Psmb8;Psmb11;Nod1;Otud7b;Psme2;Psme4;Psma8;Psmb9;Tnip3;Usp28;Usp3;Ep300;Nod2;Usp24
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.5805987842894567,-0.992699452306107,0.5238095238095238,1.0,1.0,5/40,3.94%,Dusp10;Dusp5;Dusp16;Ppp2r5a;Dusp6
prerank,Cilium Assembly R-HSA-5617833,-0.49441345242825624,-0.9925356208206401,0.467828418230563,1.0,1.0,20/183,14.54%,Asap1;Smox;Ccp110;Tubb4a;Sclt1;Nedd1;Bbs9;Nde1;Prkca;Cep83;Ift88;Atat1;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Bbs5
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.6246439990406444,-0.9921875641482433,0.5383542538354253,1.0,1.0,7/21,7.80%,Gng4;P2ry12;Gng12;Gnb4;Gnai1;Gngt2;Gnai2
prerank,Metal Ion SLC Transporters R-HSA-425410,0.5809940068217891,0.9920644737377602,0.5100671140939598,0.9992856981793709,1.0,2/26,2.33%,Slc39a6;Slc30a3
prerank,Metabolism Of Polyamines R-HSA-351202,-0.5647319988850638,-0.9920424589782133,0.5245664739884393,1.0,1.0,9/57,19.85%,Smox;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Slc25a21;Slc38a1
prerank,Sensory Perception R-HSA-9709957,-0.4707236867565482,-0.9918026462934345,0.4890038809831824,1.0,1.0,36/280,8.22%,Ldb2;Gpc6;Prkcq;Pcdh15;Whrn;Gpc5;Epb41l3;Kcnn2;Akr1b10;Myo1e;Cacna2d2;Gsn;Clic5;Stx1a;Rlbp1;Bco2;Plcb2;Msn;Trpm4;Sdc4;Grm4;Myo3a;Cabp1;Camkmt;Apoe;Or51e1;Dhrs3;Or51d1;Or52i2;Prkca;Gucy2f;Itpr3;Or2t6;Slc24a1;Tmc1;Or52k2
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5549077246982588,-0.9911096229049942,0.5085470085470085,1.0,1.0,17/69,11.27%,Pik3r1;Kcnh8;Bcl2;Gng4;Gng12;Gnb4;Gnai1;Esr1;Cav2;Ccnd1;Gngt2;Egfr;Gnai2;Foxo3;Esr2;Pik3ca;Cav1
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,0.4515995417941806,0.9908276868815803,0.4411764705882353,0.9973187568457559,1.0,14/156,2.80%,Gria1;Ank3;Nsf;Cnih3;Sptb;Sptbn1;B4galt5;Sptbn4;Ank2;Dync1i2;B4galt1;Tgfa;Sptan1;Sec24d
prerank,O-linked Glycosylation R-HSA-5173105,0.4799933908104904,0.988697028871691,0.4506172839506173,0.9980973674947577,1.0,9/98,1.92%,Sema5a;Thsd7a;St6galnac3;Adamts17;Spon1;Adamts3;Galnt14;Galnt18;B4galt5
prerank,Asparagine N-linked Glycosylation R-HSA-446203,0.4212430496433004,0.9882865415255575,0.4872881355932203,0.9937846493680818,1.0,19/273,3.42%,Gria1;St6galnac3;Ank3;Nsf;St6galnac5;Cnih3;Sptb;Sptbn1;B4galt5;Sptbn4;Ank2;Dync1i2;B4galt1;Tgfa;Sptan1;St8sia4;Sec24d;Fut8;St3gal1
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.5949678332289655,-0.9874926846741574,0.5402777777777777,1.0,1.0,4/28,3.36%,Sv2b;Stx1a;Antxr1;Cd9
prerank,Kinesins R-HSA-983189,-0.5821013876060066,-0.9873699971502762,0.5340909090909091,1.0,1.0,6/36,5.98%,Kif21b;Kif26a;Kif6;Kif13b;Kif5a;Kif16b
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.5114277877741716,-0.9852601130465332,0.5200573065902578,1.0,1.0,26/132,11.63%,Ly86;Kcnh8;Itgam;Cd180;Irak2;Casp8;Dnm3;Dusp6;Rps6ka5;Alpk1;Mapk11;Irak3;Birc3;Traf3;Btk;S100b;Map3k1;Mef2a;Rps6ka1;App;Irf3;Mapk8;Itgb2;Tlr1;Nod1;Tirap
prerank,Regulated Necrosis R-HSA-5218859,-0.5672903182169231,-0.9847961913200185,0.5236728837876614,1.0,1.0,15/49,20.21%,Casp8;Casp1;Casp4;Birc3;Il1a;Irf2;Mlkl;Il18;Cflar;Casp3;Tnfsf10;Flot2;Xiap;Ubc;Ripk1
prerank,RHO GTPases Activate ROCKs R-HSA-5627117,0.5798870462938557,0.9843564044335018,0.48412698412698413,0.9996611657779192,1.0,2/19,2.42%,Ppp1r12b;Ppp1cb
prerank,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.623226091150026,-0.9840488500945277,0.5538674033149171,1.0,1.0,7/20,21.29%,Irf3;Tlr3;Dtx4;Ticam1;Chuk;Ripk1;Nfkbia
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.5863746440082573,-0.9831403734330012,0.5639204545454546,1.0,1.0,4/34,8.11%,Runx1;Hipk2;Smarcd3;Pcgf5
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.5304319914665038,-0.9825121479262302,0.531700288184438,1.0,1.0,10/91,3.17%,Dock1;Elmo1;Itpr2;Vav2;Prkcb;Pik3r1;Nckap1l;Vav1;Ncf2;Prkcd
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.4848997991774793,-0.9817801337434175,0.5013513513513513,1.0,1.0,24/182,9.91%,Tcf7l2;Sox6;Rspo2;Cxxc4;Sox2;Tle3;Tcf7l1;Ccdc88c;Ppp2r5a;Wif1;Sox4;Lrp5;Lef1;Tle2;Rnf43;Ctnnbip1;Bcl9;Ppp2r5c;Dkk2;Sox13;Myc;Lgr5;Rspo1;Fzd2
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,-0.4956669769761827,-0.9812138561615812,0.523680649526387,1.0,1.0,23/166,14.75%,Tlr7;Irak2;Masp1;Ywhaq;Il17ra;Sting1;Trim25;Traf3;Ifih1;Rigi;Rnf135;Irf3;Nlrp12;Gja1;Nlrp3;Il17rc;Tlr1;Cav1;Nod1;Ptpn6;Tlr2;B2m;Sec24a
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.560388497455038,0.9797326309086217,0.5300353356890459,1.0,1.0,1/29,0.20%,Nr3c2
prerank,Adherens Junctions Interactions R-HSA-418990,0.56523686326717,0.9795122833352518,0.4895833333333333,1.0,1.0,7/29,2.21%,Cdh9;Cadm2;Cdh8;Cdh12;Cdh13;Cdh2;Cadm1
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.5716613948318875,-0.9794988734731679,0.553041018387553,1.0,1.0,7/41,6.20%,Tbl1x;Abca1;Arl4c;Apod;Nrip1;Apoe;Kdm3a
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.557285282772469,-0.9790736047617208,0.550354609929078,1.0,1.0,7/55,1.76%,Dock1;Elmo1;Wipf1;Vav2;Myo1e;Nckap1l;Vav1
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.557156300257717,-0.9789351614486319,0.5354558610709117,1.0,1.0,15/58,22.16%,Phyh;Pex7;Crot;Ehhadh;Idh1;Hao2;Glyat;Pex13;Acox3;Acox1;Ide;Hmgcl;Ubc;Agps;Nudt7
prerank,Potential Therapeutics For SARS R-HSA-9679191,-0.5348502779318857,-0.9786187004628059,0.534850640113798,1.0,1.0,16/91,9.57%,Vav1;Tlr7;Fxyd7;Atp1a2;S1pr1;Nfe2l2;Jak2;Atp1b3;Syk;Btk;Blnk;Vegfa;Ifngr1;Itgb1;Ap2b1;Gatad2a
prerank,Ion Homeostasis R-HSA-5578775,0.5370412898962419,0.9776754876524805,0.5017301038062284,1.0,1.0,13/48,3.67%,Ryr2;Camk2a;Camk2b;Slc8a2;Atp2b1;Orai2;Atp1b1;Atp2b3;Ryr1;Calm1;Itpr1;Camk2g;Ryr3
prerank,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.5843228444174214,0.9763929159834149,0.4982456140350877,1.0,1.0,3/20,0.68%,Prkce;Nrg2;Nrg3
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.5094115888370283,0.9761884151441934,0.5052264808362369,0.9959927767847186,1.0,22/53,17.84%,Eif3a;Eif4a1;Eif3h;Rps21;Eif4b;Rps7;Rps15a;Rps14;Rps17;Rps9;Eif4e;Rps28;Rps20;Rps3;Rps15;Rps8;Rps29;Rps12;Rps25;Eif4a2;Rpsa;Rps13
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.5324807667884985,-0.9757303471505334,0.536723163841808,1.0,1.0,15/84,13.86%,Rab31;Dennd1c;Rin3;Rin2;Rab3il1;Dennd4a;Dennd2c;Dennd3;Dennd5a;Rab7b;Rinl;Chml;Dennd5b;Dennd2d;Rab1a
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.5757760274727344,-0.9751153790836824,0.5546099290780142,1.0,1.0,4/36,10.00%,Ccnd3;E2f1;Ccnd1;Cdk2
prerank,Integrin Cell Surface Interactions R-HSA-216083,-0.5481295137459924,-0.9728785919805262,0.550354609929078,1.0,1.0,14/64,7.97%,Itga9;Itgb5;Col16a1;Itgam;Fn1;Jam3;Jam2;F11r;Cd44;Itga2;Itga6;Col9a1;Itgb1;Col9a3
prerank,DAP12 Signaling R-HSA-2424491,-0.5890406612026581,-0.9714139242056545,0.5571030640668524,1.0,1.0,7/26,6.47%,Vav2;Lcp2;Pik3r1;Tyrobp;Trem2;Syk;Btk
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.560326126646948,-0.9712036111262421,0.5463768115942029,1.0,1.0,21/60,21.29%,Casp8;Trim25;Cyld;Traf3;S100b;Map3k1;Ifih1;Rigi;Rnf135;App;Irf3;Tnfaip3;Rnf125;Uba7;Ep300;Tax1bp1;Chuk;Ubc;Ripk1;Mavs;Nfkbia
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.471081030334356,0.9710441099584352,0.5261324041811847,1.0,1.0,40/101,15.52%,Rplp1;Ssr1;Rpl15;Spcs2;Rpl6;Uba52;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Sec61a2;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Spcs1;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.4848112954957455,0.9709128258085656,0.5257731958762887,1.0,1.0,6/80,2.33%,Slc2a13;Slc44a5;Slc16a7;Slc39a6;Slc6a15;Slc30a3
prerank,Interleukin-12 Signaling R-HSA-9020591,-0.5691108099524518,-0.9685984254380376,0.537117903930131,1.0,1.0,10/39,16.15%,Jak2;Msn;Rap1b;Psme2;Il12rb1;Il12a;Rala;Cdc42;Pkn2;Pitpna
prerank,DAP12 Interactions R-HSA-2172127,-0.5799296825384607,-0.9679061909288978,0.5649171270718232,1.0,1.0,7/30,6.47%,Vav2;Lcp2;Pik3r1;Tyrobp;Trem2;Syk;Btk
prerank,Ca-dependent Events R-HSA-111996,0.5519663395227715,0.9678710135594366,0.5149253731343284,1.0,1.0,10/34,2.40%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Mapk1;Pde1b;Adcy9;Calm1;Camkk1
prerank,RAC1 GTPase Cycle R-HSA-9013149,-0.4828185001673603,-0.9673426078275034,0.5242718446601942,1.0,1.0,52/175,8.41%,Dock1;Srgap1;Dock2;Wipf1;Plekhg1;Dlc1;Vav2;Arap2;Arhgap22;Pik3r1;Arhgap23;Vrk2;Arhgap31;Srgap2;Arhgap45;Dock8;Nckap1l;Farp1;Dock5;Vav1;Arhgap25;Arhgap26;Prex1;Mcf2;Garre1;Ncf2;Dock6;Arhgap42;Arhgap24;Cdc42ep1;Swap70;Arhgef11;Arap1;Ophn1;Arhgef6;Iqgap1;Arhgef10;Mcam;Depdc1b;Arhgef19;Pld2;Plekhg2;Gmip;Itgb1;Cyba;Slc1a5;Arhgap30;Egr2;Fgd5;Ncf1;Erbin;Arhgap5
prerank,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.602955292241631,-0.9668640845844297,0.556786703601108,1.0,1.0,3/21,12.40%,Tcn2;Acaca;Sp8
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.47600389565487206,0.9648742304985085,0.5155709342560554,1.0,1.0,39/92,15.52%,Rplp1;Rpl15;Rpl6;Uba52;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Asns;Rpl7;Rps14;Gcn1;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Atf3;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12;Rps25
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.5649491766654811,-0.9644684400822124,0.5631205673758866,1.0,1.0,10/48,5.87%,Gpc6;Xylt1;Gpc5;Bcan;Cspg4;Vcan;Chst3;Cspg5;Sdc4;Dcn
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.46820823826808977,-0.9642199467539743,0.5377483443708609,1.0,1.0,2/237,3.23%,Elavl2;Colec12
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.4997283870003836,0.9633290669264344,0.5277777777777778,1.0,1.0,11/70,8.15%,Cdc40;Srsf11;Thoc2;Srsf9;Nup93;Ndc1;Ncbp1;Fyttd1;Srsf1;Nup160;Ranbp2
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.543776041234385,0.962796651306827,0.5283687943262412,1.0,1.0,5/31,2.54%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.5819515282601143,-0.9626613783065818,0.5730027548209367,1.0,1.0,6/32,8.23%,Ndrg1;Cradd;Aifm2;Casp1;Bid;Igfbp3
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.49288491425611103,-0.9605208804247326,0.5477178423236515,1.0,1.0,45/139,14.07%,Itpr2;Rxfp1;Htr7;Hck;Lyn;Gng4;Gng12;Prkar1b;Npsr1;Ggt5;Adcy7;Adam17;Gnb4;Gnai1;Syk;Gngt2;Gnas;Prkca;Itpr3;Hrh2;Gnai2;Pth2r;Adrb3;C1qtnf1;Adrb2;Adora2b;Crhr1;Nlrp3;Pthlh;Plk2;Sctr;Lhcgr;Adrb1;Adcy5;Tshb;Cysltr1;Calcr;Adm;Adora2a;Chga;Glp1r;Gnb1;Adcyap1;Calcb;Gng11
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5408026736231945,-0.9592820167955904,0.557909604519774,1.0,1.0,7/60,14.69%,Cftr;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,PCP/CE Pathway R-HSA-4086400,-0.5162674456009108,-0.9589011450080268,0.5698478561549101,1.0,1.0,15/88,14.69%,Prkcb;Smurf1;Prkcg;Prkca;Wnt5b;Ncoa3;Ap2b1;Fzd2;Psmb8;Psmb11;Rac2;Psme2;Psme4;Psma8;Psmb9
prerank,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.6043461819252591,-0.9588118583170502,0.5734463276836158,1.0,1.0,1/15,0.93%,Ddah1
prerank,Mismatch Repair R-HSA-5358508,-0.614216237616493,-0.9586814797561697,0.5972222222222222,1.0,1.0,2/15,10.80%,Pold4;Lrig1
prerank,HIV Infection R-HSA-162906,-0.47101348208698973,-0.9574999754307982,0.5459387483355526,1.0,1.0,5/214,3.35%,Elmo1;Dock2;Ccr5;Hck;Ap1m2
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.591657237611729,-0.9573678098478815,0.5692520775623269,1.0,1.0,5/21,15.76%,Bcat1;Soat1;Bckdhb;Hibadh;Acadsb
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.5712169190288299,-0.9572654683147797,0.5965665236051502,1.0,1.0,6/34,6.20%,Tbl1x;Abca1;Arl4c;Apod;Apoe;Kdm3a
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.6151440465708361,-0.9570652034560533,0.5808219178082191,1.0,1.0,4/15,15.72%,Eps15;Stam2;Sh3gl2;Sh3gl3
prerank,Cell-Cell Communication R-HSA-1500931,0.4552958969415775,0.9567179327668557,0.4966442953020134,1.0,1.0,15/111,3.09%,Kirrel3;Cdh9;Cadm2;Cdh8;Ptk2b;Cdh12;Pard3;Sptbn1;Cdh13;Cdh2;Cadm1;Ptk2;Sptan1;Pik3cb;Nck2
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.5464677277652075,0.9562794988091161,0.5080906148867314,1.0,1.0,7/31,4.91%,Nedd4l;Ncor1;Mapk1;Smad3;Ski;Mapk3;Parp1
prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.4937543523642954,-0.955997915536593,0.5668523676880223,1.0,1.0,33/133,9.32%,Rxfp1;Pde8a;Pde4d;Pde11a;Pde1a;Htr7;Pde3a;Gng4;Grk3;Gng12;Prkar1b;Npsr1;Pde2a;Adcy7;Gnb4;Gnai1;Pde10a;Gngt2;Gnas;Prkca;Pde3b;Hrh2;Gnai2;Itgb1;Pth2r;Grk5;Adrb3;C1qtnf1;Adrb2;Adora2b;Crhr1;Nlrp3;Pthlh
prerank,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.6188525000753167,-0.9557719947319901,0.5763888888888888,1.0,1.0,5/15,25.89%,Irak2;Ticam1;Ubc;Tlr4;Ly96
prerank,Drug ADME R-HSA-9748784,-0.5472199054390506,-0.9546660763469301,0.5639943741209564,1.0,1.0,6/55,4.99%,Vav2;Slco2b1;Vav1;Slc22a3;Ggt5;Slc38a3
prerank,PERK Regulates Gene Expression R-HSA-381042,0.5620998262526851,0.9540853265242036,0.550185873605948,1.0,1.0,1/29,1.44%,Atf6
prerank,Signaling By ROBO Receptors R-HSA-376176,0.41773039501484044,0.9540187334971829,0.5518518518518518,1.0,1.0,11/201,3.84%,Slit3;Robo2;Nell2;Nrp1;Dcc;Lhx9;Arhgap39;Nck2;Cap1;Arhgef7;Abl2
prerank,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.6081770707278946,-0.9532960607560599,0.5829787234042553,1.0,1.0,4/16,3.35%,Tgfb1;Tgfbr2;F11r;Smurf1
prerank,Tight Junction Interactions R-HSA-420029,-0.5870055150084019,-0.9524342403211806,0.5939226519337016,1.0,1.0,4/25,3.40%,Cldn14;F11r;Cldn1;Cldn11
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.5582214111124888,-0.9520907390233897,0.5783475783475783,1.0,1.0,9/32,24.00%,Pold4;Fen1;Wrn;Lrig1;Dscc1;Prim2;Chtf8;Dna2;Blm
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.5709885126557661,-0.9518892934225168,0.5810055865921788,1.0,1.0,6/30,7.98%,Dner;Numb;Notch1;Adam17;Adam10;Jag2
prerank,Cellular Response To Heat Stress R-HSA-3371556,0.46332264336921064,0.9512475840512097,0.5140845070422535,1.0,1.0,9/92,5.33%,Camk2a;Camk2b;Mapk1;Camk2g;Bag4;Hspa2;Mapk3;Dnajb6;Hsp90ab1
prerank,RHOF GTPase Cycle R-HSA-9035034,-0.5597989702976416,-0.9508297634348554,0.580829756795422,1.0,1.0,8/39,6.17%,Pik3r1;Srgap2;Farp1;Akap12;Syde1;Mcam;Depdc1b;Baiap2l2
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.5249851633798757,-0.9507322801172156,0.5941605839416059,1.0,1.0,9/77,8.34%,St6gal1;St8sia5;St3gal6;Neu4;St6gal2;St8sia6;Uap1;Nagk;St6galnac2
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.513778255457824,0.9504611701552999,0.5107913669064749,1.0,1.0,23/44,20.54%,Rps21;Rps7;Rps15a;Rps14;Rps17;Rps9;Rps28;Rps20;Snrpd3;Gemin8;Rps3;Rps15;Rps8;Snrpb;Rps29;Rps12;Rps25;Rpsa;Rps13;Rps23;Gemin5;Snrpg;Fau
prerank,HCMV Infection R-HSA-9609646,-0.5084837921071905,-0.9501396306378685,0.5852272727272727,1.0,1.0,7/104,10.76%,Tbl1x;Kcnh8;Pcsk1;Egfr;Itgb1;Dync1li2;Dync1h1
prerank,Lagging Strand Synthesis R-HSA-69186,-0.5819385183824272,-0.9479329909698643,0.5885714285714285,1.0,1.0,5/20,21.15%,Pold4;Fen1;Lrig1;Prim2;Dna2
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.5580949641755285,-0.9466526652351924,0.5904486251808972,1.0,1.0,4/38,10.00%,Ccnd3;E2f1;Ccnd1;Cdk2
prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.5840980405366388,-0.9455326984461093,0.5897079276773296,1.0,1.0,6/18,25.17%,Ap1m2;Ap2b1;B2m;Cd28;Cd4;Pacs1
prerank,Programmed Cell Death R-HSA-5357801,-0.4729589654711964,-0.9452980951403498,0.5649794801641587,1.0,1.0,35/188,13.85%,Prkcq;Septin4;Unc5b;Bcl2;Gsn;Prkcd;Casp8;Ywhaq;Tjp2;E2f1;Satb1;Bmf;Casp1;Casp4;Birc3;Mapt;Gas2;Bid;Ppp3cc;Il1a;Irf2;Mlkl;Mapk8;Oma1;Dapk2;Casp7;Psmb8;Psmb11;Stat3;Psme2;Il18;Cflar;Psme4;Ticam1;Psma8
prerank,Chaperone Mediated Autophagy R-HSA-9613829,-0.5816931714137832,-0.9452062368640651,0.5825242718446602,1.0,1.0,7/19,21.60%,Cftr;Ift88;Lamp2;Plin3;Ubc;Pcnt;Gfap
prerank,Mitotic Prophase R-HSA-68875,-0.5093690423204955,-0.9447988450184547,0.5805555555555556,1.0,1.0,2/95,0.94%,Prkcb;Vrk2
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.5326287399892713,-0.9447094322023073,0.5781710914454278,1.0,1.0,2/60,2.01%,Myo1e;Kat2b
prerank,Signaling By EGFR R-HSA-177929,-0.5558651063198229,-0.9438164234990145,0.5983026874115983,1.0,1.0,11/48,11.06%,Pik3r1;Eps15;Pag1;Adam17;Adam10;Egfr;Stam2;Adam12;Sh3gl2;Lrig1;Pik3ca
prerank,Sialic Acid Metabolism R-HSA-4085001,-0.5597691002646751,-0.9419921677559514,0.5942857142857143,1.0,1.0,5/33,2.93%,St6gal1;St8sia5;St3gal6;Neu4;St6gal2
prerank,UCH Proteinases R-HSA-5689603,-0.5114156413783287,-0.9413600787138034,0.6135057471264368,1.0,1.0,10/90,14.69%,Tgfb1;Tgfbr2;Smad7;Cnksr3;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.550467337536183,0.9413033995411563,0.5555555555555556,1.0,1.0,2/24,0.42%,Maml2;Maml3
prerank,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.6033289074541419,-0.9410316002481075,0.6050420168067226,1.0,1.0,6/16,25.89%,Traf3;Irf3;Ticam1;Ubc;Tlr4;Ly96
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,0.49475734739068744,0.940037314485819,0.5616438356164384,1.0,1.0,15/58,8.50%,Hdac7;Mapk1;Chd4;Chd3;Rragd;Jun;Gatad2b;Cbx6;Mapk3;Rbbp7;Hdac1;Suz12;Cbx4;Mta3;Rcor1
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.5173848319679034,0.9396981186014641,0.5422535211267606,1.0,1.0,12/34,4.82%,Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Abi1;Arpc2;Actr3;Cyfip2;Mapk3
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.48002501163807504,-0.9396490688062191,0.5720108695652174,1.0,1.0,25/135,22.17%,Rbbp8;Cnksr3;Eya4;Rad51b;Lrig3;Pold4;Fen1;Wrn;Mapk8;Cdk2;Nsd2;Eya2;Abl1;Eme1;Prkdc;Xrcc3;Top3a;Polk;Brca1;Apbb1;Ubc;Lrif1;Dna2;Artn;Rmi1
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.587057691506097,-0.9395191780198175,0.6131284916201117,1.0,1.0,8/24,8.36%,Pla2g4a;Gng4;Gna15;Gng12;Gnb4;Gngt2;Gna14;P2ry1
prerank,p75NTR Signals Via NF-kB R-HSA-193639,-0.5951730729045827,-0.9391528927751386,0.6129905277401895,1.0,1.0,1/16,2.47%,Ngf
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.5497219905630037,-0.9382941078014213,0.6067892503536068,1.0,1.0,11/41,24.82%,Rbbp8;Rad51b;Wrn;Xrcc3;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.5290597849639211,-0.9365273074201341,0.6130952380952381,1.0,1.0,9/63,8.34%,St6gal1;St8sia5;St3gal6;Neu4;St6gal2;St8sia6;Uap1;Nagk;St6galnac2
prerank,Sensory Processing Of Sound R-HSA-9659379,-0.5156218076640905,-0.9348732383596988,0.591304347826087,1.0,1.0,12/73,5.55%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Cacna2d2;Gsn;Clic5;Stx1a;Msn;Myo3a;Cabp1
prerank,Signaling By NOTCH R-HSA-157118,0.41554779809351755,0.934427877823134,0.594488188976378,1.0,1.0,13/186,2.86%,Maml2;Nbea;Maml3;Tnrc6c;Cntn1;Tle1;Hdac7;Ncor1;Notch2;B4galt1;Tle4;Smad3;Jun
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.5476001878429323,-0.932846973056476,0.6025280898876404,1.0,1.0,10/39,24.82%,Rbbp8;Rad51b;Wrn;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.5748107152458012,-0.9323225211725171,0.6267806267806267,1.0,1.0,3/21,10.80%,Pold4;Fen1;Lrig1
prerank,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.5856012497324428,-0.9321920136464669,0.6108726752503576,1.0,1.0,5/20,9.72%,Rspo2;Lrp5;Rnf43;Lgr5;Rspo1
prerank,Translation Of Structural Proteins R-HSA-9683701,-0.5570682267653823,-0.9313835488829267,0.5942446043165468,1.0,1.0,3/29,1.96%,St6gal1;Parp8;Parp4
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.5377528595886267,-0.9312026790348755,0.6143884892086331,1.0,1.0,4/49,9.53%,Rbbp8;Rad51b;Neil3;Wrn
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5686542865832047,-0.9304080223242566,0.5947075208913649,1.0,1.0,4/24,7.98%,Wwp2;Adam10;Egfr;Jag2
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.49843114252656295,-0.9299362271032994,0.6210670314637483,1.0,1.0,14/99,3.80%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Vav1;Cd86;Pdgfra;Fgfr3;Erbb3;Pip4k2a;Ppp2r5a
prerank,Meiosis R-HSA-1500620,0.4814448864216167,0.9296659156361214,0.5979020979020979,1.0,1.0,3/72,4.67%,Syne1;Rad50;Hspa2
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.5781876568178356,-0.9282237010393372,0.6061026352288488,1.0,1.0,4/23,2.58%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,SARS-CoV-1 Infection R-HSA-9678108,-0.5276525123249975,-0.9277990230721955,0.6183644189383071,1.0,1.0,3/50,1.96%,St6gal1;Parp8;Parp4
prerank,Signaling By BMP R-HSA-201451,-0.563240178580577,-0.9277686087233383,0.5991440798858774,1.0,1.0,8/25,10.35%,Smad7;Smurf1;Bmpr1b;Amhr2;Smad1;Acvr2b;Smad6;Smad9
prerank,Cytoprotection By HMOX1 R-HSA-9707564,-0.5320275476085722,-0.9274509060661563,0.6151685393258427,1.0,1.0,7/54,12.95%,Tbl1x;Nfe2l2;Smarcd3;Txnip;Nlrp3;Stat3;Cox16
prerank,PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.5982090309431323,-0.9267536031868762,0.6231086657496562,1.0,1.0,4/15,2.58%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.5564190957927484,-0.92644855178053,0.6263079222720478,1.0,1.0,6/32,20.00%,Usp43;Trim25;Pold4;Uba7;Polk;Ubc
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.5064352820401323,-0.926200295819763,0.6225895316804407,1.0,1.0,12/80,3.17%,Dock1;Elmo1;Itpr2;Wipf1;Vav2;Pik3r1;Myo1e;Nckap1l;Hck;Vav1;Lyn;Prkcd
prerank,Glycolysis R-HSA-70171,-0.5259870131793319,-0.9261703982678112,0.6183844011142061,1.0,1.0,5/62,8.06%,Pfkp;Pfkfb4;Pfkfb3;Prkca;Map4k2
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.4953443777143939,0.925484636584379,0.5559006211180124,1.0,1.0,7/51,4.91%,Nedd4l;Ncor1;Mapk1;Smad3;Ski;Mapk3;Parp1
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.5448412627708413,-0.9254122440292996,0.6165951359084406,1.0,1.0,10/38,24.82%,Rbbp8;Rad51b;Wrn;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.5760161316452553,-0.9251851890354278,0.6150627615062761,1.0,1.0,4/24,2.58%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.4566750093216463,0.925052935546314,0.5950155763239875,1.0,1.0,13/91,4.91%,Itga8;Nedd4l;Pard3;Ncor1;Mapk1;Ppp1cb;Smad3;Usp15;Itgb8;Ski;Tgfb2;Mapk3;Parp1
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.4882343287747557,-0.9249687971157813,0.6346414073071719,1.0,1.0,14/106,3.80%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Vav1;Cd86;Pdgfra;Fgfr3;Erbb3;Pip4k2a;Ppp2r5a
prerank,Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.5849681731631977,-0.9248355730086057,0.6223776223776224,1.0,1.0,7/17,25.89%,Tlr1;Tlr2;S100a1;Tlr6;Tlr4;Gsdmd;Ly96
prerank,Signaling By VEGF R-HSA-194138,-0.4922073784747406,-0.9243164568376779,0.6195965417867435,1.0,1.0,21/100,9.21%,Dock1;Elmo1;Itpr2;Vav2;Prkcb;Pik3r1;Nckap1l;Vav1;Ncf2;Prkcd;Mapk11;Prr5;Vegfa;Prkca;Itpr3;Cyba;Ncf1;Ctnna1;Vegfd;Flt1;Wasf2
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.5136004769734284,-0.9239002719809982,0.6288515406162465,1.0,1.0,10/71,16.01%,Epas1;Vegfa;Limd1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ep300
prerank,ECM Proteoglycans R-HSA-3000178,-0.5282808708183833,-0.9232760736316913,0.6268011527377522,1.0,1.0,17/54,7.97%,Itga9;Itgb5;Lama4;Bcan;Lrp4;Tgfb1;Sparc;Lama2;Vcan;Lama1;Itga2;Dcn;Tnn;Hapln1;Col9a1;Itgb1;Col9a3
prerank,Signaling To ERKs R-HSA-187687,0.5253262926758556,0.9226446478560519,0.5966666666666667,1.0,1.0,7/33,5.34%,Bcl11b;Rit2;Mapk1;Map2k1;Src;Mapk3;Ywhab
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.41950548428341056,-0.9224903517896978,0.6707768187422934,1.0,1.0,92/478,9.25%,Dock1;Kit;Erbb4;Elmo1;Itpr2;Alk;Gab2;Ptn;Vav2;Prkcb;Pik3r1;Ptpru;Stat5b;Lama4;Nrg1;Tec;Fgf1;Nckap1l;Flrt2;Kcnh8;Vav1;Sparc;Col6a2;Lyn;Lama2;Pdgfra;Fgfr3;Ngf;Erbb3;Tns3;Pcsk6;Gabrg3;Igf1;Ncf2;Fer;Eps15;Stat6;Prkcd;Shc3;Trib1;Col6a1;Dnm3;Flrt1;Lama1;Lamc2;Dusp6;Pag1;Rps6ka5;Itga2;Fosb;Jak2;Col6a5;Sgk1;Adam17;Mapk11;Egr1;Adam10;Esr1;Fes;Apoe;Rap1b;Vgf;Ralb;Prr5;Col6a3;S100b;Col9a1;Egfr;Wwox;Mef2a;Vegfa;Prkca;Adap1;Pde3b;Itpr3;Stam2;Arc;Rps6ka1;Itgb1;Cyba;Col9a3;Egr2;Ncf1;Erbin;Myc;Ctnna1;Vegfd;Itga3;Flt1;Adam12;Wasf2;Ap2b1
prerank,Cell-cell Junction Organization R-HSA-421270,0.492060908183879,0.9215749115256623,0.564625850340136,1.0,1.0,8/56,2.21%,Cdh9;Cadm2;Cdh8;Cdh12;Pard3;Cdh13;Cdh2;Cadm1
prerank,Keratinization R-HSA-6805567,-0.5236428093008902,-0.9215027000363357,0.6277777777777778,1.0,1.0,9/60,12.58%,Pcsk6;Kazn;Klk8;Evpl;Dsc3;Rcan1;Krt25;Jup;Krt1
prerank,Protein Localization R-HSA-9609507,-0.467465694944179,-0.921312439609249,0.5941828254847645,1.0,1.0,21/151,20.83%,Stx1a;Slc25a13;Phyh;Pex7;App;Crot;Cyb5a;Abcd1;Ehhadh;Cmc2;Idh1;Hao2;Glyat;Pex13;Acox3;Acox1;Ide;Hmgcl;Ubc;Sec61g;Agps
prerank,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.5826272279646177,-0.921024108806444,0.6389280677009873,1.0,1.0,3/19,14.59%,E2f1;Myc;Lin54
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.4415411862853583,0.919201500981581,0.6096654275092936,1.0,1.0,9/109,2.62%,Zfpm2;Dock10;Kif26b;Carmil1;Dock4;Dock11;Ehd3;Dock3;Ehd1
prerank,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.5809350678692266,-0.9189785770942529,0.6206896551724138,1.0,1.0,4/17,22.05%,Casp8;Chuk;Ubc;Usp14
prerank,Heme Signaling R-HSA-9707616,-0.5350640320824156,-0.917351556267451,0.6104972375690608,1.0,1.0,5/42,5.28%,Tbl1x;Npas2;Nrip1;Nfe2l2;Smarcd3
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.5465656320174876,-0.9168860601394045,0.6294706723891274,1.0,1.0,2/35,0.81%,Gpc6;Gpc5
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,0.5331587587996865,0.916646551450491,0.5666666666666667,1.0,1.0,6/24,11.26%,Ago2;Ago1;Dicer1;Polr2e;Polr2f;Ran
prerank,Apoptosis R-HSA-109581,-0.46415864182947636,-0.915601929523927,0.6344827586206897,1.0,1.0,28/161,13.85%,Prkcq;Septin4;Unc5b;Bcl2;Gsn;Prkcd;Casp8;Ywhaq;Tjp2;E2f1;Satb1;Bmf;Mapt;Gas2;Bid;Ppp3cc;Mapk8;Oma1;Dapk2;Casp7;Psmb8;Psmb11;Stat3;Psme2;Cflar;Psme4;Ticam1;Psma8
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5226814246662222,-0.9149671391021279,0.6108726752503576,1.0,1.0,11/49,11.68%,Septin4;Bcl2;Casp8;Ywhaq;E2f1;Bmf;Bid;Ppp3cc;Mapk8;Casp7;Stat3
prerank,Activation Of SMO R-HSA-5635838,0.5550689412895081,0.9144266197949162,0.6133828996282528,1.0,1.0,3/18,4.74%,Cdon;Ptch1;Efcab7
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.5090844529482411,-0.913834242908659,0.6347826086956522,1.0,1.0,15/64,24.82%,Rbbp8;Rad51b;Pold4;Wrn;Eme1;Xrcc3;Top3a;Polk;Brca1;Ubc;Dna2;Artn;Rmi1;Blm;Bard1
prerank,Voltage Gated Potassium Channels R-HSA-1296072,0.49995662700835225,0.9130765238840474,0.5816326530612245,1.0,1.0,12/43,3.31%,Kcnd2;Kcnh1;Kcnab1;Kcnd3;Kcnc3;Kcng2;Kcna4;Kcnc4;Kcna1;Kcng3;Kcng1;Kcnab2
prerank,Metabolism Of Folate And Pterines R-HSA-196757,-0.5863728506316896,-0.9130545522651259,0.6676056338028169,1.0,1.0,3/15,15.06%,Aldh1l1;Mthfd1l;Folr2
prerank,Gene Silencing By RNA R-HSA-211000,0.442964720153682,0.9062267353549288,0.6340579710144928,1.0,1.0,13/92,9.37%,Tnrc6c;Ago2;Ago1;Tnrc6b;Nup93;Ndc1;H2bc4;Nup160;Ranbp2;Dicer1;Polr2e;H2az1;Polr2f
prerank,RAF Activation R-HSA-5673000,0.5016707441858402,0.9061771625135497,0.5689655172413793,1.0,1.0,9/30,4.63%,Camk2a;Camk2b;Map2k1;Calm1;Ppp1cb;Camk2g;Mras;Ksr1;Src
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.5621142208155857,-0.9049832330579811,0.6321678321678321,1.0,1.0,4/20,9.45%,Plagl1;Plk3;Rgcc;Plk2
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.5471462043473665,-0.9046122029282767,0.6480938416422287,1.0,1.0,2/33,4.04%,Rbbp8;E2f1
prerank,TBC/RABGAPs R-HSA-8854214,-0.5219272427825102,-0.9039097435355079,0.6378066378066378,1.0,1.0,8/42,24.62%,Optn;Tbc1d10c;Rab7b;Rab43;Rab6b;Rab6a;Rab33b;Rabgap1
prerank,HSF1-dependent Transactivation R-HSA-3371571,0.504335039063266,0.9034501192045229,0.6007194244604317,1.0,1.0,2/34,0.48%,Camk2a;Camk2b
prerank,Mitotic Anaphase R-HSA-68882,-0.4385577101243505,-0.9019049535491503,0.6679946879150066,1.0,1.0,26/218,16.33%,Vrk2;Ppp2r5a;Tubb4a;Tubb3;Clasp2;Nde1;Sirt2;Pmepa1;Ppp2r5c;Ccnb1;Dync1li2;Dync1h1;Ndc80;Psmb8;Psmb11;Aurkb;Psme2;Psme4;Psma8;Ppp2r5e;Pafah1b1;Zwint;Psmb9;Bub1;Ndel1;Kif2c
prerank,Smooth Muscle Contraction R-HSA-445355,0.504412681205501,0.9013905141908064,0.6015325670498084,1.0,1.0,6/40,3.18%,Sorbs1;Cald1;Cacna1h;Calm1;Anxa6;Gucy1b1
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.4384060969398299,-0.9013290912588005,0.6741721854304635,1.0,1.0,26/219,16.33%,Vrk2;Ppp2r5a;Tubb4a;Tubb3;Clasp2;Nde1;Sirt2;Pmepa1;Ppp2r5c;Ccnb1;Dync1li2;Dync1h1;Ndc80;Psmb8;Psmb11;Aurkb;Psme2;Psme4;Psma8;Ppp2r5e;Pafah1b1;Zwint;Psmb9;Bub1;Ndel1;Kif2c
prerank,Signaling By TGFB Family Members R-HSA-9006936,0.43468300354523676,0.9007311045161643,0.625,1.0,1.0,18/116,5.23%,Itga8;Nedd4l;Pard3;Acvr2a;Ncor1;Mapk1;Ppp1cb;Smad3;Usp15;Itgb8;Ski;Bmpr1a;Tgfb2;Inhba;Acvr1c;Mapk3;Parp1;Grem2
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.5438240212133126,-0.9004042182266445,0.6587078651685393,1.0,1.0,1/28,1.27%,Fgf1
prerank,Opioid Signaling R-HSA-111885,0.4457766487307902,0.9003812862947492,0.6042402826855123,1.0,1.0,21/86,3.49%,Ppp3ca;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gng7;Gnaq;Gnal;Mapk1;Pde1b;Adcy9;Calm1;Camkk1;Pde4a;Gng2;Ppp3r1;Itpr1;Pdyn;Camk2g
prerank,Cellular Response To Starvation R-HSA-9711097,0.419594817789315,0.8996278660436146,0.6872586872586872,1.0,1.0,52/145,14.89%,Atp6v1a;Rragd;Fnip2;Kptn;Atp6v0c;Rplp1;Atp6v0e2;Rpl15;Mios;Atp6v1d;Rpl6;Uba52;Nprl3;Rps21;Rpl18;Rps7;Rpl31;Rps15a;Rpl9;Atp6v1c2;Rpl35a;Asns;Rpl7;Rps14;Gcn1;Rps17;Rps9;Rragb;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Slc38a9;Atf3;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rptor;Rplp0;Castor2;Rps8;Rps29;Rpl12;Rsl24d1;Rps12
prerank,G1/S-Specific Transcription R-HSA-69205,-0.546473906632847,-0.8994554720408227,0.6470588235294118,1.0,1.0,8/29,26.16%,E2f1;Lin54;E2f6;Cdt1;Lin52;Cdk1;Tyms;Rrm2
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.5269739454135935,0.8990822021222489,0.6084142394822006,1.0,1.0,2/26,1.58%,Foxo1;Akt3
prerank,M Phase R-HSA-68886,-0.41789631789885007,-0.8984342033971336,0.7139240506329114,1.0,1.0,38/348,14.91%,Prkcb;Vrk2;Ccp110;Ppp2r5a;Tubb4a;Tubb3;Nedd1;Clasp2;Ncaph;Nde1;Sirt2;Prkca;Pmepa1;Ppp2r5c;Nek7;Ccnb1;Dync1li2;Nek2;Dync1h1;Ndc80;Psmb8;Psmb11;Aurkb;Plk4;Psme2;Akap9;Cntrl;Mastl;Psme4;Cep43;Lpin3;Psma8;Rab1a;Ppp2r5e;Pafah1b1;Zwint;Psmb9;Bub1
prerank,Interferon Signaling R-HSA-913531,0.4104184555068538,0.8979835733040317,0.7,1.0,1.0,6/153,1.43%,Camk2a;Camk2b;Sgip1;Bcl11b;Ncam1;Pdzd2
prerank,Ub-specific Processing Proteases R-HSA-5689880,-0.45229100284375423,-0.8972549227399471,0.6657381615598886,1.0,1.0,21/171,16.52%,Smad7;Smad2;Cftr;Ccp110;Smad1;Cyld;Birc3;Ifih1;Rigi;Stam2;Myc;Adrb2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Usp28;Usp3;Usp24
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.5334566896800685,-0.8971911535783611,0.6507042253521127,1.0,1.0,9/33,24.82%,Rbbp8;Wrn;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.40539768798418335,-0.8958799266531654,0.7426470588235294,1.0,1.0,57/487,14.91%,Prkcb;Vrk2;Optn;Lyn;Cdc14a;Ccnd3;Ccp110;Ppp2r5a;Tubb4a;E2f1;Tubb3;Jak2;Nedd1;Clasp2;Ncaph;Phlda1;Nde1;Ccnd1;Sirt2;Prkca;Cdc25b;Pmepa1;Ppp2r5c;Nek7;Pold4;Myc;Fen1;Ccnb1;Cables1;Dync1li2;Cdk2;Nek2;Dync1h1;Ndc80;Lrig1;Psmb8;Psmb11;Aurkb;Plk4;Mcm10;Psme2;Akap9;Cntrl;Mastl;Psme4;Cep43;Lpin3;Psma8;Rab1a;Abl1;Ppp2r5e;Esco2;Pafah1b1;Zwint;Lin54;Psmb9;Bub1
prerank,Telomere Maintenance R-HSA-157579,-0.48414529725867805,-0.8957911074438721,0.6726726726726727,1.0,1.0,10/78,18.17%,Ankrd28;Pold4;Fen1;Wrn;Cdk2;Lrig1;Pif1;Dscc1;Prim2;Chtf8
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.5259100266416976,-0.8944113399653586,0.6598240469208211,1.0,1.0,6/39,20.00%,Usp43;Trim25;Pold4;Uba7;Polk;Ubc
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.532532023266633,-0.8944063103612766,0.647887323943662,1.0,1.0,5/31,6.05%,Apbb1ip;Fn1;Vcl;Iqgap1;Rap1b
prerank,Phospholipid Metabolism R-HSA-1483257,-0.4391256476303176,-0.8942296552279827,0.6851595006934813,1.0,1.0,39/203,11.36%,Synj2;Inpp5d;Pik3r1;Cpne7;Pitpnm3;Mboat1;Pla2g4a;Tnfaip8;Pik3r5;Lpcat2;Enpp6;Plaat3;Pip4k2a;Pik3cg;Pnpla7;Osbpl10;Pld4;Sh2d3c;Gpat3;Pla2g4c;Lpgat1;Pld2;Plekha1;Pcyt2;Tnfaip8l3;Pik3c2b;Inpp5f;Inppl1;Pi4k2b;Pik3r6;Rufy1;Ptpn13;Osbpl5;Agk;Pla2g6;Plaat1;Pik3c2a;Pik3ca;Clstn1
prerank,Signaling By ERBB2 R-HSA-1227986,0.4917870142586065,0.8938223075441613,0.6095890410958904,1.0,1.0,4/48,1.58%,Prkce;Nrg2;Nrg3;Akt3
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,0.512323636332766,0.8930255955448321,0.6170886075949367,1.0,1.0,8/30,10.42%,Gtf2h2;Ccnh;Gtf2h5;Polr2e;Ubtf;Polr2f;Mnat1;Taf1c
prerank,RET Signaling R-HSA-8853659,-0.5319572861821663,-0.892952358050613,0.680635838150289,1.0,1.0,11/39,13.09%,Gab2;Pik3r1;Shc3;Ret;Prkca;Grb10;Nrtn;Pik3ca;Clstn1;Grb7;Gfra3
prerank,Signaling By NOTCH3 R-HSA-9012852,0.4788360141006619,0.8910518111106258,0.6007604562737643,1.0,1.0,2/47,0.42%,Maml2;Maml3
prerank,MAP2K And MAPK Activation R-HSA-5674135,-0.5296453879615926,-0.8904963936994681,0.6562054208273894,1.0,1.0,5/35,6.05%,Apbb1ip;Fn1;Vcl;Iqgap1;Rap1b
prerank,Phase 4 - Resting Membrane Potential R-HSA-5576886,0.5496205562751043,0.8904485464215108,0.5958188153310104,1.0,1.0,7/18,6.91%,Kcnk10;Kcnk1;Kcnj2;Kcnj4;Kcnk9;Kcnk2;Kcnk12
prerank,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.5717062384166361,-0.8898953430843487,0.6689280868385346,1.0,1.0,5/17,6.80%,Gng4;Gng12;Gnb4;Btk;Gngt2
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.4903400334211705,0.8884238393653605,0.6348122866894198,1.0,1.0,4/36,2.54%,Rgs7;Gng7;Gnaq;Gng2
prerank,Platelet Homeostasis R-HSA-418346,-0.4864395319969264,-0.887650476349418,0.67,1.0,1.0,21/82,7.76%,Itpr2;Slc8a1;Pde11a;Trpc3;Pde1a;Pla2g4a;Gng4;P2rx7;Pde5a;Trpc7;Gng12;Prkg2;Ppp2r5a;P2rx4;Pde2a;Gnb4;Pde10a;Gngt2;Gnas;Itpr3;Ppp2r5c
prerank,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.5652794700743952,-0.8868896174635073,0.6880984952120383,1.0,1.0,5/18,7.01%,Gng4;Gng12;Gnb4;Gngt2;Gnas
prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.5356036383424028,0.8863846217986018,0.6078431372549019,1.0,1.0,4/21,3.77%,Ppp1r12b;Calm1;Ppp1cb;Arhgef7
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.42825159024505277,-0.8861418575576372,0.72400513478819,1.0,1.0,18/256,8.60%,Asap1;Tbl1x;Camk4;Smox;Ccp110;Tubb4a;Sclt1;Nedd1;Mapk11;Smarcd3;Prkab2;Bbs9;Nde1;Prkaa2;Prkca;Cep83;Ift88;Atat1
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.540986845080944,-0.8851089223689562,0.6729106628242075,1.0,1.0,7/29,9.70%,Kcnh8;Dusp6;Rps6ka5;Mapk11;Mef2a;Rps6ka1;Mapk8
prerank,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.5658202243913404,-0.8841103435015308,0.6825613079019074,1.0,1.0,5/17,21.29%,Tlr3;Ticam1;Chuk;Ripk1;Nfkbia
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.5535554167655048,-0.8830572277563585,0.6900826446280992,1.0,1.0,7/24,8.78%,Gng4;Pik3r5;Gng12;Pik3cg;Gnb4;Gngt2;Pik3r6
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.48654133297637725,-0.8827267593492838,0.6515580736543909,1.0,1.0,25/82,15.90%,Gng4;Gng12;Smox;Adgre1;Gnb4;Gngt2;Gnas;Wnt2;Pth2r;C1qtnf1;Crhr1;Pthlh;Fzd2;Sctr;Wnt10a;Shh;Calcr;Adm;Glp1r;Gnb1;Adcyap1;Calcb;Gng11;Calcrl;Calca
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.4888380636880537,-0.8822666476933151,0.6781115879828327,1.0,1.0,17/68,20.84%,Ccp110;Tubb4a;Nedd1;Nde1;Prkca;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Cep192;Csnk1e;Cep290;Pcnt;Alms1
prerank,Netrin-1 Signaling R-HSA-373752,0.4769593860758521,0.8820321175155839,0.6305732484076433,1.0,1.0,9/47,2.33%,Slit3;Trpc6;Dscam;Ablim3;Dscaml1;Dcc;Ablim1;Unc5a;Ptk2
prerank,Signal Transduction By L1 R-HSA-445144,-0.5387048001376866,-0.8809188347990882,0.6515580736543909,1.0,1.0,5/20,7.92%,Vav2;Itga9;L1cam;Egfr;Itgb1
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.524622525467205,-0.8804736077017282,0.6671388101983002,1.0,1.0,7/35,9.71%,Slco2b1;Slco1c1;Apod;Slc29a3;Nlrp3;Slc28a1;Slc35d2
prerank,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5349834877789852,0.8800798441830057,0.6058394160583942,1.0,1.0,2/16,0.97%,Ntrk3;Ntf3
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,-0.5032626666891731,-0.8797961492368799,0.6765578635014837,1.0,1.0,6/50,5.52%,St6gal1;Galntl6;Galnt9;Galnt6;Gcnt4;Galnt5
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.49644952838445106,0.879428054944469,0.6130030959752322,1.0,1.0,8/26,16.21%,Pou2f1;Polr2e;Polr2f;Polr3f;Snapc4;Polr2k;Polr3e;Polr3gl
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.5367340506440953,-0.8793471010878927,0.6807639836289222,1.0,1.0,2/28,7.31%,Colec12;Lsm11
prerank,PI Metabolism R-HSA-1483255,-0.4758913564766236,-0.8788264806569402,0.7040229885057471,1.0,1.0,18/81,9.24%,Synj2;Inpp5d;Pik3r1;Tnfaip8;Pik3r5;Enpp6;Pip4k2a;Pik3cg;Pnpla7;Plekha1;Tnfaip8l3;Pik3c2b;Inpp5f;Inppl1;Pi4k2b;Pik3r6;Rufy1;Ptpn13
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.5303905751944669,-0.8785961777146435,0.6657534246575343,1.0,1.0,10/32,13.83%,Trim25;Cyld;Traf3;Ifih1;Rigi;Rnf135;Irf3;Tnfaip3;Rnf125;Uba7
prerank,Oncogenic MAPK Signaling R-HSA-6802957,-0.4913660578399735,-0.8779384958046628,0.6955882352941176,1.0,1.0,14/74,7.44%,Camk2d;Apbb1ip;Dusp10;Qki;Fn1;Nf1;Dusp16;Dusp6;Jak2;Vcl;Iqgap1;Rap1b;Spred3;Zc3hav1
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.5475746226840136,-0.8762966592589903,0.6689098250336474,1.0,1.0,1/20,3.23%,Colec12
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.5445857009586474,-0.8753859148720605,0.6680790960451978,1.0,1.0,8/21,25.89%,Birc3;Ticam1;Chuk;Ube2v1;Ubc;Ripk1;Tlr4;Ly96
prerank,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.5605642248903799,-0.8753551613160573,0.6951724137931035,1.0,1.0,5/19,6.80%,Gng4;Gng12;Arhgef6;Gnb4;Gngt2
prerank,DNA Repair R-HSA-73894,-0.4142912590802752,-0.875065896273135,0.7461139896373057,1.0,1.0,29/288,19.07%,Rbbp8;Cnksr3;Eya4;Usp43;Trim25;Rad51b;Fancc;Neil3;Lrig3;Pold4;Fen1;Wrn;Mapk8;Cdk2;Mgmt;Nsd2;Lrig1;Eya2;Uba7;Abl1;Cul4a;Eme1;Ep300;Prkdc;Xrcc3;Top3a;Polk;Brca1;Apbb1
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.48224100371917134,-0.8749177524762315,0.6842105263157895,1.0,1.0,17/71,20.84%,Ccp110;Tubb4a;Nedd1;Nde1;Prkca;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Cep192;Csnk1e;Cep290;Pcnt;Alms1
prerank,Sphingolipid Metabolism R-HSA-428157,-0.4790758064173627,-0.8736549579824019,0.7061340941512125,1.0,1.0,9/80,6.30%,Fa2h;Plpp3;Prkd3;Neu4;Sgpp2;Asah2;Cerk;Sptlc2;Gltp
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,0.38425093334196225,0.873131457457727,0.7697594501718213,1.0,1.0,4/168,2.61%,Slc4a4;Slc24a4;Abcc8;Slc1a1
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.49026079944637385,-0.873083474023963,0.6816269284712483,1.0,1.0,8/63,14.69%,Epas1;Limd1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Recycling Pathway Of L1 R-HSA-437239,-0.5392059383662414,-0.8724517521209765,0.6979020979020979,1.0,1.0,12/25,16.58%,Dnm3;Numb;Rps6ka5;Msn;L1cam;Rps6ka1;Ap2b1;Sh3gl2;Dpysl2;Ezr;Rdx;Cltc
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.524775104454987,-0.8724086118407152,0.6894586894586895,1.0,1.0,11/35,20.21%,Casp8;Cyld;Birc3;Tnfaip3;Otud7b;Cflar;Tax1bp1;Chuk;Xiap;Ubc;Ripk1
prerank,Reproduction R-HSA-1474165,0.42865469271344275,0.8719920839811018,0.7090301003344481,1.0,1.0,7/90,6.83%,Syne1;B4galt1;Rad50;Hspa2;Dido1;Ovgp1;H2bc4
prerank,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.5614187419413681,-0.8690107648407309,0.6951048951048951,1.0,1.0,4/16,24.34%,E2f1;Lin54;Lin52;Cdk1
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.5233748234881453,-0.8678193013628644,0.688293370944993,1.0,1.0,6/33,14.27%,Pla2g4a;Dync1li2;Pla2g6;Dync1h1;Pafah1b3;Pafah1b1
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,0.41645918255142295,0.8675583686411033,0.7068965517241379,1.0,1.0,5/95,1.84%,Erc2;Mmp16;Spock3;Col25a1;Mmp17
prerank,TNF Signaling R-HSA-75893,-0.5103842422103947,-0.8666616351853873,0.6962025316455697,1.0,1.0,12/44,20.21%,Casp8;Adam17;Cyld;Birc3;Tnfaip3;Otud7b;Cflar;Tax1bp1;Chuk;Xiap;Ubc;Ripk1
prerank,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.5379760024149375,-0.8665446470566476,0.6961483594864479,1.0,1.0,4/18,10.06%,St3gal6;Notch1;Mfng;Lfng
prerank,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.5109542426690261,0.8662364877344003,0.6116504854368932,1.0,1.0,3/23,2.15%,Dapk1;Dcc;Unc5a
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.49717799699580434,-0.8657059035839444,0.6909871244635193,1.0,1.0,7/51,14.69%,Ccnd1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.47840838601720304,-0.8654612869077603,0.7120115774240231,1.0,1.0,13/77,16.65%,Nfe2l2;Notch1;Gsta3;Myc;Psmb8;Mafg;Psme2;Idh1;Slc7a11;Psmb9;Ep300;Mafk;Tkt
prerank,Regulation Of Apoptosis R-HSA-169911,-0.49555394704718386,-0.8647410224373657,0.6857962697274032,1.0,1.0,9/52,20.00%,Oma1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Pkn2;Ubc
prerank,mTORC1-mediated Signaling R-HSA-166208,0.5091058216215567,0.8637391128390041,0.643598615916955,1.0,1.0,9/24,16.46%,Rragd;Ywhab;Eif4b;Rragb;Eif4e;Slc38a9;Rptor;Lamtor5;Eef2k
prerank,L1CAM Interactions R-HSA-373760,0.4163511346429854,0.8637027390199883,0.6956521739130435,1.0,1.0,20/95,2.88%,Ank3;Nrcam;Scn3a;Scn2a;Nrp1;Cntn1;Nrp2;Scn8a;Ncam1;Sptb;Scn3b;Sptbn1;Mapk1;Dnm1;Map2k1;Sptbn4;Ank2;Sptan1;Scn9a;Rps6ka2
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,-0.5248506380266185,-0.8627993235825981,0.7132667617689016,1.0,1.0,4/28,1.95%,Vav2;Lcp2;Vav1;Lyn
prerank,G-protein Mediated Events R-HSA-112040,0.4600233941485582,0.8604675369682139,0.6753246753246753,1.0,1.0,13/51,2.40%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnaq;Gnal;Mapk1;Pde1b;Adcy9;Calm1;Camkk1
prerank,RHOG GTPase Cycle R-HSA-9013408,-0.47780323556400306,-0.859891681825193,0.7002923976608187,1.0,1.0,16/72,5.73%,Dock1;Dock2;Vav2;Pik3r1;Vrk2;Dock5;Arhgef26;Vav1;Prex1;Mcf2;Garre1;Cdc42ep1;Ophn1;Rhog;Mcam;Depdc1b
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.49977013276876986,-0.8593528801051351,0.7178362573099415,1.0,1.0,3/44,0.87%,Fa2h;Plpp3;Prkd3
prerank,GPER1 Signaling R-HSA-9634597,0.473460005915609,0.8591181126370092,0.6689419795221843,1.0,1.0,5/41,2.54%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,Myogenesis R-HSA-525793,-0.5211440844948989,-0.8583004594196777,0.7130681818181818,1.0,1.0,6/26,8.72%,Tcf7l2;Tcf7l1;Cdh4;Mapk11;Mef2a;Ctnna1
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.42176283727399355,0.8582122889921115,0.7640845070422535,1.0,1.0,7/98,3.85%,Ppp3ca;Calm1;Ppp3r1;Btrc;Fbxw11;Itpr1;Plcg2
prerank,Cellular Hexose Transport R-HSA-189200,-0.5553913709925149,-0.8579272981523295,0.7117962466487936,1.0,1.0,7/15,35.57%,Slc45a3;Slc2a8;Slc5a1;Slc5a2;Slc2a1;Slc2a10;Slc5a10
prerank,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.518783585114998,-0.8573009468902768,0.7010159651669086,1.0,1.0,5/25,20.00%,Lrig3;Pold4;Lrig1;Polk;Ubc
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.464269002747127,-0.857063178079398,0.7006896551724138,1.0,1.0,12/93,6.59%,Tcf7l2;Runx1;Zfhx3;Tgfb1;Tcf7l1;Kat2b;Smurf1;Wwtr1;Notch1;Hdac4;Lef1;Ccnd1
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.5442947663152385,-0.8569958608657433,0.7080491132332879,1.0,1.0,4/19,15.72%,Eps15;Stam2;Sh3gl2;Sh3gl3
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,-0.41131206203154014,-0.8559072736321999,0.7623376623376623,1.0,1.0,20/257,5.57%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Nr4a1;Vav1;Cd86;Pdgfra;Fgfr3;Erbb3;Nr2e1;Pip4k2a;Ppp2r5a;Wwp2;Rhog;Egr1;Esr1
prerank,Tie2 Signaling R-HSA-210993,-0.5402203793134437,-0.8558593573640894,0.695898161244696,1.0,1.0,2/17,3.12%,Pik3r1;Angpt1
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.5193099471621466,-0.8551159896002496,0.7336122733612274,1.0,1.0,9/31,7.41%,Erbb4;Nrg1;Sparc;Adam17;Esr1;Apoe;S100b;Wwox;Adap1
prerank,DNA Damage Bypass R-HSA-73893,-0.49248872637420615,-0.8548755275292974,0.7185714285714285,1.0,1.0,7/48,20.00%,Usp43;Trim25;Pold4;Uba7;Cul4a;Polk;Ubc
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.408739423176063,-0.8535410131945064,0.8063241106719368,1.0,1.0,37/262,7.84%,Camk2d;Kit;Erbb4;Apbb1ip;Prkcq;Dusp10;Rasgrp3;Pik3r1;Nrg1;Fgf1;Fn1;Rasgrp1;Pdgfra;Fgfr3;Erbb3;Nf1;Angpt1;Shc3;Dusp5;Dusp16;Prkg2;Ppp2r5a;Dusp6;Jak2;Vcl;Iqgap1;Rasal1;Grin2d;Dlg1;Rap1b;Ret;Dab2ip;Egfr;Spred3;Zdhhc9;Ppp2r5c;Rasal3
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.5363569896754575,-0.8533834858307312,0.6989100817438693,1.0,1.0,3/17,6.59%,Runx1;Ccnd3;Ccnd1
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,-0.41050780473606957,-0.8533198732612343,0.8023715415019763,1.0,1.0,37/257,7.84%,Camk2d;Kit;Erbb4;Apbb1ip;Prkcq;Dusp10;Rasgrp3;Pik3r1;Nrg1;Fgf1;Fn1;Rasgrp1;Pdgfra;Fgfr3;Erbb3;Nf1;Angpt1;Shc3;Dusp5;Dusp16;Prkg2;Ppp2r5a;Dusp6;Jak2;Vcl;Iqgap1;Rasal1;Grin2d;Dlg1;Rap1b;Ret;Dab2ip;Egfr;Spred3;Zdhhc9;Ppp2r5c;Rasal3
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.432002382539609,0.8526181765573428,0.75177304964539,1.0,1.0,13/79,10.58%,Cdc40;Srsf11;Thoc2;Srsf9;Nup93;Ndc1;Ncbp1;Fyttd1;Srsf1;Nup160;Ranbp2;Cpsf2;Eif4e
prerank,PLC Beta Mediated Events R-HSA-112043,0.45993587660521806,0.8503710499558971,0.6643835616438356,1.0,1.0,12/46,2.40%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnaq;Mapk1;Pde1b;Adcy9;Calm1;Camkk1
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.5183561911049438,-0.8502865541659543,0.7078651685393258,1.0,1.0,10/27,22.31%,Casp8;Birc3;Mlkl;Cflar;Tnfsf10;Flot2;Xiap;Ubc;Ripk1;Pdcd6ip
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.45556409274496346,-0.8473148739641769,0.7417027417027418,1.0,1.0,18/99,16.65%,Prkcd;Nfe2l2;Notch1;Gsta3;Myc;Psmb8;Psmb11;Mafg;Psme2;Trim21;Psme4;Idh1;Slc7a11;Psma8;Psmb9;Ep300;Mafk;Tkt
prerank,Diseases Of Glycosylation R-HSA-3781865,-0.4366479575393687,-0.8463789933761869,0.7492997198879552,1.0,1.0,17/136,4.97%,Gpc6;Ext1;Adamts16;Adamtsl1;Gpc5;Adamts2;Thsd4;Bcan;Cspg4;Adamts4;B3glct;Vcan;Chst3;Adamts6;Cspg5;Sdc4;Notch1
prerank,TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.5240737453472111,-0.8459492461010987,0.7239884393063584,1.0,1.0,5/25,11.98%,Tnfrsf1b;Tnfrsf13b;Tnfrsf11b;Edaradd;Tnfrsf17
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.44716009921848937,-0.8448592455090512,0.7475317348377997,1.0,1.0,23/112,11.68%,Pik3r1;Kcnh8;Ngf;Shc3;Trib1;Dnm3;Dusp6;Rps6ka5;Fosb;Sgk1;Mapk11;Egr1;Vgf;Ralb;Mef2a;Arc;Rps6ka1;Egr2;Ap2b1;Sh3gl2;F3;Pik3ca;Stat3
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,0.47256564924576877,0.8445800873425886,0.6823899371069182,1.0,1.0,11/34,16.21%,Pou2f1;Gtf3c1;Polr2e;Polr2f;Gtf3c2;Gtf3c4;Polr3f;Snapc4;Polr2k;Polr3e;Polr3gl
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.45946898620733734,-0.8445238785786554,0.7514285714285714,1.0,1.0,11/87,14.69%,Cdc14a;Ccnb1;Cdk2;Nek2;Psmb8;Psmb11;Aurkb;Psme2;Psme4;Psma8;Psmb9
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.48125938494723725,-0.8434271367565724,0.7334273624823695,1.0,1.0,16/51,11.36%,Synj2;Inpp5d;Pik3r1;Pik3r5;Pip4k2a;Pik3cg;Plekha1;Pik3c2b;Inppl1;Pi4k2b;Pik3r6;Rufy1;Ptpn13;Pik3c2a;Pik3ca;Clstn1
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.44487379569718755,0.8426416509793383,0.6935483870967742,1.0,1.0,6/50,4.17%,Ralgapa2;Prkag2;Calm1;Myo5a;Exoc4;Ywhaz
prerank,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.5185991053921023,-0.8416107651933807,0.723314606741573,1.0,1.0,7/21,30.01%,E2f1;Ccnb1;Prim2;Cdk1;Slc25a2;Rb1;Tfdp2
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.43650228542111896,0.8409706056868974,0.6862068965517242,1.0,1.0,13/56,10.60%,Jun;Gtf2f2;Cdk12;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Polr2e;Atm;Polr2f;Mnat1;Ccnk;Ccnt2
prerank,RAC2 GTPase Cycle R-HSA-9013404,-0.4571508971038914,-0.8407430871240286,0.7414772727272727,1.0,1.0,20/86,5.73%,Dock1;Dock2;Vav2;Pik3r1;Vrk2;Nckap1l;Vav1;Arhgap26;Prex1;Mcf2;Garre1;Ncf2;Arhgap42;Cdc42ep1;Swap70;Ophn1;Iqgap1;Syde1;Mcam;Depdc1b
prerank,RND1 GTPase Cycle R-HSA-9696273,0.4689812457841924,0.8406665219091467,0.6982456140350877,1.0,1.0,5/41,3.04%,Plekhg5;Rasal2;Rras2;Pkp4;Vangl2
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.4730432111842554,-0.8399240998159535,0.7201767304860088,1.0,1.0,10/65,5.55%,Pcdh15;Whrn;Epb41l3;Myo1e;Cacna2d2;Clic5;Stx1a;Msn;Myo3a;Cabp1
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.482137375983608,0.8395341531684044,0.6618705035971223,1.0,1.0,7/28,2.93%,Grik4;Plcb1;Gng7;Ncald;Calm1;Gng2;Grik5
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.517540459775544,-0.8393012043072763,0.7273972602739726,1.0,1.0,2/23,6.00%,Smox;Bbs9
prerank,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5037972753984312,-0.8392340536235686,0.7369901547116737,1.0,1.0,6/29,24.35%,Tdrd9;Mybl1;Piwil1;Fkbp6;Mael;Piwil4
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,0.5079154361860085,0.8388125218072238,0.6645367412140575,1.0,1.0,6/17,16.21%,Polr2e;Polr2f;Polr3f;Polr2k;Polr3e;Polr3gl
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.48264162178300624,-0.8385560818607005,0.7189728958630528,1.0,1.0,7/50,17.51%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Slc25a21
prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.5391813182083639,-0.8378607709138758,0.7366946778711485,1.0,1.0,4/15,8.72%,Bcl2;Ywhaq;Bid;Ppp3cc
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.5117089195556592,-0.8373132109528132,0.7254098360655737,1.0,1.0,5/23,8.50%,Kcnh8;Bcl2;Ccnd1;Egfr;Foxo3
prerank,Diseases Of Metabolism R-HSA-5668914,-0.4087559444650528,-0.8359362040378142,0.7972789115646258,1.0,1.0,21/225,4.97%,Gpc6;Ext1;Adamts16;Adamtsl1;Gpc5;Adamts2;Thsd4;Tbxas1;Bcan;Cspg4;Adamts4;B3glct;Tcn2;Vcan;Chst3;Gbe1;Adamts6;Cspg5;Cyp26b1;Sdc4;Notch1
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.4412647697148963,-0.8345890837305311,0.7610241820768137,1.0,1.0,6/102,10.47%,Myo1e;Kat2b;Tet2;Phf1;Gatad2a;Phf19
prerank,Viral Messenger RNA Synthesis R-HSA-168325,0.4440567895663849,0.8342492464631374,0.7129032258064516,1.0,1.0,13/43,16.30%,Gtf2f2;Nup93;Ndc1;Nup160;Ranbp2;Polr2e;Gnl3;Polr2f;Nup155;Nup153;Polr2k;Nup210;Polr2g
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.5052371488469058,-0.8341919886700829,0.7207334273624824,1.0,1.0,10/29,22.31%,Casp8;Birc3;Mlkl;Cflar;Tnfsf10;Flot2;Xiap;Ubc;Ripk1;Pdcd6ip
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.422446220858798,0.8338731148486139,0.7887788778877888,1.0,1.0,5/79,2.97%,Ppp3ca;Calm1;Ppp3r1;Btrc;Fbxw11
prerank,Neddylation R-HSA-8951664,-0.40914868067512283,-0.8330091269330081,0.8058902275769746,1.0,1.0,28/231,16.51%,Socs2;Spsb4;Btbd1;Asb2;Nfe2l2;Wsb1;Fbxl19;Epas1;Fbxo7;Cul7;Klhl13;Cish;Fbxl4;Psmb8;Psmb11;Fbxw8;Socs6;Psme2;Tulp4;Psme4;Psma8;Asb4;Psmb9;Dcun1d3;Cul4a;Fbxl12;Fbxo44;Fbxo30
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.5000646128002656,-0.8327809393693676,0.7539118065433855,1.0,1.0,1/30,1.27%,Fgf1
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.4496640385314915,0.8323378770050167,0.6837060702875399,1.0,1.0,7/44,4.13%,Itga8;Nedd4l;Ppp1cb;Smad3;Usp15;Itgb8;Tgfb2
prerank,RND3 GTPase Cycle R-HSA-9696264,0.46592871328060864,0.8323043543613603,0.6605839416058394,1.0,1.0,5/40,3.04%,Plekhg5;Rasal2;Arhgap21;Pkp4;Vangl2
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,0.40636958711414456,0.8322627604573103,0.8087774294670846,1.0,1.0,10/99,4.67%,Ppp3ca;Igfbp5;Sparcl1;Cdh2;Tmem132a;Gpc3;Lamb1;Lamc1;Scg2;Golm1
prerank,Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.5307495170275538,-0.8317741232909713,0.7280453257790368,1.0,1.0,4/17,12.03%,Slc6a7;Slc6a1;Slc6a9;Slc6a5
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.4658425098691941,-0.8315453360288803,0.7177304964539007,1.0,1.0,9/52,10.82%,Homer2;Tpd52;Ap1m2;Hip1r;Dtnbp1;Ap3s1;Sh3gl2;Picalm;Pik3c2a
prerank,Recycling Of Bile Acids And Salts R-HSA-159418,-0.5233234221986475,-0.8301795181504162,0.7080394922425952,1.0,1.0,5/15,22.43%,Abcc3;Slc10a1;Slc10a2;Slc51a;Alb
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.389308814119981,-0.8301404360646748,0.8413098236775819,1.0,1.0,27/357,8.80%,Lnx1;Hecw2;Sh3rf1;Trim36;Itgb5;Rnf220;Ctss;Herc6;Rnf144b;Ncf2;Spsb4;Smurf1;Btbd1;Asb2;Mrc1;Wsb1;Fbxl19;Fbxo7;Cul7;Btk;Klhl13;Lonrf1;Cyba;Ncf1;Fbxl4;Mylip;Herc4
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.5014857034847823,-0.8290830755063356,0.73582295988935,1.0,1.0,8/28,2.31%,Itpr2;Vav2;Lcp2;Tec;Nfatc1;Vav1;Lyn;Nfatc2
prerank,Signaling By WNT R-HSA-195721,-0.3922818053923311,-0.8253040531265147,0.8414322250639387,1.0,1.0,40/277,8.47%,Tcf7l2;Itpr2;Sox6;Prkcb;Wls;Rspo2;Cxxc4;Nfatc1;Sox2;Tle3;Tcf7l1;Gng4;Ccdc88c;Smurf1;Gng12;Gnao1;Prkg2;Ppp2r5a;Nlk;Plcb2;Prkcg;Wif1;Sox4;Gnb4;Lrp5;Lef1;Tle2;Rnf43;Ctnnbip1;Gngt2;Bcl9;Wnt2;Prkca;Itpr3;Ppp2r5c;Dkk2;Wnt5b;Sox13;Ncoa3;Myc
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.4553694602538158,0.8243066958477018,0.7025316455696202,1.0,1.0,1/44,0.39%,Nsf
prerank,Amyloid Fiber Formation R-HSA-977225,0.42527858683833725,0.8242402555695089,0.7435064935064936,1.0,1.0,6/58,4.27%,Calb1;Snca;Sorl1;Tspan5;Sncaip;Tspan33
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.4527612892633457,-0.8239682309083913,0.7549295774647887,1.0,1.0,18/81,20.70%,Btk;Tapbp;Tlr1;Psmb8;Psmb11;Tirap;Psme2;Psme4;Psma8;Tlr2;B2m;S100a1;Psmb9;Tlr6;Vamp8;Chuk;Ubc;Sec61g
prerank,Early Phase Of HIV Life Cycle R-HSA-162594,0.5173097355021216,0.8232004978455074,0.6618181818181819,1.0,1.0,1/15,0.58%,Sgip1
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.49244719280732824,-0.8221842621287945,0.7492877492877493,1.0,1.0,7/32,16.15%,Msn;Rap1b;Psme2;Rala;Cdc42;Pkn2;Pitpna
prerank,Meiotic Recombination R-HSA-912446,-0.4768305440589985,-0.8218029708048677,0.7411598302687411,1.0,1.0,7/42,24.00%,Rbbp8;Cdk2;Top3a;Brca1;Artn;H2aj;Blm
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.49970750994516494,-0.8217750692375828,0.739251040221914,1.0,1.0,5/26,3.35%,Tgfb1;Tgfbr2;Smad7;Smad2;Smurf1
prerank,Signaling By Hedgehog R-HSA-5358351,-0.4238027243738515,-0.8215568680316335,0.8128415300546448,1.0,1.0,24/134,13.24%,Gpc5;Gpr161;Hhip;Smurf1;Prkar1b;Numb;Smox;Gli3;Adcy7;Adam17;Dzip1;Gnas;Prkca;Intu;Ift88;Psmb8;Shh;Psmb11;Gli2;Kif7;Adcy5;Psme2;Gas1;Psme4
prerank,Deadenylation Of mRNA R-HSA-429947,0.4915580198950089,0.8214750139677798,0.6711409395973155,1.0,1.0,9/24,10.58%,Cnot2;Cnot6l;Eif4a1;Cnot4;Eif4b;Pan3;Cnot3;Cnot1;Eif4e
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.5154495104616684,-0.8185753259830688,0.7448275862068966,1.0,1.0,3/20,2.58%,Erbb4;Nrg1;Erbb3
prerank,NOD1/2 Signaling Pathway R-HSA-168638,-0.49598555287451374,-0.8184908743169258,0.7496382054992764,1.0,1.0,9/32,11.32%,Irak2;Casp8;Casp1;Mapk11;Casp4;Cyld;Birc3;Tnfaip3;Nod1
prerank,Transcription Of HIV Genome R-HSA-167172,0.42306382612868343,0.8175061414280886,0.7824561403508772,1.0,1.0,12/64,10.80%,Gtf2f2;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Ncbp1;Polr2e;Polr2f;Mnat1;Ccnk;Ccnt2;Rngtt
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,0.44351305993402157,0.8173903227171728,0.7408759124087592,1.0,1.0,8/42,9.51%,Ercc4;Parp1;Gtf2h2;Ccnh;Gtf2h5;Sumo2;Uba52;Mnat1
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.4192425444535656,0.8167255797981803,0.7428571428571429,1.0,1.0,15/62,11.99%,Gtf2h2;Ccnh;Gtf2h5;H2bc4;Hdac1;Sin3b;Polr2e;H2az1;Ubtf;Polr2f;Mnat1;Taf1c;Smarca5;H2ac6;Sap30bp
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.4628362729442011,-0.8155939916858859,0.7525035765379113,1.0,1.0,8/58,14.69%,Numb;Prkca;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.4852714492594139,0.8151669509687661,0.6721854304635762,1.0,1.0,3/19,3.64%,Rims1;Snap25;Syt1
prerank,Interleukin-12 Family Signaling R-HSA-447115,-0.4675829107040503,-0.8142422827470697,0.7572254335260116,1.0,1.0,13/49,16.15%,Jak2;Msn;Rap1b;Il6st;Stat3;Ebi3;Psme2;Il12rb1;Il12a;Rala;Cdc42;Pkn2;Pitpna
prerank,Insulin Receptor Recycling R-HSA-77387,0.4966730761037311,0.8133339124322778,0.7116104868913857,1.0,1.0,7/23,9.41%,Atp6v1a;Atp6v0c;Atp6v0e2;Atp6v1d;Atp6v0a1;Atp6v0a4;Atp6v1c2
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.3853129252631364,0.8131530017760722,0.8387096774193549,1.0,1.0,10/111,4.67%,Ppp3ca;Igfbp5;Sparcl1;Cdh2;Tmem132a;Gpc3;Lamb1;Lamc1;Scg2;Golm1
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.5098793708515195,-0.8128722319989296,0.7566433566433567,1.0,1.0,9/23,14.07%,Gng4;Gna15;Gng12;Gnb4;Gngt2;Gna14;Gna13;Gnb1;Gng11
prerank,Lewis Blood Group Biosynthesis R-HSA-9037629,-0.5161725548027687,-0.8126932318755113,0.7548209366391184,1.0,1.0,1/15,1.52%,St3gal6
prerank,DNA Double Strand Break Response R-HSA-5693606,-0.47102284615928613,-0.8126180534120546,0.7489421720733427,1.0,1.0,10/49,21.74%,Cnksr3;Eya4;Mapk8;Nsd2;Eya2;Abl1;Brca1;Apbb1;Ubc;Artn
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.44408837319643957,-0.8125676768047171,0.7784090909090909,1.0,1.0,17/77,20.84%,Ccp110;Tubb4a;Nedd1;Nde1;Prkca;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Cep192;Csnk1e;Cep290;Pcnt;Alms1
prerank,Centrosome Maturation R-HSA-380287,-0.44508936520967957,-0.8121131034990893,0.7825464949928469,1.0,1.0,17/77,20.84%,Ccp110;Tubb4a;Nedd1;Nde1;Prkca;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Cep192;Csnk1e;Cep290;Pcnt;Alms1
prerank,Regulation Of TP53 Activity R-HSA-5633007,0.3749425707191969,0.8120601760114071,0.8959731543624161,1.0,1.0,11/143,4.18%,Prkag2;Map2k6;Ppp1r13b;Pdzd2;Akt3;Usp2;Chd4;Chd3;Gatad2b;Rad50;Cdk5r1
prerank,MAP Kinase Activation R-HSA-450294,0.426978500613712,0.8110774120596265,0.7414330218068536,1.0,1.0,13/61,5.02%,Map2k6;Mapk1;Map2k1;Tnip2;Btrc;Mapk10;Jun;Rps6ka2;Fbxw11;Mef2c;Ripk2;Mapk3;Map2k4
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.4606405462490855,0.8107405801148939,0.7248322147651006,1.0,1.0,8/31,3.96%,Camk2a;Camk2b;Tnrc6c;Ncor1;Calm1;Camk2g;Ago2;Ago1
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.4855787991667758,-0.8105802246202919,0.7706293706293706,1.0,1.0,1/32,1.27%,Fgf1
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.4713003069809981,-0.8103529228618416,0.7542613636363636,1.0,1.0,10/48,21.74%,Cnksr3;Eya4;Mapk8;Nsd2;Eya2;Abl1;Brca1;Apbb1;Ubc;Artn
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.436426886565653,-0.8090355248151938,0.7971223021582734,1.0,1.0,22/96,20.93%,Ccp110;Tubb4a;Sclt1;Nedd1;Nde1;Prkca;Cep83;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1;Cep192;Cep97;Csnk1e;Rpgrip1l;Cep290;Pcnt;Alms1;Kif24
prerank,Platelet Calcium Homeostasis R-HSA-418360,-0.4968367850371889,-0.8089578764294713,0.7731811697574893,1.0,1.0,6/26,4.29%,Itpr2;Slc8a1;Trpc3;P2rx7;Trpc7;P2rx4
prerank,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.510010695615336,-0.8083670570583921,0.759493670886076,1.0,1.0,5/16,30.01%,Ccnb1;Ep300;Cdk1;Cdc25c;Tfdp2
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.49381768908226426,-0.8074926090246436,0.7726027397260274,1.0,1.0,11/29,14.07%,Gng4;Gng12;Gnb4;Gngt2;Gnas;C1qtnf1;Sctr;Glp1r;Gnb1;Adcyap1;Gng11
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.41298329577818854,-0.8061705559981305,0.8208092485549133,1.0,1.0,17/145,15.63%,Lyn;Ccnd3;E2f1;Jak2;Ccnd1;Myc;Ccnb1;Cables1;Cdk2;Psmb8;Mcm10;Psme2;Abl1;Lin54;Psmb9;E2f6;Cdt1
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,0.4384375630549655,0.8050768248077822,0.7298136645962733,1.0,1.0,12/47,11.34%,Gtf2h2;Ccnh;Gtf2h5;H2bc4;Polr2e;H2az1;Ubtf;Polr2f;Mnat1;Cbx3;Taf1c;H2ac6
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.40886420014269764,0.8041017617496462,0.7732919254658385,1.0,1.0,15/65,11.99%,Gtf2h2;Ccnh;Gtf2h5;H2bc4;Hdac1;Sin3b;Polr2e;H2az1;Ubtf;Polr2f;Mnat1;Taf1c;Smarca5;H2ac6;Sap30bp
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.48090442314473353,-0.8040789573434687,0.7653958944281525,1.0,1.0,4/36,8.47%,Smad7;Smad2;Wwtr1;Myc
prerank,Blood Group Systems Biosynthesis R-HSA-9033658,-0.5048385720254902,-0.8035986083920409,0.7554945054945055,1.0,1.0,1/18,1.52%,St3gal6
prerank,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.4835901307723202,-0.8032192439951438,0.7727930535455861,1.0,1.0,13/31,13.65%,Slc7a7;Slc38a3;Slc7a2;Slc7a3;Slc38a2;Slc1a5;Slc36a1;Slc7a10;Slc1a4;Slc7a1;Slc43a1;Slc38a4;Slc7a11
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.47655848581258003,-0.7996323694780837,0.7749648382559775,1.0,1.0,10/35,24.82%,Rbbp8;Wrn;Abl1;Top3a;Brca1;Dna2;Artn;Rmi1;Blm;Bard1
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.4056286002107668,0.7992464334440252,0.7861842105263158,1.0,1.0,2/72,0.46%,Nsf;Kif26b
prerank,Hyaluronan Metabolism R-HSA-2142845,0.4876247824828005,0.7991176702980756,0.7043795620437956,1.0,1.0,1/15,0.83%,Cemip
prerank,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.48354708712439004,-0.7990800193425108,0.7521246458923513,1.0,1.0,3/25,10.80%,Pold4;Fen1;Lrig1
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.4599557933707037,-0.7990092498051026,0.7696709585121603,1.0,1.0,8/49,20.00%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Pkn2;Ubc
prerank,SUMOylation Of Transcription Factors R-HSA-3232118,-0.5069284509316322,-0.7989864944830077,0.7773049645390071,1.0,1.0,1/17,5.44%,Mitf
prerank,Homology Directed Repair R-HSA-5693538,-0.4215417543139914,-0.7984673136579132,0.8286908077994429,1.0,1.0,18/106,22.17%,Rbbp8;Rad51b;Lrig3;Pold4;Fen1;Wrn;Cdk2;Nsd2;Abl1;Eme1;Xrcc3;Top3a;Polk;Brca1;Ubc;Dna2;Artn;Rmi1
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.4004288621121742,0.7981562478843989,0.835016835016835,1.0,1.0,12/74,9.08%,Mapk1;Bag4;Hspa2;Mapk3;Dnajb6;Nup93;Ndc1;Ywhae;Hspa12a;Nup160;Ranbp2;Atm
prerank,Interferon Gamma Signaling R-HSA-877300,0.4044047296943728,0.7973111273552136,0.7971014492753623,1.0,1.0,4/64,1.42%,Camk2a;Camk2b;Bcl11b;Ncam1
prerank,Unfolded Protein Response (UPR) R-HSA-381119,-0.4340041259039268,-0.7972996222105596,0.8125,1.0,1.0,4/85,7.29%,Creb3l2;Edem1;Cul7;Crebrf
prerank,SUMOylation R-HSA-2990846,-0.407330172994853,-0.7969660352694764,0.8630705394190872,1.0,1.0,10/163,5.57%,Satb2;Thrb;Hipk2;Rara;Nrip1;Nr4a2;Satb1;Hdac4;Mitf;Esr1
prerank,Cell Junction Organization R-HSA-446728,-0.43532459111091637,-0.7956062652339105,0.8028368794326242,1.0,1.0,16/81,4.92%,Cdh6;Sdk1;Lama4;Cdh18;Cdh19;Nectin3;Cdh10;Cldn14;Lims1;Cdh4;F11r;Cldn1;Cldn11;Lamc2;Itga6;Arhgef6
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.4676685437248351,0.7947684743522484,0.7554858934169278,1.0,1.0,9/26,16.21%,Gtf3c1;Polr2e;Polr2f;Gtf3c2;Gtf3c4;Polr3f;Polr2k;Polr3e;Polr3gl
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.4454079245822893,-0.7947022258002454,0.7868383404864091,1.0,1.0,5/64,10.10%,Rbbp8;Ywhaq;Ccnb1;Wrn;Nsd2
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.4086862368153618,-0.7946344003272835,0.8609179415855355,1.0,1.0,10/157,5.57%,Satb2;Thrb;Hipk2;Rara;Nrip1;Nr4a2;Satb1;Hdac4;Mitf;Esr1
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.45106647990461024,-0.7945929040466283,0.7763532763532763,1.0,1.0,11/55,27.63%,Psmb8;Shh;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Psmd11;Sel1l;Psme1
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,-0.45333076047500803,-0.7942670911099986,0.7829787234042553,1.0,1.0,10/51,6.63%,Thrb;Rxrg;Nr4a1;Nr2e1;Nr4a3;Rara;Rorb;Nr4a2;Esr1;Nr6a1
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.4433241115680503,0.7939559944693431,0.7482758620689656,1.0,1.0,10/33,13.18%,Nup93;Xpo1;Ndc1;Npm1;Nup160;Ranbp2;Ranbp1;Ran;Nup155;Nup153
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.4915430769996355,0.7924549311408325,0.7081967213114754,1.0,1.0,2/19,3.30%,Map2k6;Ripk2
prerank,Azathioprine ADME R-HSA-9748787,-0.4988243916893033,-0.791292508477908,0.7694444444444445,1.0,1.0,2/19,1.76%,Vav2;Vav1
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.47467762860342816,-0.7912698202212931,0.7865329512893983,1.0,1.0,11/34,19.00%,Ncf2;Cyba;Ncf1;Atp6v1b1;Ncf4;Rac2;Lpo;Hvcn1;Tcirg1;Atp6v0a2;Cybb
prerank,G-protein Activation R-HSA-202040,-0.49162990629306536,-0.7906603646556477,0.763265306122449,1.0,1.0,6/23,8.24%,Gng4;Gna15;Gng12;Gnb4;Gngt2;Gna14
prerank,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.4776889329946887,-0.7896576640660866,0.7704225352112676,1.0,1.0,10/24,37.99%,Pold4;Dscc1;Prim2;Chtf8;Rfc2;Ctc1;Rfc4;Slc19a1;Rfc3;Terf1
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.47798926656245344,-0.7888540425524982,0.7945205479452054,1.0,1.0,8/32,7.60%,Itpr2;Hck;Lyn;Prkar1b;Adcy7;Syk;Prkca;Itpr3
prerank,Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.5031515135282071,-0.7880296443149645,0.7734487734487735,1.0,1.0,5/15,4.29%,Itpr2;Trpc3;P2rx7;Trpc7;P2rx4
prerank,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.49424085589338124,-0.7877562562786166,0.7691256830601093,1.0,1.0,8/18,33.03%,Podxl2;Papss2;Tpst2;Sult6b1;Slc26a1;Slc35b2;Papss1;Sult2b1
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.45685568768928836,-0.786350344424805,0.7914285714285715,1.0,1.0,4/38,10.80%,Lrig3;Pold4;Fen1;Lrig1
prerank,Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.49776803442134676,-0.7855019560790589,0.7854251012145749,1.0,1.0,4/18,17.00%,Dio2;Tshb;Chga;Tph1
prerank,Plasma Lipoprotein Remodeling R-HSA-8963899,0.4524906698265605,0.785264130856972,0.7292418772563177,1.0,1.0,1/26,0.60%,Pcsk5
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.413533429427186,-0.7851109851878988,0.8463687150837989,1.0,1.0,36/111,14.07%,Rxfp1;Htr7;Gng4;Gng12;Prkar1b;Npsr1;Adcy7;Gnb4;Gnai1;Gngt2;Gnas;Prkca;Hrh2;Gnai2;Pth2r;Adrb3;C1qtnf1;Adrb2;Adora2b;Crhr1;Nlrp3;Pthlh;Sctr;Lhcgr;Adrb1;Adcy5;Tshb;Calcr;Adm;Adora2a;Chga;Glp1r;Gnb1;Adcyap1;Calcb;Gng11
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.42278040528704086,-0.7850617043485342,0.8216292134831461,1.0,1.0,18/94,13.05%,Chrm2;Syt9;Grk3;Dab2;Eps15;Cftr;Egfr;Stam2;Adrb2;Nlrp3;Ap2b1;Sh3gl2;Picalm;Fcho2;Ldlrap1;Scarb2;Syt12;Il7r
prerank,Activation Of BH3-only Proteins R-HSA-114452,-0.4782978201455588,-0.7845706417745459,0.7912087912087912,1.0,1.0,7/26,9.70%,Bcl2;Ywhaq;E2f1;Bmf;Bid;Ppp3cc;Mapk8
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.40720491180446416,-0.7840724364232146,0.8484419263456091,1.0,1.0,14/123,7.38%,Cpne7;Pitpnm3;Mboat1;Pla2g4a;Lpcat2;Plaat3;Osbpl10;Pld4;Sh2d3c;Gpat3;Pla2g4c;Lpgat1;Pld2;Pcyt2
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.48103740805282635,-0.7824200579714757,0.8011444921316166,1.0,1.0,6/29,23.08%,Cftr;Ift88;Plin3;Ubc;Pcnt;Mvb12a
prerank,RAC3 GTPase Cycle R-HSA-9013423,-0.4228351088580005,-0.7819824699427245,0.8520055325034578,1.0,1.0,29/90,9.26%,Vav2;Arap2;Pik3r1;Vrk2;Srgap2;Nckap1l;Arhgap26;Prex1;Mcf2;Garre1;Ncf2;Arhgap42;Cdc42ep1;Swap70;Ophn1;Syde1;Mcam;Depdc1b;Arhgap6;Itgb1;Cyba;Slc1a5;Ncoa3;Ncf1;Erbin;Arhgap5;Arap3;Wasf2;Nox3
prerank,Ion Transport By P-type ATPases R-HSA-936837,-0.4509326870201606,-0.7808013669075154,0.8078484438430311,1.0,1.0,10/51,6.87%,Camk2d;Atp8b1;Atp13a4;Atp10a;Fxyd7;Atp1a2;Atp1b3;Atp7a;Atp2c2;Atp13a5
prerank,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.46377278389832355,0.7796483603093536,0.7120622568093385,1.0,1.0,5/21,3.85%,Prkce;Pik3cb;Plpp4;Itpr1;Plcg2
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.44137864699132956,-0.7785941018321191,0.8076923076923077,1.0,1.0,11/54,27.63%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Hspb1;Hspa1a;Psmd11;Psme1
prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.44771668218403354,0.7766102236940169,0.7692307692307693,1.0,1.0,1/28,0.58%,Cyp7b1
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.4730534444325197,-0.7764959404253039,0.7869318181818182,1.0,1.0,3/28,2.58%,Erbb4;Nrg1;Erbb3
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,0.4215590204316999,0.7754068237368865,0.8210526315789474,1.0,1.0,9/53,7.67%,Atp6v1a;Rragd;Fnip2;Kptn;Atp6v0c;Atp6v0e2;Mios;Atp6v1d;Nprl3
prerank,G0 And Early G1 R-HSA-1538133,-0.471573949376853,-0.7746435203157563,0.7813370473537604,1.0,1.0,4/27,14.59%,E2f1;Myc;Cdk2;Lin54
prerank,Intra-Golgi Traffic R-HSA-6811438,0.44058598983076663,0.7741188332555344,0.7653061224489796,1.0,1.0,1/35,0.39%,Nsf
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.4399885642589658,-0.7733705793616781,0.806966618287373,1.0,1.0,7/58,14.69%,Psmb8;Shh;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.44962262639850953,0.7730775408456124,0.7100371747211895,1.0,1.0,5/15,11.63%,Nt5c3b;Exosc8;Skic3;Skic8;Exosc2
prerank,RHO GTPase Effectors R-HSA-195258,-0.3728112751125763,-0.7728405978252637,0.9152317880794701,1.0,1.0,35/249,11.00%,Wipf1;Prkcb;Srgap2;Nckap1l;Fmnl3;Ncf2;Rhoq;Cftr;Prkcd;Ywhaq;Ppp2r5a;Kif5a;Rhog;Mapk11;Iqgap1;Clasp2;Ppp1r14a;Btk;Nde1;Rhpn2;Prkca;Ppp2r5c;Itgb1;Cyba;Mylk;Ncf1;Ctnna1;Arpc1b;Wasf2;Nox3;Dync1li2;Ncf4;Dync1h1;Ndc80;Aurkb
prerank,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.4962058675390034,-0.772466503824811,0.7986394557823129,1.0,1.0,4/15,7.90%,Cckbr;Egfr;Prkca;Rps6ka1
prerank,G2/M Checkpoints R-HSA-69481,-0.39593140933584986,-0.7716646839538595,0.8616874135546335,1.0,1.0,25/135,25.25%,Rbbp8;Ywhaq;Ccnb1;Wrn;Cdk2;Nsd2;Psmb8;Psmb11;Mcm10;Psme2;Psme4;Psma8;Psmb9;Top3a;Brca1;Ubc;Dna2;Artn;Rmi1;Blm;Cdk1;Slc25a2;Bard1;Psmd11;Mcm3
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.4272973618117605,-0.7709652381720736,0.8506401137980085,1.0,1.0,20/75,34.41%,Ccnb1;Nek2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Cdk1;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1;Pttg1;Sem1
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.4409974546134874,-0.7705189732281695,0.8416547788873039,1.0,1.0,8/59,6.05%,Camk2d;Apbb1ip;Qki;Fn1;Jak2;Vcl;Iqgap1;Rap1b
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.4519143929707407,-0.7692955733873412,0.8244170096021948,1.0,1.0,3/49,5.28%,Tbl1x;Camk4;Smarcd3
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,-0.4227106653115242,-0.7687699889326531,0.8565279770444764,1.0,1.0,11/81,8.24%,Kif13a;Gng4;Gna15;Gng12;Rgs6;Tubb4a;Tubb3;Gnb4;Fkbp9;Gngt2;Gna14
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.41416541573102017,-0.7686488101240764,0.8410041841004184,1.0,1.0,14/86,14.27%,Optn;Ccp110;Tubb4a;Nedd1;Nde1;Prkca;Ccnb1;Nek2;Dync1h1;Plk4;Akap9;Cntrl;Cep43;Pafah1b1
prerank,Glycosphingolipid Metabolism R-HSA-1660662,-0.457586241865045,-0.7647689352886305,0.8235294117647058,1.0,1.0,7/36,12.71%,Neu4;Asah2;Cerk;Gltp;Asah1;Neu2;Hexa
prerank,Protein Folding R-HSA-391251,-0.41539365204748596,-0.7621869068818266,0.8645533141210374,1.0,1.0,11/87,8.24%,Kif13a;Gng4;Gna15;Gng12;Rgs6;Tubb4a;Tubb3;Gnb4;Fkbp9;Gngt2;Gna14
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.4444317554820472,0.762088436937033,0.7395833333333334,1.0,1.0,1/28,0.58%,Cyp7b1
prerank,Cristae Formation R-HSA-8949613,0.4473720533634807,0.7620791371607207,0.7045454545454546,1.0,1.0,3/15,10.44%,Chchd3;Apoo;Mtx1
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.42209585454063947,-0.7607978172277803,0.8616262482168331,1.0,1.0,20/76,34.41%,Ccnb1;Nek2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Cdk1;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1;Pttg1;Sem1
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,-0.46744321703723757,-0.7606448445557936,0.8225352112676056,1.0,1.0,10/31,8.78%,Gng4;Pik3r5;Gng12;Pik3cg;Plcb2;Arhgef6;Gnb4;Btk;Gngt2;Pik3r6
prerank,Termination Of O-glycan Biosynthesis R-HSA-977068,-0.47383586615122997,-0.7596791232927561,0.8072463768115942,1.0,1.0,1/19,0.12%,St6gal1
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.4085256000624428,-0.7594611576285124,0.8755426917510853,1.0,1.0,16/97,9.70%,Kcnh8;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;Birc3;Traf3;S100b;Mef2a;Rps6ka1;App;Irf3;Tlr3;Mapk8
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.3610755297407662,-0.7589896376159923,0.9507133592736705,1.0,1.0,20/298,8.80%,Lnx1;Hecw2;Sh3rf1;Trim36;Rnf220;Herc6;Rnf144b;Spsb4;Smurf1;Btbd1;Asb2;Wsb1;Fbxl19;Fbxo7;Cul7;Klhl13;Lonrf1;Fbxl4;Mylip;Herc4
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.46128680232886354,-0.7586595403596909,0.8228021978021978,1.0,1.0,7/31,8.24%,Gng4;Gna15;Gng12;Gna12;Gnb4;Gngt2;Gna14
prerank,Regulation Of TP53 Degradation R-HSA-6804757,-0.44569430102532215,-0.7576090741016772,0.811965811965812,1.0,1.0,5/35,10.00%,Rffl;Sgk1;Prr5;Ppp2r5c;Cdk2
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.4030800793476646,-0.7567002529804843,0.8809523809523809,1.0,1.0,16/101,22.17%,Rbbp8;Rad51b;Pold4;Wrn;Cdk2;Nsd2;Abl1;Eme1;Xrcc3;Top3a;Polk;Brca1;Ubc;Dna2;Artn;Rmi1
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.42852419055843505,-0.75522942612677,0.8470254957507082,1.0,1.0,8/58,14.69%,Gli3;Prkca;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.47285918337389415,-0.7547228451748638,0.8178025034770514,1.0,1.0,6/19,5.87%,Bcan;Cspg4;Vcan;Chst3;Cspg5;Dcn
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.425507001883317,0.7547078098021499,0.8076923076923077,1.0,1.0,9/31,13.18%,Nup93;Xpo1;Ndc1;Nup160;Ranbp2;Ranbp1;Ran;Nup155;Nup153
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,0.4118291116469596,0.7530641830741553,0.7916666666666666,1.0,1.0,12/46,10.67%,Rbbp5;Smyd2;Dot1l;Ehmt1;Kmt5a;Nsd1;Rbbp7;Suz12;Ash1l;Setdb1;Ezh2;Kmt2d
prerank,Presynaptic Function Of Kainate Receptors R-HSA-500657,0.44658469354111335,0.7529453411993434,0.7864768683274022,1.0,1.0,3/20,2.54%,Plcb1;Gng7;Gng2
prerank,Aggrephagy R-HSA-9646399,-0.4622938136733681,-0.7503204003510486,0.8206214689265536,1.0,1.0,4/23,10.76%,Cftr;Ift88;Dync1li2;Dync1h1
prerank,Polo-like Kinase Mediated Events R-HSA-156711,-0.4814081940343425,-0.7502095950878885,0.8254847645429363,1.0,1.0,6/16,33.70%,Ccnb1;Lin54;Ep300;Lin52;Cdc25c;Foxm1
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.4539461109865955,0.7500827106070864,0.8055555555555556,1.0,1.0,3/21,4.78%,Sec14l2;Sec24d;Sec23a
prerank,DARPP-32 Events R-HSA-180024,-0.46244420360975363,-0.7500685117032108,0.8156498673740054,1.0,1.0,3/23,3.42%,Pde4b;Pde4d;Prkar1b
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.37263203781259147,0.7496706402898581,0.9013605442176871,1.0,1.0,17/71,13.20%,Rprd1a;Pou2f1;Gtf2f2;Ints10;Ints6;Ncbp1;Pou2f2;Nabp1;Polr2e;Rprd1b;Polr2f;Ccnk;Ccnt2;Srrt;Ints3;Taf5;Ints2
prerank,G Alpha (Z) Signaling Events R-HSA-418597,-0.4461787731243968,-0.7482837319464329,0.8569364161849711,1.0,1.0,17/46,7.80%,Rgs20;Prkcq;Prkcb;Gng4;Prkcd;Prkch;Gng12;Prkcg;Adcy7;Gnb4;Gnai1;Rgsl1;Gngt2;Gnas;Prkca;Rgs16;Gnai2
prerank,Mitotic G2-G2/M Phases R-HSA-453274,-0.3761270876564825,-0.748044624676985,0.9345156889495225,1.0,1.0,25/178,14.69%,Optn;Ccp110;Tubb4a;E2f1;Nedd1;Phlda1;Nde1;Prkca;Cdc25b;Ccnb1;Cdk2;Nek2;Dync1h1;Psmb8;Psmb11;Plk4;Psme2;Akap9;Cntrl;Psme4;Cep43;Psma8;Pafah1b1;Lin54;Psmb9
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,0.38546512816762757,0.7475356287821309,0.8794788273615635,1.0,1.0,4/67,4.50%,Akt3;Prex2;Nedd4;Tnks
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,0.3856870584472438,0.7469234527298596,0.9066666666666666,1.0,1.0,14/60,13.18%,Ago2;Ago1;Nup93;Ndc1;H2bc4;Nup160;Ranbp2;Polr2e;H2az1;Polr2f;Ran;H2ac6;Nup155;Nup153
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.4396537801186127,-0.7468867798829147,0.8203677510608204,1.0,1.0,7/38,6.05%,Camk2d;Apbb1ip;Fn1;Jak2;Vcl;Iqgap1;Rap1b
prerank,Signaling By RAF1 Mutants R-HSA-9656223,-0.4431373261313107,-0.7468441668191124,0.8208744710860366,1.0,1.0,7/36,6.05%,Camk2d;Apbb1ip;Fn1;Jak2;Vcl;Iqgap1;Rap1b
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.40543798008656473,-0.7457532740344819,0.8890489913544669,1.0,1.0,11/83,11.00%,Rbbp8;Hipk2;Nuak1;Plk3;Mapk11;Prkab2;Dyrk2;Prkaa2;Wrn;Cdk2;Aurkb
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.43995447407511923,-0.7451744608800959,0.84,1.0,1.0,5/36,10.00%,Rffl;Sgk1;Prr5;Ppp2r5c;Cdk2
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.41459307192890676,-0.7449614739475615,0.8457223001402524,1.0,1.0,8/61,15.23%,Relb;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ccl17
prerank,RHO GTPases Activate Formins R-HSA-5663220,-0.3878522858871358,-0.7434423609659436,0.898876404494382,1.0,1.0,19/114,16.33%,Srgap2;Fmnl3;Ppp2r5a;Clasp2;Nde1;Ppp2r5c;Itgb1;Dync1li2;Dync1h1;Ndc80;Aurkb;Diaph3;Ppp2r5e;Pafah1b1;Zwint;Cdc42;Bub1;Ndel1;Kif2c
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,0.4134121325081903,0.7427527330260806,0.7859531772575251,1.0,1.0,2/32,3.03%,Clvs2;Clvs1
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,-0.34666008117720487,-0.7422494236410929,0.9747793190416141,1.0,1.0,30/330,10.00%,Ndrg1;Rbbp8;Rffl;Hipk2;Cradd;Aifm2;Nuak1;Pip4k2a;Ywhaq;Plagl1;E2f1;Plk3;Sgk1;Casp1;Mapk11;Prkab2;Prr5;Dyrk2;Fancc;Rgcc;Prkaa2;E2f7;Ppp2r5c;Bid;Igfbp3;Ccnb1;Plk2;Wrn;Gatad2a;Cdk2
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.4204191837940364,0.7422405447429786,0.8131487889273357,1.0,1.0,9/31,13.18%,Nup93;Xpo1;Ndc1;Nup160;Ranbp2;Gnl3;Ran;Nup155;Nup153
prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.45947341525097196,-0.7417311475441353,0.8254189944134078,1.0,1.0,3/24,10.00%,Cdc25b;Ccnb1;Cdk2
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,-0.3969968380130695,-0.7412374503884794,0.8850574712643678,1.0,1.0,14/100,8.37%,Kcnh8;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;Birc3;Traf3;S100b;Mef2a;Rps6ka1;App;Irf3
prerank,HDMs Demethylate Histones R-HSA-3214842,0.4467203269831732,0.7407723631111978,0.7752808988764045,1.0,1.0,2/21,3.92%,Kdm7a;Arid5b
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.39155643622492003,-0.7403024759283267,0.9036827195467422,1.0,1.0,7/105,5.98%,Kif21b;Pla2g4a;Kif26a;Kif6;Kif13b;Kif5a;Kif16b
prerank,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.4467779095971868,0.7395115036906961,0.7935943060498221,1.0,1.0,3/19,2.54%,Plcb1;Gng7;Gng2
prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.32206212159550396,0.7393536762477465,1.0,1.0,1.0,53/218,11.34%,Arid1b;Kat6b;Ncor1;Kdm7a;Chd4;Chd3;Smarca2;Phf21a;Gatad2b;Arid5b;Trrap;Rbbp5;Elp2;Smyd2;Dot1l;Ncoa1;Smarca4;Ehmt1;Zzz3;Smarcd2;Actl6b;Kmt5a;Hdac8;Nsd1;Brwd1;Rbbp7;H2bc4;Tbl1xr1;Hdac1;Jade3;Suz12;Ash1l;Crebbp;Mta3;Rcor1;Taf5l;Setdb1;H2az1;Ncor2;Kat2a;Hcfc1;Eny2;Phf20;H2ac25;Ezh2;Morf4l2;Riox2;Kmt2d;Dr1;Kdm1a;Atxn7l3;Kat7;H2ac6
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.3858039409656858,0.7386884357436271,0.8566433566433567,1.0,1.0,2/62,3.04%,Prickle1;Vangl2
prerank,Base Excision Repair R-HSA-73884,-0.41134289580647176,-0.7377366088144304,0.8726752503576538,1.0,1.0,5/59,10.80%,Neil3;Lrig3;Pold4;Fen1;Lrig1
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.397654583065524,-0.7376004764706743,0.9038189533239038,1.0,1.0,13/96,7.99%,Kcnh8;Tlr7;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;S100b;Map3k1;Mef2a;Rps6ka1;App
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.397143200992331,-0.7371042133613721,0.9008498583569405,1.0,1.0,13/97,7.99%,Kcnh8;Tlr7;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;S100b;Map3k1;Mef2a;Rps6ka1;App
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.42420121841838376,-0.7367368110758511,0.8530670470756063,1.0,1.0,6/49,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Signaling By NODAL R-HSA-1181150,0.4377309664967517,0.7365407319189248,0.7815699658703071,1.0,1.0,5/20,4.82%,Acvr2a;Mapk1;Smad3;Acvr1c;Mapk3
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.4565275541770565,-0.7363287140899517,0.8526011560693642,1.0,1.0,6/24,16.84%,Dusp16;Mrc1;Tlr2;B2m;Ltf;Rnf213
prerank,Mitochondrial Biogenesis R-HSA-1592230,0.37274878060784455,0.7360311363814996,0.9087837837837838,1.0,1.0,8/73,3.59%,Prkag2;Ncor1;Calm1;Crtc1;Crtc3;Mef2c;Chchd3;Mef2d
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.41197267324904635,-0.735341735098316,0.8603667136812412,1.0,1.0,7/58,14.69%,Relb;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,0.3783613748448121,0.7351418719034805,0.9047619047619048,1.0,1.0,19/65,10.42%,Chd4;Chd3;Gatad2b;Mapk3;Gtf2h2;Ccnh;Gtf2h5;Rbbp7;H2bc4;Hdac1;Mta3;Polr2e;H2az1;Ubtf;Polr2f;Mnat1;Kat2a;Cbx3;Taf1c
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.45497288482201786,-0.7346763531493467,0.8371757925072046,1.0,1.0,7/26,20.21%,Cyld;Birc3;Tnfaip3;Otud7b;Chuk;Xiap;Ripk1
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.39767296021977677,-0.7346113779506526,0.903271692745377,1.0,1.0,13/95,7.99%,Kcnh8;Tlr7;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;S100b;Map3k1;Mef2a;Rps6ka1;App
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.4108738124134632,-0.7341181904157223,0.8953323903818954,1.0,1.0,11/61,11.67%,Abca1;Pcsk6;Lcat;Lipg;Apoe;Prkca;Mylip;Soat1;Ap2b1;Npc2;Ldlrap1
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.39406494973681544,-0.733999203378147,0.90625,1.0,1.0,13/100,7.99%,Kcnh8;Tlr7;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;S100b;Map3k1;Mef2a;Rps6ka1;App
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.4138354515615013,-0.7324213177821433,0.8695035460992908,1.0,1.0,7/58,14.69%,Ccnb1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.4334334630854439,-0.7321431247864664,0.8531073446327684,1.0,1.0,4/33,6.66%,Tbxas1;Arnt2;Cyp26b1;Cyp27a1
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.4065499722842943,-0.7267298889118744,0.8814285714285715,1.0,1.0,12/68,24.82%,Rbbp8;Wrn;Cdk2;Nsd2;Top3a;Brca1;Ubc;Dna2;Artn;Rmi1;Blm;Bard1
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.44601105649021733,-0.7264807829142083,0.8549931600547196,1.0,1.0,3/23,9.93%,Myo6;Tmod3;Msi2
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.34917758904360663,-0.7255182280189348,0.9772727272727273,1.0,1.0,27/252,16.33%,Rbbp8;Ywhaq;Ppp2r5a;Clasp2;Nde1;Ppp2r5c;Ccnb1;Wrn;Dync1li2;Cdk2;Nsd2;Dync1h1;Ndc80;Psmb8;Psmb11;Aurkb;Mcm10;Psme2;Psme4;Psma8;Ppp2r5e;Pafah1b1;Zwint;Psmb9;Bub1;Ndel1;Kif2c
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,0.39764526455629406,0.7252204625350305,0.8681672025723473,1.0,1.0,15/45,10.42%,Chd4;Chd3;Gatad2b;Gtf2h2;Ccnh;Gtf2h5;Rbbp7;Hdac1;Mta3;Polr2e;Ubtf;Polr2f;Mnat1;Kat2a;Taf1c
prerank,Mitotic Prometaphase R-HSA-68877,-0.3585796427684965,-0.7248565470738086,0.967828418230563,1.0,1.0,28/179,17.02%,Ccp110;Ppp2r5a;Tubb4a;Nedd1;Clasp2;Ncaph;Nde1;Prkca;Pmepa1;Ppp2r5c;Nek7;Ccnb1;Dync1li2;Nek2;Dync1h1;Ndc80;Aurkb;Plk4;Akap9;Cntrl;Cep43;Ppp2r5e;Pafah1b1;Zwint;Bub1;Ndel1;Kif2c;Cep192
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.4017905493941793,-0.7234735971625019,0.9071428571428571,1.0,1.0,17/73,32.74%,Nek2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Cdk1;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1
prerank,Nucleotide Catabolism R-HSA-8956319,0.4255537369252888,0.7229817661639641,0.8391608391608392,1.0,1.0,4/30,2.83%,Dpyd;Gda;Nt5c2;Upp2
prerank,Interleukin-17 Signaling R-HSA-448424,0.3750757986989258,0.7221176975796181,0.9206349206349206,1.0,1.0,11/68,3.30%,Map2k6;Mapk1;Map2k1;Tnip2;Btrc;Mapk10;Jun;Rps6ka2;Fbxw11;Mef2c;Ripk2
prerank,HIV Transcription Initiation R-HSA-167161,0.39203938034819424,0.721756232170777,0.8487972508591065,1.0,1.0,7/45,9.51%,Gtf2f2;Gtf2h2;Ccnh;Gtf2h5;Polr2e;Polr2f;Mnat1
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.40546545970358794,0.7196404104702181,0.8556701030927835,1.0,1.0,1/36,0.58%,Cyp7b1
prerank,Macroautophagy R-HSA-1632852,0.3375998924177351,0.7194574410610091,0.9575163398692811,1.0,1.0,15/110,9.08%,Prkag2;Dync1i2;Rragd;Nbr1;Src;Rb1cc1;Dync1i1;Dynll1;Pgam5;Park7;Uba52;Mfn2;Gabarapl1;Uvrag;Atm
prerank,Hedgehog Off State R-HSA-5610787,0.3533313688344626,0.7193846185264536,0.9539007092198581,1.0,1.0,4/97,2.60%,Adcy1;Adcy2;Adcy9;Btrc
prerank,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.4356189838027909,-0.7191176572731618,0.85273492286115,1.0,1.0,9/27,7.92%,Itgb5;Tgfb1;Ltbp1;Bmp7;Bmp4;Ltbp3;Fbln2;Fbln5;Itgb1
prerank,Chromosome Maintenance R-HSA-73886,-0.3788411930636257,-0.7183776274540007,0.9277286135693216,1.0,1.0,12/103,18.17%,Ankrd28;Hjurp;Pold4;Fen1;Wrn;Cdk2;Lrig1;Mis18a;Pif1;Dscc1;Prim2;Chtf8
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,0.3800578084735876,0.7179821975026505,0.8737201365187713,1.0,1.0,18/48,20.82%,Clns1a;Nup93;Ndc1;Ncbp1;Nup160;Ranbp2;Snrpd3;Gemin8;Nup155;Nup153;Snrpb;Nup210;Tpr;Nup62;Gemin5;Snrpg;Nup37;Lin9
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,0.3580571253131547,0.7179521480759915,0.9324324324324325,1.0,1.0,20/74,16.30%,Gtf2f2;Gtf2h2;Ccnh;Ssrp1;Gtf2h5;Ncbp1;Polr2e;Skic8;Polr2f;Mnat1;Ccnk;Ccnt2;Rtf1;Dmap1;Taf5;Elob;Cdc73;Polr2k;Cdk9;Polr2g
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.4076735452431546,-0.7160715629168151,0.8877980364656382,1.0,1.0,6/51,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.3800021596141198,-0.7155959831239568,0.9277777777777778,1.0,1.0,18/106,11.63%,Kcnh8;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;Irak3;Btk;S100b;Map3k1;Mef2a;Rps6ka1;App;Mapk8;Tlr1;Nod1;Tirap
prerank,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.43291134338603166,0.7137563122459595,0.7913669064748201,1.0,1.0,6/21,4.05%,Prkg1;Pde1b;Kcnma1;Gucy1b1;Itpr1;Kcnmb4
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.4028957273006114,-0.7135564115041761,0.8794835007173601,1.0,1.0,10/59,27.63%,Ccnd1;Cdk2;Psmb8;Psme2;Psmb9;Ubc;Ptk6;Psmd11;Cdkn1b;Psme1
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.4029061620926425,-0.7135167924439977,0.891583452211127,1.0,1.0,7/62,14.69%,Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,G2/M Transition R-HSA-69275,-0.35829853547865537,-0.7127256900784632,0.963265306122449,1.0,1.0,24/176,14.69%,Optn;Ccp110;Tubb4a;Nedd1;Phlda1;Nde1;Prkca;Cdc25b;Ccnb1;Cdk2;Nek2;Dync1h1;Psmb8;Psmb11;Plk4;Psme2;Akap9;Cntrl;Psme4;Cep43;Psma8;Pafah1b1;Lin54;Psmb9
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.42159450821489414,0.7127157220701814,0.8448275862068966,1.0,1.0,4/26,3.77%,Vav3;Akt3;Calm1;Arhgef7
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.3863248469996512,-0.7121574820660604,0.9293785310734464,1.0,1.0,13/90,7.99%,Kcnh8;Irak2;Casp8;Dusp6;Rps6ka5;Alpk1;Mapk11;S100b;Tlr5;Map3k1;Mef2a;Rps6ka1;App
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.3724518238703615,-0.7121489193173448,0.9556509298998569,1.0,1.0,12/124,7.60%,Itpr2;Nfatc1;Lyn;Nfatc2;Relb;Prkcd;Casp8;Rps6ka5;Fcer1g;Syk;Prkca;Itpr3
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.3884996506575401,-0.7112334507778234,0.9256559766763849,1.0,1.0,10/84,14.69%,E2f1;Ccnd1;Cdc25b;Myc;Cables1;Cdk2;Psmb8;Psme2;Lin54;Psmb9
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.3914015444825292,-0.710783234344496,0.9087018544935807,1.0,1.0,11/66,10.82%,Homer2;Tpd52;Ctsz;Ap1m2;Hip1r;Dtnbp1;App;Ap3s1;Sh3gl2;Picalm;Pik3c2a
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.39661934779031066,-0.7102731504049422,0.9106881405563689,1.0,1.0,21/73,36.56%,Psmb8;Psmb11;Aurkb;Psme2;Psme4;Psma8;Psmb9;Ubc;Psmd11;Anapc1;Psme1;Anapc5;Rb1;Psmc6;Anapc11;Anapc2;Psma1;Pttg1;Sem1;Fzr1;Anapc10
prerank,Regulation Of RAS By GAPs R-HSA-5658442,0.36992169536683595,0.7087307974480888,0.9285714285714286,1.0,1.0,3/65,4.34%,Rasal2;Spred2;Syngap1
prerank,Autophagy R-HSA-9612973,0.3326709874646136,0.7086708538512272,0.974910394265233,1.0,1.0,16/124,8.21%,Prkag2;Dync1i2;Rragd;Nbr1;Vps37b;Src;Hsp90ab1;Rb1cc1;Dync1i1;Dynll1;Eef1a1;Pgam5;Park7;Uba52;Mfn2;Gabarapl1
prerank,HDACs Deacetylate Histones R-HSA-3214815,0.38323284842753236,0.7078038534574846,0.8811881188118812,1.0,1.0,12/48,8.50%,Ncor1;Chd4;Chd3;Phf21a;Gatad2b;Hdac8;Rbbp7;H2bc4;Tbl1xr1;Hdac1;Mta3;Rcor1
prerank,Nuclear Import Of Rev Protein R-HSA-180746,0.3969340690197354,0.7054098106270024,0.8732876712328768,1.0,1.0,8/30,13.18%,Nup93;Ndc1;Npm1;Nup160;Ranbp2;Ran;Nup155;Nup153
prerank,RNA Polymerase I Transcription R-HSA-73864,0.3626914202495647,0.7038052156731335,0.9369085173501577,1.0,1.0,19/66,10.42%,Chd4;Chd3;Gatad2b;Mapk3;Gtf2h2;Ccnh;Gtf2h5;Rbbp7;H2bc4;Hdac1;Mta3;Polr2e;H2az1;Ubtf;Polr2f;Mnat1;Kat2a;Cbx3;Taf1c
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.3934849202519023,-0.7016822607691869,0.9056338028169014,1.0,1.0,7/64,14.69%,Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.3915105480084891,-0.7003669369275186,0.9179856115107914,1.0,1.0,19/72,36.56%,Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1;Sem1;Fzr1;Anapc10
prerank,Triglyceride Catabolism R-HSA-163560,-0.4441490630602119,-0.6994094027095336,0.885989010989011,1.0,1.0,5/18,13.98%,Prkca;Fabp7;Cav1;Abhd5;Plin3
prerank,DNA Replication R-HSA-69306,-0.35637081157555484,-0.6986459811491097,0.971830985915493,1.0,1.0,44/142,37.47%,Pold4;Fen1;Cdk2;Lrig1;Psmb8;Psmb11;Mcm10;Psme2;Psme4;Psma8;Psmb9;Cdt1;Prim2;Ubc;Dna2;Gins4;H2aj;Slc25a2;Psmd11;Anapc1;Mcm3;Psme1;Anapc5;H2bc3;H2ac4;Rfc2;Psmc6;H3c13;Pole4;H2bc11;Anapc11;Anapc2;Psma1;Gins3;Rfc4;H2bc9;Sem1;Slc19a1;Fzr1;Rfc3;Anapc10;Orc5;Dbf4;H3c7
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.43157104148046066,-0.6969778249523295,0.869684499314129,1.0,1.0,2/21,11.53%,Edem1;Uggt2
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.38649917102428466,0.6956272389632882,0.8707692307692307,1.0,1.0,5/36,7.23%,Arsb;Arsj;Dph5;Fn3krp;Tpst1
prerank,RHOH GTPase Cycle R-HSA-9013407,-0.40952086099037244,-0.6954051699670363,0.8914285714285715,1.0,1.0,9/34,17.24%,Rhoh;Slc1a5;Cav1;Arhgdib;Jup;Stom;Osbpl11;Pkn2;Arhgdig
prerank,Synthesis Of DNA R-HSA-69239,-0.36350373466316355,-0.6941591300125403,0.9540229885057471,1.0,1.0,35/119,37.16%,Pold4;Fen1;Cdk2;Lrig1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Cdt1;Prim2;Ubc;Dna2;Gins4;Slc25a2;Psmd11;Anapc1;Mcm3;Psme1;Anapc5;Rfc2;Psmc6;Pole4;Anapc11;Anapc2;Psma1;Gins3;Rfc4;Sem1;Slc19a1;Fzr1;Rfc3;Anapc10;Orc5
prerank,Elastic Fibre Formation R-HSA-1566948,-0.41463909500011664,-0.693769113267491,0.8994252873563219,1.0,1.0,9/37,7.92%,Itgb5;Tgfb1;Ltbp1;Bmp7;Bmp4;Ltbp3;Fbln2;Fbln5;Itgb1
prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.4357245143328422,-0.6936932153815327,0.8472032742155525,1.0,1.0,1/16,5.05%,Mapk11
prerank,HSF1 Activation R-HSA-3371511,0.3963251234332567,0.6932523332507862,0.8362369337979094,1.0,1.0,8/27,15.06%,Dnajb6;Hsp90ab1;Eef1a1;Ywhae;Hdac6;Ubb;Mrpl18;Fkbp4
prerank,DNA Strand Elongation R-HSA-69190,-0.4113309093286205,-0.6907749205918687,0.8911465892597968,1.0,1.0,12/31,36.38%,Pold4;Fen1;Lrig1;Prim2;Dna2;Gins4;Mcm3;Rfc2;Gins3;Rfc4;Slc19a1;Rfc3
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3685500814263188,-0.6906642492764212,0.9426573426573427,1.0,1.0,14/89,16.33%,Ppp2r5a;Clasp2;Nde1;Ppp2r5c;Dync1li2;Dync1h1;Ndc80;Aurkb;Ppp2r5e;Pafah1b1;Zwint;Bub1;Ndel1;Kif2c
prerank,S Phase R-HSA-69242,-0.34669996199397773,-0.6906150863229611,0.9816124469589816,1.0,1.0,19/161,15.63%,E2f1;Ccnd1;Cdc25b;Pmepa1;Pold4;Myc;Fen1;Cables1;Cdk2;Lrig1;Psmb8;Psmb11;Psme2;Psme4;Psma8;Esco2;Lin54;Psmb9;Cdt1
prerank,Protein Methylation R-HSA-8876725,0.42160336799611103,0.6893997033270484,0.8229166666666666,1.0,1.0,4/17,9.89%,Calm1;Eef1a1;Eef2;Vcpkmt
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.3867139330176642,-0.6875981522003778,0.9259796806966618,1.0,1.0,17/67,34.41%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1;Pttg1;Sem1
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.3841814206841326,-0.6868125904703103,0.923836389280677,1.0,1.0,12/71,20.00%,Smurf1;Esr1;Dlx5;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Nr3c1;Dlx6;Ubc
prerank,Interleukin-6 Family Signaling R-HSA-6783589,-0.4236710235663368,-0.6856511989795905,0.874820143884892,1.0,1.0,7/22,19.04%,Jak2;Il6st;Clcf1;Stat3;Il11;Ccm2;Osmr
prerank,cGMP Effects R-HSA-418457,-0.43661682086954196,-0.6842115642002016,0.876358695652174,1.0,1.0,6/15,6.75%,Pde11a;Pde1a;Pde5a;Prkg2;Pde2a;Pde10a
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.3995919351376784,0.684119547993622,0.8734177215189873,1.0,1.0,9/27,16.21%,Gtf3c1;Polr2e;Polr2f;Gtf3c2;Gtf3c4;Polr3f;Polr2k;Polr3e;Polr3gl
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,0.3999662072967497,0.6836641965116943,0.8267148014440433,1.0,1.0,1/21,0.76%,Add2
prerank,Stabilization Of P53 R-HSA-69541,-0.3879878022578168,-0.6806900752923435,0.9191489361702128,1.0,1.0,6/54,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Selective Autophagy R-HSA-9663891,0.35495753131136554,0.6798656824319499,0.9467455621301775,1.0,1.0,10/59,7.82%,Prkag2;Dync1i2;Nbr1;Src;Dync1i1;Dynll1;Pgam5;Park7;Uba52;Mfn2
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.40786159734048477,0.6777198127322164,0.8909774436090225,1.0,1.0,3/29,4.07%,Arsb;Lct;Galns
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3569584321191853,-0.6753775825073278,0.9551192145862553,1.0,1.0,16/102,16.33%,Ppp2r5a;Clasp2;Nde1;Pmepa1;Ppp2r5c;Ccnb1;Dync1li2;Dync1h1;Ndc80;Aurkb;Ppp2r5e;Pafah1b1;Zwint;Bub1;Ndel1;Kif2c
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.3752715241256975,-0.6753709089846007,0.9401709401709402,1.0,1.0,16/72,32.74%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Ubc;Cdk1;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.3855613372131861,-0.6739724927183217,0.9322033898305084,1.0,1.0,6/52,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.4258871546741672,-0.6733465940501298,0.8706896551724138,1.0,1.0,6/16,19.04%,Jak2;Il6st;Clcf1;Il11;Ccm2;Osmr
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.3922996014457705,-0.6721771474001595,0.9171428571428571,1.0,1.0,2/51,9.11%,Colec12;Rpp25
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.41553913891720345,0.6717579251823955,0.8482758620689655,1.0,1.0,7/17,11.72%,Smyd2;Ehmt1;Kmt5a;Uba52;Chek2;Atm;Ubb
prerank,Separation Of Sister Chromatids R-HSA-2467813,-0.33587209025942233,-0.6694855919942864,0.9890710382513661,1.0,1.0,21/166,16.33%,Ppp2r5a;Clasp2;Nde1;Pmepa1;Ppp2r5c;Dync1li2;Dync1h1;Ndc80;Psmb8;Psmb11;Aurkb;Psme2;Psme4;Psma8;Ppp2r5e;Pafah1b1;Zwint;Psmb9;Bub1;Ndel1;Kif2c
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.3784598054660657,0.6679118710099794,0.9166666666666666,1.0,1.0,9/32,13.18%,Nup93;Xpo1;Ndc1;Nup160;Ranbp2;Gnl3;Ran;Nup155;Nup153
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.3784975000257338,-0.6669826785016089,0.9372325249643366,1.0,1.0,8/58,14.69%,Prkca;Psmb8;Psmb11;Gli2;Psme2;Psme4;Psma8;Psmb9
prerank,EGFR Downregulation R-HSA-182971,0.3836284352799089,0.6662958494469182,0.8846153846153846,1.0,1.0,5/30,3.94%,Ptpn3;Tgfa;Ptprk;Arhgef7;Sh3gl1
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.3566352331406366,0.6659563684524803,0.9292929292929293,1.0,1.0,1/54,1.34%,Fbxl7
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.3731043693310014,0.66507836080624,0.9163763066202091,1.0,1.0,7/31,13.18%,Nup93;Ndc1;Sumo2;Nup160;Ranbp2;Nup155;Nup153
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.41539462769638696,-0.6647872928316317,0.8903133903133903,1.0,1.0,7/21,33.89%,Mfn1;Ubc;Mterf3;Tomm6;Tomm40;Tomm7;Pink1
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.42422129038220535,-0.6621754744177147,0.8982808022922636,1.0,1.0,5/18,19.59%,Irak2;Mapk8;Nod1;Nod2;Ube2v1
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.33501608621981444,0.6621558399282496,0.9574468085106383,1.0,1.0,10/71,8.15%,Hdac7;Rad52;Parp1;Herc2;Nup93;Ndc1;Sumo2;Cbx4;Nup160;Ranbp2
prerank,Circadian Clock R-HSA-400253,-0.3731597461983107,-0.660382223343695,0.9380403458213257,1.0,1.0,4/65,5.28%,Tbl1x;Npas2;Nrip1;Smarcd3
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.3796849090706377,-0.6600021717013248,0.9217877094972067,1.0,1.0,6/48,20.00%,Rnf152;Rnf144a;Bcl10;Prkdc;Pex13;Ubc
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.360446801418765,-0.6594744992687737,0.959479015918958,1.0,1.0,9/82,14.69%,E2f1;Ccnd1;Myc;Cables1;Cdk2;Psmb8;Psme2;Lin54;Psmb9
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,0.3694853219143471,0.6588022406012947,0.930379746835443,1.0,1.0,6/43,6.76%,Arid1b;Smarca2;Smarca4;Smarcd2;Actl6b;Rbbp7
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.36665889752596653,0.6545082101737753,0.9084507042253521,1.0,1.0,8/31,13.18%,Nup93;Ndc1;Ncbp1;Nup160;Ranbp2;Eif4e;Nup155;Nup153
prerank,mRNA 3-End Processing R-HSA-72187,0.3421096179548436,0.652811464441525,0.9573770491803278,1.0,1.0,12/58,10.93%,Cdc40;Srsf11;Thoc2;Srsf9;Cstf3;Nudt21;Ncbp1;Fyttd1;Srsf1;Cpsf2;Cstf2t;Papola
prerank,Intraflagellar Transport R-HSA-5620924,0.36880523320127395,0.6524710106366348,0.9450171821305842,1.0,1.0,15/39,14.38%,Dync2h1;Cluap1;Ift57;Dynll1;Ttc26;Hspb11;Ift122;Wdr35;Tnpo1;Ift74;Wdr19;Dync2li1;Ift22;Kif17;Ift80
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,0.37662660957380756,0.6520125158265137,0.8971061093247589,1.0,1.0,8/27,7.05%,B4galt5;Chst1;B4galt1;St3gal1;B3gnt2;Ogn;B4galt6;B4galt4
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.36980688322399724,0.6516938548224175,0.9010989010989011,1.0,1.0,7/26,12.82%,Nup93;Ndc1;Ahctf1;Nup160;Tnpo1;Ran;Nup155
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.34918125313327636,0.6515750437301654,0.928082191780822,1.0,1.0,17/42,18.48%,Nup93;Ndc1;Sumo2;Cbx4;Nop58;Nup160;Ranbp2;Nup155;Hnrnpk;Nup153;Hnrnpc;Nup210;Phc2;Rnf2;Tpr;Cbx2;Nup62
prerank,Oncogene Induced Senescence R-HSA-2559585,-0.39188229807221214,-0.6504026685420728,0.9150805270863837,1.0,1.0,2/32,4.04%,Ets1;E2f1
prerank,Degradation Of AXIN R-HSA-4641257,-0.3662995254488004,-0.646625934675059,0.9468531468531468,1.0,1.0,6/54,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.3875196682390363,-0.646582226019275,0.9287790697674418,1.0,1.0,15/37,20.74%,Trim25;Esr1;Traf3;Ifih1;Rigi;Rnf135;Tnfaip3;Nod1;Otud7b;Tnip3;Nod2;Tnip1;Ubc;Ripk1;Mavs
prerank,Selenoamino Acid Metabolism R-HSA-2408522,0.3101824566417512,0.6439823427603567,0.9826388888888888,1.0,1.0,38/99,14.89%,Txnrd1;Rplp1;Rpl15;Rpl6;Uba52;Rps21;Rpl18;Secisbp2;Rps7;Rpl31;Rps15a;Rpl9;Rpl35a;Rpl7;Rps14;Rps17;Rps9;Rpl4;Rps28;Rplp2;Rpl3;Rpl13a;Rps20;Rpl27;Sephs2;Rpl36a;Rps3;Rpl34;Rpl5;Rps15;Rpl23;Rpl8;Rplp0;Rps8;Rps29;Rpl12;Rsl24d1;Rps12
prerank,Phosphorylation Of APC/C R-HSA-176412,-0.39885754647150434,-0.6438942683882657,0.8972602739726028,1.0,1.0,7/20,36.56%,Ccnb1;Cdk1;Anapc1;Anapc5;Anapc11;Anapc2;Anapc10
prerank,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.4048775223064825,-0.6422872902608846,0.898876404494382,1.0,1.0,6/16,31.89%,Pi4k2b;Pik3c2a;Inpp5e;Sacm1l;Pik3c3;Vac14
prerank,Fertilization R-HSA-1187000,-0.39902201134020127,-0.6415456633504147,0.8979885057471264,1.0,1.0,3/18,15.95%,Cd9;Izumo4;Hvcn1
prerank,tRNA Processing R-HSA-72306,-0.34829320226950594,-0.6411463680127785,0.9763560500695411,1.0,1.0,3/96,9.11%,Colec12;Trmt9b;Rpp25
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.3394915488668324,-0.6411356367577136,0.9813486370157819,1.0,1.0,14/106,16.33%,Ppp2r5a;Clasp2;Nde1;Ppp2r5c;Dync1li2;Dync1h1;Ndc80;Aurkb;Ppp2r5e;Pafah1b1;Zwint;Bub1;Ndel1;Kif2c
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.3976035084614262,-0.6386056887344241,0.9113924050632911,1.0,1.0,4/21,28.93%,Idh2;Ldlr;Cs;Ldhd
prerank,Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.3847732392454407,0.6375405417168308,0.861003861003861,1.0,1.0,2/21,3.11%,Napepld;Stra6
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.3762488812083171,-0.637369092894653,0.941747572815534,1.0,1.0,2/40,4.02%,Hipk2;Nrip1
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.3540980277177477,0.6356377469580566,0.9305555555555556,1.0,1.0,5/32,8.15%,Nek6;Nup93;Ndc1;Nup160;Ranbp2
prerank,Mitochondrial Protein Import R-HSA-1268020,-0.3587645270689474,-0.6348077887862552,0.9563318777292577,1.0,1.0,1/59,2.97%,Slc25a13
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.3355954940750015,0.6339353093317373,0.9515570934256056,1.0,1.0,15/50,17.53%,Gtf2h2;Ccnh;Gtf2h5;Uba52;Polr2e;Polr2f;Mnat1;Ubb;Rbx1;Ercc8;Ppie;Polr2k;Polr2g;Usp7;Gps1
prerank,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.3877490886495337,0.6319503213603899,0.890625,1.0,1.0,5/16,11.63%,Ywhab;Dcp1a;Exosc8;Tnpo1;Exosc2
prerank,Fanconi Anemia Pathway R-HSA-6783310,-0.37402206591434184,-0.6297507903950531,0.937950937950938,1.0,1.0,4/35,22.23%,Fancc;Eme1;Ubc;Fancd2
prerank,Calnexin/calreticulin Cycle R-HSA-901042,-0.38168285840849103,-0.6265273028326637,0.914804469273743,1.0,1.0,2/26,11.53%,Edem1;Uggt2
prerank,Attenuation Phase R-HSA-3371568,0.36306852437637055,0.6241164525013907,0.9075342465753424,1.0,1.0,4/24,8.03%,Hspa2;Dnajb6;Hsp90ab1;Crebbp
prerank,Orc1 Removal From Chromatin R-HSA-68949,-0.3466436745043524,-0.622116648018627,0.9667149059334298,1.0,1.0,12/69,25.25%,Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Cdt1;Ubc;Slc25a2;Psmd11;Mcm3
prerank,G1/S Transition R-HSA-69206,-0.3221460298503422,-0.6218258356569633,0.9941944847605225,1.0,1.0,24/127,26.27%,E2f1;Ccnd1;Myc;Ccnb1;Cables1;Cdk2;Psmb8;Mcm10;Psme2;Lin54;Psmb9;E2f6;Cdt1;Prim2;Ubc;Ptk6;Lin52;Cdk1;Slc25a2;Psmd11;Mcm3;Tyms;Rrm2;Cdkn1b
prerank,Ephrin Signaling R-HSA-3928664,0.3729550319041497,0.6175957146164985,0.8943089430894309,1.0,1.0,7/18,6.19%,Nck2;Arhgef7;Fyn;Src;Efnb3;Sdcbp;Ephb2
prerank,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.3717810422243474,-0.6135067378581356,0.9396067415730337,1.0,1.0,13/30,33.90%,Ccnb1;Smc4;H2aj;Rab33b;Phf8;Cdk1;Rb1;H2bc3;H2ac4;H3c13;Ncapg2;H2bc11;H2bc9
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.32126945797316975,0.6112878129836664,0.9801324503311258,1.0,1.0,7/66,7.50%,Mapk1;Jun;Rps6ka2;Mapk3;Ehmt1;H2bc4;Uba52
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.3425879497783947,0.610273830343466,0.9435736677115988,1.0,1.0,8/32,7.05%,B4galt5;Chst1;B4galt1;St3gal1;B3gnt2;Ogn;B4galt6;B4galt4
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.33997998882133557,-0.6102287864152903,0.9801980198019802,1.0,1.0,7/62,20.00%,Lrig3;Pold4;Lrig1;Cul4a;Ep300;Polk;Ubc
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.3361279869486635,0.6095147237441422,0.9575163398692811,1.0,1.0,10/34,16.30%,Atrx;H2bc4;Polr2e;H2az1;Polr2f;H2ac6;Terf2ip;H2bc21;Polr2k;Polr2g
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.3696587926072159,-0.6075647851702204,0.9222065063649222,1.0,1.0,7/24,32.08%,Ccnb1;Ubc;Cdk1;Anapc1;Anapc5;Anapc11;Anapc2
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.3400355931270826,0.6062969134312619,0.9584775086505191,1.0,1.0,7/31,13.18%,Nup93;Ndc1;Nup160;Ranbp2;Gnl3;Nup155;Nup153
prerank,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.38206362152164475,-0.6027693439446411,0.9164383561643835,1.0,1.0,3/15,30.27%,Gale;Gfpt1;Dolk
prerank,HATs Acetylate Histones R-HSA-3214847,0.2917084384243197,0.6005713483755853,0.9969604863221885,1.0,1.0,20/92,11.34%,Kat6b;Trrap;Elp2;Ncoa1;Zzz3;Rbbp7;H2bc4;Jade3;Crebbp;Taf5l;Kat2a;Hcfc1;Eny2;Phf20;H2ac25;Morf4l2;Dr1;Atxn7l3;Kat7;H2ac6
prerank,Negative Regulation Of MET Activity R-HSA-6807004,-0.374353396551396,-0.5993475623449185,0.9254571026722925,1.0,1.0,5/21,11.43%,Eps15;Stam2;Sh3gl2;Lrig1;Ptpn1
prerank,Nucleotide Salvage R-HSA-8956321,-0.377834889757892,-0.5957433458636404,0.9407616361071932,1.0,1.0,3/21,12.11%,Ampd3;Cda;Ada
prerank,HCMV Late Events R-HSA-9610379,-0.32883797791772174,-0.592657365691574,0.9859943977591037,1.0,1.0,1/74,2.66%,Pcsk1
prerank,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.3763566818616251,-0.5899819424106595,0.9357923497267759,1.0,1.0,2/16,17.93%,Zfp36l1;Exosc5
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,0.34607956358650693,0.5847908603910551,0.9742647058823529,1.0,1.0,8/28,9.41%,Atp6v1a;Steap3;Atp6v0c;Atp6v0e2;Atp6v1d;Atp6v0a1;Atp6v0a4;Atp6v1c2
prerank,Digestion And Absorption R-HSA-8963743,-0.37360283144555234,-0.583129566058914,0.943502824858757,1.0,1.0,8/17,23.69%,Slc2a5;Gucy2c;Pir;Mgam;Pnlip;Pmel;Slc5a1;Chit1
prerank,RHO GTPases Activate PKNs R-HSA-5625740,0.32034238323224945,0.5819363692650832,0.9851301115241635,1.0,1.0,9/49,9.46%,Ppp1r12b;Ppp1cb;Ywhaz;Ywhab;H2bc4;Ywhae;Ywhah;H2az1;Pdpk1
prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.3277821996294513,0.5809642607420338,0.9554794520547946,1.0,1.0,9/41,11.34%,Cenpp;Rsf1;Rbbp7;H2bc4;Npm1;H2az1;Smarca5;Cenpm;H2ac6
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.3445008061931859,-0.5800078386790715,0.9597222222222223,1.0,1.0,2/39,14.67%,Trmt9b;Nsun6
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.3444001921467812,-0.5781093572555406,0.9678770949720671,1.0,1.0,2/35,11.53%,Edem1;Uggt2
prerank,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.3573866800183209,-0.5765999866750372,0.9330601092896175,1.0,1.0,8/17,42.48%,Piga;Pigz;Pign;Pigm;Pigp;Pigv;Pigc;Pigq
prerank,Metabolism Of Cofactors R-HSA-8978934,-0.36070604773624343,-0.5749476622337083,0.9431818181818182,1.0,1.0,1/19,3.76%,Prkg2
prerank,Influenza Infection R-HSA-168255,-0.29446518905635666,-0.5742112341207751,1.0,1.0,1.0,2/146,5.64%,Tgfb1;Eif2ak2
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.31852806024786984,0.5734682582624137,0.9655172413793104,1.0,1.0,8/32,13.18%,Nup93;Ndc1;Ncbp1;Nup160;Ranbp2;Eif4e;Nup155;Nup153
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.31585795590821075,-0.5718821960838398,0.9914040114613181,1.0,1.0,8/80,14.69%,Ccnb1;Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.3439750063972343,-0.5703940847678843,0.9682080924855492,1.0,1.0,9/29,33.90%,Neil3;H2aj;Nthl1;Tdg;H2bc3;H2ac4;Neil2;H2bc11;H2bc9
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.3579706606241372,-0.5687155712157816,0.9628040057224606,1.0,1.0,1/20,3.43%,Dusp16
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.34890377589548194,-0.5682544371255116,0.9534246575342465,1.0,1.0,4/20,28.99%,Abcd1;Pex13;Pxmp2;Pxmp4
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.29996833815695473,-0.5666675186303253,0.9986168741355463,1.0,1.0,15/93,16.33%,Ppp2r5a;Clasp2;Nde1;Ppp2r5c;Nek7;Dync1li2;Dync1h1;Ndc80;Aurkb;Ppp2r5e;Pafah1b1;Zwint;Bub1;Ndel1;Kif2c
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.3076281564196572,0.5533139036859378,0.9849056603773585,1.0,1.0,10/38,14.80%,Nup93;Ndc1;Ncbp1;Nup160;Ranbp2;Cpsf2;Eif4e;Nup155;Nup153;Wdr33
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.3081860521120521,0.5485637405473891,0.974910394265233,1.0,1.0,8/35,13.96%,Nup93;Ndc1;Nup160;Ranbp2;Vhl;Nup155;Nup153;Pias1
prerank,Iron Uptake And Transport R-HSA-917937,0.2922098845292294,0.5472163773306163,0.993006993006993,1.0,1.0,13/54,9.41%,Atp6v1a;Steap3;Atp6v0c;Atp6v0e2;Flvcr1;Slc22a17;Atp6v1d;Atp6v0a1;Uba52;Cul1;Fth1;Atp6v0a4;Atp6v1c2
prerank,Activation Of Pre-Replicative Complex R-HSA-68962,-0.331783824173407,-0.5469642392672873,0.9755395683453237,1.0,1.0,6/31,25.25%,Cdk2;Mcm10;Cdt1;Prim2;Slc25a2;Mcm3
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.31122527504672204,-0.5450209276707306,0.99002849002849,1.0,1.0,4/51,14.69%,Nfe2l2;Psmb8;Psme2;Psmb9
prerank,Cleavage Of Damaged Purine R-HSA-110331,-0.330793181535811,-0.5438997322472403,0.9676511954992968,1.0,1.0,1/24,6.90%,Neil3
prerank,Translesion Synthesis By REV1 R-HSA-110312,0.3291617920720877,0.5428745131179558,0.9588607594936709,1.0,1.0,3/16,11.72%,Rev1;Uba52;Ubb
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.310017443579187,-0.5418748943533721,0.9899569583931134,1.0,1.0,6/51,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.2825492905956816,-0.5388596755642667,1.0,1.0,1.0,33/114,38.97%,Cdk2;Psmb8;Mcm10;Psme2;Psmb9;Cdt1;Prim2;Ubc;H2aj;Slc25a2;Psmd11;Anapc1;Mcm3;Psme1;Anapc5;H2bc3;H2ac4;Psmc6;H3c13;Pole4;H2bc11;Anapc11;Anapc2;Psma1;H2bc9;Sem1;Fzr1;Anapc10;Orc5;Dbf4;H3c7;Psmd12;Mcm8
prerank,Translesion Synthesis By POLI R-HSA-5656121,0.3286327820650327,0.5375509634942612,0.964516129032258,1.0,1.0,3/17,11.72%,Rev1;Uba52;Ubb
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.29413941718536835,-0.5371862191658835,1.0,1.0,1.0,19/90,32.74%,Cdk2;Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9;Cdt1;Ubc;Slc25a2;Psmd11;Anapc1;Mcm3;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.3057630711097168,-0.5358181865816698,0.9928774928774928,1.0,1.0,6/54,14.69%,Psmb8;Psmb11;Psme2;Psme4;Psma8;Psmb9
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.301827328058967,-0.5340458950577872,0.9956204379562044,1.0,1.0,15/63,36.56%,Psmb8;Psme2;Psmb9;Ubc;Psmd11;Anapc1;Psme1;Anapc5;Psmc6;Anapc11;Anapc2;Psma1;Sem1;Fzr1;Anapc10
prerank,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.32064602106074447,-0.5330745796699212,0.9854651162790697,1.0,1.0,9/31,33.90%,Neil3;H2aj;Nthl1;Tdg;H2bc3;H2ac4;Neil2;H2bc11;H2bc9
prerank,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.33892261879675395,-0.5329360416439983,0.9568151147098516,1.0,1.0,4/15,33.76%,Dnmt3a;Pcgf2;Ring1;Scmh1
prerank,PRC2 Methylates Histones And DNA R-HSA-212300,-0.32124834185181383,-0.5316109978761443,0.9792243767313019,1.0,1.0,9/30,31.11%,Phf1;Phf19;Dnmt3a;H2aj;Jarid2;H2bc3;H2ac4;H3c13;H2bc11
prerank,Mitochondrial Translation Initiation R-HSA-5368286,0.2595820686777897,0.5259658741228767,1.0,1.0,1.0,37/82,25.70%,Mrps26;Mrps22;Mrpl58;Mrpl33;Mtif2;Mrpl21;Mrpl23;Ptcd3;Mrps15;Mrpl16;Mrpl45;Mrpl18;Mrpl41;Mrpl9;Mrpl50;Mrpl30;Mrpl1;Mrpl34;Gadd45gip1;Mrpl3;Mrpl39;Mrps17;Mrpl37;Mrpl57;Mrpl55;Mrpl32;Dlgap3;Mrpl51;Mrpl13;Mrps9;Mrps21;Mrpl10;Mrps16;Mrpl17;Mrps31;Mrpl44;Mrpl46
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,-0.2912437846163207,-0.5210335697791925,0.995702005730659,1.0,1.0,3/66,11.42%,Colec12;Lsm11;Srsf5
prerank,RNA Polymerase I Promoter Opening R-HSA-73728,0.3133349190690505,0.5182173759545416,0.975,1.0,1.0,5/20,11.34%,Mapk3;H2bc4;H2az1;Ubtf;H2ac6
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.30335047848400054,-0.5062349016512678,0.986013986013986,1.0,1.0,9/30,37.87%,Pold4;Cul4a;Ubc;Rfc2;Pole4;Rfc4;Slc19a1;Rfc3;Dtl
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.3138001733628149,-0.5059400079450176,0.9829059829059829,1.0,1.0,3/28,17.73%,Map4k2;Map4k5;Pom121
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.29171605006267265,-0.5049582864630703,0.994579945799458,1.0,1.0,12/52,29.55%,Slc16a1;Idh2;Ldhb;Pdk4;Ldlr;Ppard;Ldha;Adhfe1;Ldhc;Cs;Ldhd;Slc16a8
prerank,Protein Ubiquitination R-HSA-8852135,0.2581715112696068,0.5031964113696447,1.0,1.0,1.0,21/68,12.92%,Ube2w;Shprh;Ube2e3;Ube2q2;Ube2g2;H2bc4;Uba52;Ube2r2;Ube2k;Rad18;Uchl3;Ube2b;Skic8;Derl1;Rtf1;Ubb;Ube2d3;Wac;Ube2d1;Ube2h;Ube2t
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.3030182875434131,-0.5031668357238301,0.9817671809256662,1.0,1.0,6/26,32.08%,Nek2;Ubc;Anapc1;Anapc5;Anapc11;Anapc2
prerank,Mitophagy R-HSA-5205647,-0.3070958916409937,-0.501031349495325,0.9774011299435028,1.0,1.0,1/27,5.01%,Mfn1
prerank,Mitochondrial Translation Termination R-HSA-5419276,0.24343201502257894,0.4971217064364658,1.0,1.0,1.0,36/82,25.70%,Mrps26;Mrps22;Mrpl58;Mrpl33;Mrpl21;Mrpl23;Ptcd3;Mrps15;Mrpl16;Mrpl45;Mrpl18;Mrpl41;Mrpl9;Mrpl50;Mrpl30;Mrpl1;Mrpl34;Gadd45gip1;Mrpl3;Mrpl39;Mrps17;Mrpl37;Mrpl57;Mrpl55;Mrpl32;Dlgap3;Mrpl51;Mrpl13;Mrps9;Mrps21;Mrpl10;Mrps16;Mrpl17;Mrps31;Mrpl44;Mrpl46
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.27185613053544666,0.4945708007614457,0.9962825278810409,1.0,1.0,9/39,13.18%,Nup93;Ndc1;Ncbp1;Nup160;Ranbp2;Cpsf2;Eif4e;Nup155;Nup153
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.27004624245055603,-0.494209828852729,1.0,1.0,1.0,7/75,20.00%,Lrig3;Pold4;Lrig1;Cul4a;Ep300;Polk;Ubc
prerank,DNA Methylation R-HSA-5334118,-0.30460626050982964,-0.49143141857090444,0.9862637362637363,1.0,1.0,9/22,37.47%,Dnmt3a;H2aj;H2bc3;H2ac4;H3c13;H2bc11;Dnmt3l;H2bc9;H3c7
prerank,Dual Incision In GG-NER R-HSA-5696400,0.2648487652291395,0.48707057607338783,0.9931506849315068,1.0,1.0,5/41,7.50%,Ercc4;Parp1;Gtf2h2;Gtf2h5;Uba52
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.28971263574998984,-0.48504917658431745,0.9887482419127989,1.0,1.0,1/37,5.64%,Eif2ak2
prerank,Mitochondrial Translation R-HSA-5368287,0.2319355124088699,0.4774351013748336,1.0,1.0,1.0,37/88,25.70%,Mrps26;Mrps22;Mrpl58;Mrpl33;Mtif2;Mrpl21;Mrpl23;Ptcd3;Mrps15;Mrpl16;Mrpl45;Mrpl18;Mrpl41;Mrpl9;Mrpl50;Mrpl30;Mrpl1;Mrpl34;Gadd45gip1;Mrpl3;Mrpl39;Mrps17;Mrpl37;Mrpl57;Mrpl55;Mrpl32;Dlgap3;Mrpl51;Mrpl13;Mrps9;Mrps21;Mrpl10;Mrps16;Mrpl17;Mrps31;Mrpl44;Mrpl46
prerank,IRE1alpha Activates Chaperones R-HSA-381070,-0.27556934828327684,-0.4763069512796443,0.9986013986013986,1.0,1.0,9/47,26.27%,Edem1;Cul7;Shc1;Wfs1;Tln1;Dnajb11;Kdelr3;Atp6v0d1;Gfpt1
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.2773053656120284,-0.474705667349785,1.0,1.0,1.0,9/45,26.27%,Edem1;Cul7;Shc1;Wfs1;Tln1;Dnajb11;Kdelr3;Atp6v0d1;Gfpt1
prerank,Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,0.28833309397575646,0.47409315043422773,0.9767441860465116,1.0,1.0,4/15,9.46%,Pdhb;Gstz1;Pdk3;Pdpk1
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.2898201983576004,-0.466071072035211,0.9874125874125874,1.0,1.0,7/20,36.56%,Anapc1;Anapc5;Rb1;Anapc11;Anapc2;Fzr1;Anapc10
prerank,Mitochondrial Translation Elongation R-HSA-5389840,0.2266737696656641,0.4660592117762509,1.0,1.0,1.0,36/82,25.70%,Mrps26;Mrps22;Mrpl58;Mrpl33;Mrpl21;Mrpl23;Ptcd3;Mrps15;Mrpl16;Mrpl45;Mrpl18;Mrpl41;Mrpl9;Mrpl50;Mrpl30;Mrpl1;Mrpl34;Gadd45gip1;Mrpl3;Mrpl39;Mrps17;Mrpl37;Mrpl57;Mrpl55;Mrpl32;Dlgap3;Mrpl51;Mrpl13;Mrps9;Mrps21;Mrpl10;Mrps16;Mrpl17;Mrps31;Mrpl44;Mrpl46
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.2517612528317906,0.4631160493268243,0.993127147766323,1.0,1.0,5/40,9.08%,Rad50;Babam2;Herc2;H2bc4;Atm
prerank,Dual Incision In TC-NER R-HSA-6782135,0.23615953567622172,0.45424043278905407,1.0,1.0,1.0,16/63,16.30%,Ercc4;Gtf2h2;Ccnh;Gtf2h5;Uba52;Polr2e;Polr2f;Mnat1;Ubb;Pold3;Rbx1;Ercc8;Ppie;Polr2k;Rfc5;Polr2g
prerank,Translesion Synthesis By POLK R-HSA-5655862,0.26787373747902116,0.4452170424219736,0.9876160990712074,1.0,1.0,2/17,7.50%,Rev1;Uba52
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.23850363021809437,0.4415600434304137,0.9967532467532467,1.0,1.0,5/40,9.08%,Rad50;Hira;H2bc4;H2az1;Atm
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.2613695497696753,-0.4308534936827358,1.0,1.0,1.0,3/29,16.55%,Dhtkd1;Bckdhb;Agxt2
prerank,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.2527058018311223,0.423888324570033,1.0,1.0,1.0,5/26,11.34%,Orc3;H2bc4;Orc6;H2az1;H2ac6
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.2173512336774423,-0.42248819058582154,1.0,1.0,1.0,19/146,29.55%,Slc16a1;Ndufaf2;Coq10b;Cox16;Idh2;Ucp3;Ldhb;Pdk4;Ldlr;Ppard;Slc25a27;Ldha;Adhfe1;Nubpl;Ldhc;Pm20d1;Cs;Ldhd;Slc16a8
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.2404989111167304,-0.42120792024146075,0.9971387696709585,1.0,1.0,11/53,34.41%,Psmb8;Psme2;Tacc3;Psmb9;Ubc;Psmd11;Psme1;Psmc6;Psma1;Notch4;Sem1
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.2517412194122685,0.42100379909126784,0.9927007299270073,1.0,1.0,21/21,74.85%,Cdc26;Ube2d1;Cdc23;Anapc7;Bub3;Ube2e1;Bub1b;Cdc16;Cdc20;Ube2c;Anapc16;Cdc27;Ube2s;Anapc15;Anapc4;Mad2l1;Anapc10;Anapc2;Anapc11;Anapc5;Anapc1
prerank,Complex I Biogenesis R-HSA-6799198,0.22391424440621693,0.42017705838709535,1.0,1.0,1.0,21/50,24.73%,Ndufs3;Ndufv3;Ndufb4;Ndufb10;Ndufs4;Ndufb7;Ecsit;Ndufaf4;Ndufaf5;Ndufb1;Ndufs5;Ndufa5;Ndufa8;Acad9;Ndufb5;Ndufs8;Ndufc2;Ndufa10;Ndufaf1;Ndufs1;Ndufc1
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.22527076656261302,-0.4185312623173217,1.0,1.0,1.0,28/98,38.97%,Psmb8;Psme2;Psmb9;Cdt1;Ubc;H2aj;Slc25a2;Psmd11;Anapc1;Mcm3;Psme1;Anapc5;H2bc3;H2ac4;Psmc6;H3c13;H2bc11;Anapc11;Anapc2;Psma1;H2bc9;Sem1;Fzr1;Anapc10;Orc5;H3c7;Psmd12;Mcm8
prerank,Pyruvate Metabolism R-HSA-70268,-0.2548312569852472,-0.4169807764725547,0.9972972972972973,1.0,1.0,8/29,29.55%,Slc16a1;Ldhb;Pdk4;Ppard;Ldha;Ldhc;Ldhd;Slc16a8
prerank,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.24214079245019177,-0.40580943496890454,1.0,1.0,1.0,12/35,38.97%,Cdk2;Mcm10;Slc25a2;Mcm3;Rrad;Cdc25c;Rfc2;Rfc4;Rfc3;Orc5;Dbf4;Mcm8
prerank,Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.24685113246778662,-0.4029154215526574,0.995850622406639,1.0,1.0,11/23,42.42%,H2aj;H2bc3;H2ac4;H3c13;H2bc11;Pkn1;H2bc9;Areg;H3c7;Kdm4c;H2ac7
prerank,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.23330229092940963,0.39773437608616535,0.9967845659163987,1.0,1.0,25/25,76.69%,H2bc4;H2az1;Taf1c;H2ac6;H2bc21;H2ax;H2ac20;Tbp;H2az2;Taf1a;H2bc14;H2bc15;Rrp8;Sirt1;Taf1d;Taf1b;Suv39h1;H2ac7;H3c7;H2bc9;H2bc11;H3c13;H2ac4;H2bc3;H2aj
prerank,Packaging Of Telomere Ends R-HSA-171306,0.23325884543761663,0.38840021143743725,1.0,1.0,1.0,20/20,76.69%,H2bc4;H2az1;H2ac6;Terf2ip;H2bc21;H2ax;H2ac20;Tinf2;H2az2;Acd;H2bc14;H2bc15;Terf2;H2ac7;Terf1;H2bc9;H2bc11;H2ac4;H2bc3;H2aj
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,0.20289418261297335,0.36626726728418335,1.0,1.0,1.0,9/36,19.41%,Parp1;Uba52;Ubb;Rbx1;Ruvbl1;Ino80;Gps1;Nfrkb;Tfpt
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.22143056418721452,-0.3658298242923753,0.9986091794158554,1.0,1.0,5/29,30.89%,Stam2;Ubc;Mvb12a;Vps37c;Vta1
prerank,Respiratory Electron Transport R-HSA-611105,-0.19917842681728642,-0.3657259862259019,1.0,1.0,1.0,3/89,12.95%,Ndufaf2;Coq10b;Cox16
prerank,Nucleotide Excision Repair R-HSA-5696398,-0.1905986483928575,-0.3635069461028754,1.0,1.0,1.0,7/105,20.00%,Lrig3;Pold4;Lrig1;Cul4a;Ep300;Polk;Ubc
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.1966258227725636,-0.3593140066434447,1.0,1.0,1.0,6/81,20.00%,Lrig3;Pold4;Lrig1;Cul4a;Polk;Ubc
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.1933595354199657,-0.35838265383226925,1.0,1.0,1.0,5/97,19.11%,Ndufaf2;Coq10b;Cox16;Ucp3;Slc25a27
prerank,Defective Pyroptosis R-HSA-9710421,0.20414911954762904,0.35136441217522685,1.0,1.0,1.0,6/30,11.34%,Rbbp7;H2bc4;Suz12;H2az1;Ezh2;H2ac6
prerank,Translesion Synthesis By POLH R-HSA-110320,-0.21442458507006162,-0.34187649697440065,0.9985855728429985,0.999683766515107,1.0,7/19,40.99%,Ubc;Rfc2;Polh;Rfc4;Slc19a1;Rfc3;Ufd1
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.19023301720798869,0.33944380942867514,1.0,0.9993959032949603,1.0,8/41,13.18%,Nup93;Ndc1;Sumo2;Nup160;Ranbp2;Top1;Nup155;Nup153
